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“When nothing seems to help, I go look at a stonecuter
hammering away at his rock, perhaps a hundred times
without as much as a crack showing in it. Yet at the
hundred and first blow it wil split in two, and I know it
was not that blow that did it, but al that had gone before.”
Jacob A. Ris
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Abstract
Stroke is a loss of brain function caused by a disturbance on the blood supply to the
brain. The main consequence of a stroke is a serious long-term disability, and it a↵ects
milions of people around the world every year. Motor recovery after stroke is primarily
based on physical therapy and the most common rehabilitation method focuses on the
task specific approach. Gait is one of the most important daily life activity a↵ected in
stroke victims, leading to poor ambulatory activity. Therefore, much e↵ort has been
devoted to improve gait rehabilitation.
Traditional gait therapy is mostly based on treadmil training, with patient’s body weight
partialy supported by a harness system. Physical therapists need to manualy assist
patients in the correct way to move their legs. However, this technique is usualy very
exhausting for therapists and, as a result, the training duration is limited by the physical
conditions of the therapists themselves. Moreover, multiple therapists are required to
assist a single patient on both legs, and it is very di cult to coordinate and properly
control the body segments of interest.
In order to help physical therapists to improve the rehabilitation process, robotic exo-
skeletons can come into play. Robotics exoskeletons consist of mechatronic structures
attached to subject’s limbs in order to assist or enhance movements. These robotic
devices have emerged as a promising approach to restore gait and improve motor func-
tion of impaired stroke victims, by applying intensive and repetitive training. However,
active subject participation during the therapy is paramount to many of the potential
recovery pathways and, therefore, it is an important feature of the gait training. To this
end, robotics devices should not impose fixed limb trajectories while patient remains
passive.
These have been the main motivations for the research of this dissertation. The overal
aim was to generate the necessary knowledge to design, develop and validate a novel
lower limb robotic exoskeleton and an assist-as-needed therapy for gait rehabilitation
in post-stroke patients. Research activities were conducted towards the development
of the hardware and the control methods required to proof the concept with a clinical
evaluation.
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The first part of the research was dedicated to design and implement a lightweight
robotic exoskeleton with a comfortable embodiment to the user. It was envisioned as
a completely actuated device in the sagittal plane, capable of providing the necessary
torque to move the hip, knee and ankle joints through the walking process. The de-
vice, that does not extend above mid-abdomen and requires nothing to be worn over
the shoulders or above the lower back, presumably renders more comfort to the user.
Furthermore, the robotic exoskeleton is an autonomous device capable of overground
walking, aiming to motivate and engage patients by performing gait rehabilitation in a
real environment.
The second research part was devoted to implement a control approach that assist the
patient only when needed. This method creates a force field that guides patient’s limb
in a correct trajectory. In this way, the robotic exoskeleton only applies forces when
the patient deviates from the trajectory. The force field provides haptic feedback that
is processed by the patient, thus leading to a continuous improvement of the motor
functions.
Finaly, research was conducted to evaluate the robotic exoskeleton and its control ap-
proach in a clinical study with post-stroke patients. This study aimed to be a proof-of-
concept of al design and implementation applied to a real clinical rehabilitation scenario.
Several aspects were evaluated: the robotic exoskeleton control performance, patients’
attitudes and motivation towards the use of the device, patients’ safety and tolerance
to the intensive robotic training and the impact of the robotic training on the walking
function of the patients.
Results have shown that the device is safe, easy to use and have positive impact on
walking functions. The patients tolerated the walking therapy very wel and were moti-
vated by training with the device. These results motivate further research on overground
walking therapy for stroke rehabilitation with the robotic exoskeleton.
The work presented in this dissertation comprises al the way from the research to
implementation and evaluation of a final device. The technology resulting from the work
presented here has been transferred to a spin-o↵company, which is now commercializing
the device in di↵erent countries as a research tool to be used in clinical studies.
Resumen
Un accidente cerebrovascular es una p´erdida de la funci´on cerebral causada por una
perturbaci´on en el suministro sangu´ıneo al cerebro. La principal consecuencia de esta
enfermedad es una grave discapacidad a largo plazo, que afecta a milones de personas
en todo el mundo a cada a˜no. La recuperaci´on motora despu´es de un accidente cere-
brovascular se basa principalmente en la terapia f´ısica, y el m´etodo de rehabilitaci´on
m´as frecuente se centra en un entrenamiento espec´ıfico. La marcha es una de las m´as
importantes actividades de la vida diaria afectada por un accidente cerebrovascular,
conduciendo a una capacidad ambulatoria deficiente. Debido a eso, mucho esfuerzo se
ha dedicado a la rehabilitaci´on de la marcha.
La terapia tradicional de la marcha se basa principalmente en el entrenamiento en cinta
rodante, con descarga de peso parcial usando un sistema de arn´es. Los fisioterapeutas
ayudan manualmente a los pacientes a mover sus piernas en la forma correcta. Sin em-
bargo, esta t´ecnica suele ser muy extenuante para los terapeutas, limitando la duraci´on
de la terapia por las condiciones f´ısicas de estos. Adem´as, se requieren m´ultiples ter-
apeutas para asistir a un solo paciente en ambas piernas, siendo muy dif´ıcil de coordinar
y controlar adecuadamente los segmentos corporales de inter´es.
Con el fin de ayudar a los terapeutas f´ısicos a mejorar el proceso de rehabilitaci´on, los
exosqueletos rob´oticos pueden ser muy ´utiles. Los exoesqueletos rob´oticos consisten en
estructuras mecatr´onicas conectadas a las extremidades del usuario, con el fin de asistir
sus movimientos. Estos dispositivos rob´oticos han surgido como una forma promete-
dora de restaurar la marcha y mejorar la funci´on motora en v´ıctimas de accidentes
cerebrovasculares, aplicando un entrenamiento intensivo y repetitivo. Sin embargo, la
participaci´on activa del paciente en la terapia es primordial para muchas de las posibles
v´ıas de recuperaci´on y, por lo tanto, es una caracter´ıstica importante del entrenamiento
de la marcha. Para este fin, los dispositivos rob´oticos no deben imponer trayectorias
fijas en las extremidades del paciente mientras este permanece pasivo.
Estos desaf´ıos en los procesos de rehabilitaci´on han sido la principal motivaci´on para la
investigaci´on en esta tesis doctoral. El objetivo principal es generar los conocimientos
necesarios para dise˜nar, desarrolar y validar un exoesqueleto rob´otico y una terapia
de asistencia bajo demanda para la rehabilitaci´on de la marcha en pacientes tras un
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accidente cerebrovascular. Actividades de investigaci´on fueron levadas a cabo para el
desarrolo del hardware y de los m´etodos de control necesarios para una prueba de
concepto mediante una evaluaci´on cl´ınica.
La primera parte de la investigaci´on fue dedicada a dise˜nar e implementar un ex-
oesqueleto rob´otico ligero y c´omodo para el usuario. Fue concebido un dispositivo com-
pletamente actuado en el plano sagital, capaz de proporcionar el par necesario para
mover las articulaciones de la cadera, rodila y tobilo durante la marcha. El disposi-
tivo no se extiende por encima de mitad del abdomen y no requiere levar nada sobre
los hombros o en el tronco, proporcionando m´as comodidad al usuario. Adem´as, el
exoesqueleto rob´otico es un dispositivo aut´onomo capaz de asistir marcha ambulatoria,
con el objetivo de motivar a los pacientes por medio de rehabilitaci´on en un entorno
real.
La segunda parte de la investigaci´on fue dedicada a implementar una estrategia de
control para ayudar al paciente bajo demanda. El m´etodo crea un campo de fuerzas
que gu´ıa la extremidad del paciente en la trayectoria correcta. De esta manera, el
exoesqueleto rob´otico s´olo aplica fuerzas cuando el paciente se desv´ıa de la trayectoria. El
campo de fuerza proporciona retroalimentaci´on h´aptica que es procesada por el paciente,
lo que conduce a una mejora continua de las funciones motoras.
Por ´ultimo, fue levada a cabo una investigaci´on para evaluar el exoesqueleto rob´otico
y su estrategia de control en un estudio cl´ınico con pacientes que han sufrido un ac-
cidente cerebrovascular. Este estudio fue una prueba de concepto del dise˜no y de la
implementaci´on del dispositivo aplicada a un escenario de rehabilitaci´on cl´ınica real.
Se evaluaron varios aspectos: el desempe˜no de la estrategia de control, las actitudes y
motivaci´on de los pacientes hacia el uso del dispositivo, la seguridad del paciente y su
tolerancia a la terapia rob´otica intensiva y el impacto de la rehabilitaci´on en la marcha
de los pacientes.
Los resultados han demostrado que el dispositivo es seguro, f´acil de usar y tiene un
impacto positivo en la marcha. Los pacientes toleraron la terapia rob´otica muy bien y
estuvieron motivados por el entrenamiento con el dispositivo. Estos resultados motivan
a seguir la investigaci´on con el exoesqueleto rob´otico aplicado a la rehabilitaci´on de
marcha en pacientes que han sufrido un accidente cerebrovascular.
El trabajo presentado en esta tesis doctoral comprende todo el camino desde la inves-
tigaci´on hasta la ejecuci´on y evaluaci´on de un dispositivo terminado. La tecnolog´ıa
resultante del trabajo que aqu´ı se presenta ha sido transferida a una empresa spin-o↵,
que ahora est´a comercializando el dispositivo en diferentes pa´ıses como una herramienta
de investigaci´on para ser utilizada en estudios cl´ınicos.
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Chapter 1
Introduction to Stroke and Gait
Rehabilitation
This introductory chapter presents the background and rationale of this dissertation. It
starts by giving an overview about the main consequences of a stroke, including phys-
iological, functional, social and economical impacts. Next, the chapter highlights the
importance of rehabilitation for improving quality of life of persons a↵ected by stroke,
with special emphasis on gait restoration. Trends for walking rehabilitation currently
available in clinical setings are reviewed. Recent evidences show that novel approaches
based on robotic interventions can potentialy increase the rehabilitation outcomes. Sub-
sequently, robotics devices developed for gait restoration after stroke are reviewed. The
chapter folows by explaining the reasons that encouraged the development of the ex-
oskeleton for gait rehabilitation: the large number of people a↵ected by stroke, the high
costs of hospitalized patients, the high level of physical e↵ort demanded from multiple
therapists when performing manual therapy and some limitations of existing robotic de-
vices. Objectives and organization of the work are presented in the last section of this
chapter.
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1.1 Stroke
The human brain is always bursting with energy. It consist of about 86 bilions of cels
caled neurons, with a roughly equal number of non-neuronal cels caled glia [1]. The
brain consumes about 20% of the total energy used by the human body, more than any
other organ [2]. Its metabolism basicaly uses glucose as energy source and oxygen, both
carried to the brain by the bloodstream.
The human brain weights about 1.5 kg [3]. Although this represents only about 2% of
the human body mass, the brain uses 15% of the cardiac blood stream, 20% of total
oxygen consumption in the body and 25% of total glucose utilization [4]. The energy
consumption in the brain does not vary quite a lot over time, but some active regions
of the cortex can consume more energy than other temporarily inactive parts [5].
The brain can soak so much information that not even the most sophisticated computer
in the world can compare to it. The bilions of neurons settled in specific brain regions
are responsible for controling everything we do, from moving a finger to doing a complex
math calculation. The exact understanding of which functions are controled by each
brain region remains under investigation. Although there is not a strict relationship
between brain region and function, current knowledge shows that they are closely related
[6], and, as represented in figure 1.1, left brain hemisphere controls the right side of the
body and vice-versa. If a brain region is damaged, its functions can be sometimes
assumed by a neighboring region in the ipsilateral side or a corresponding region in the
contralateral side, depending on the damaged area [7].
Right Hemisphere Left Hemisphere Left SideRight Side
Figure 1.1:Regions of the human brain and functions performed seems to be closely
related. In general, left brain hemisphere controls the right side of the body and vice-
versa.
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A leading case of brain damage occurs when the blood supply stops flowing to the brain,
leading neurons to start dying very quickly. Deprived from oxygen and glucose in the
brain, humans normaly looses consciousness within five to ten seconds. If oxygen and
glucose supply is not restored soon, the brain start experiencing irreversible damages.
The loss of brain function due to a disturbance in the blood supply is known as stroke
[8]. The brain area a↵ected after a stroke cannot function normaly due to neurons’
death, which might result in permanent neurological damage or death. More commonly,
a person a↵ected by stroke has inability to move the limbs on one side of the body, fails
to speak or to understand speech and exhibits vision impairment [9]. More specificaly,
the level of impairment after a stroke depends mainly on the brain region a↵ected.
Plasticity is defined as the property of the human brain to adapt to environmental chal-
lenges and experiences, including brain damage [10–12]. Due to plasticity, lost functions
can be compensated or relearned after stroke, based on mechanisms of reorganization
[13], unmasking previously inactive synapses and/or generating new ones. The advances
in non-invasive technologies have increased our understanding of brain reorganization
after stroke [14–16].
The main factors that determine functional recovery after stroke are the location of
the lesion in the brain, the extension of that lesion and the nature of stroke (ischemic
or hemorrhagic) [17]. Motor impairment can be caused by injury in the motor cortex,
pre-motor cortex or associated pathways in the cerebrum or cerebelum [18]. Such im-
pairments a↵ect an individual’s ability to complete everyday activities and participate in
everyday life situations [19]. Recovery is hindered above al by the involvement of major
white-matter tracts and by damage or disconnection of the hippocampus, a structure
that plays a key role in the learning of neurological functions [20]. Functional recovery
is based on the restitution of the brain tissue and on the relearning and compensation
of lost functions.
1.2 Classification of Stroke
Stroke is a medical condition that can be better prevented with appropriate care, changes
in lifestyle and treatment of some risk factors with adequate medications [20]. Risk
factors include age, high blood pressure, diabetes, high cholesterol, smoking, lack of
exercise, overweight and atrial fibrilation [9]. Stroke can be either ischemic or hemor-
rhagic. The management of these subtypes is di↵erent, therefore, the clinical distinction
between these subtypes is the first important and urgent step in stroke management.
Classification can be done in the emergency room and conveys important prognostic
information, because the type of stroke wil influence both acute treatments and sec-
ondary prevention strategies. Ischemic strokes are the most prevalent type, accounting
for about 85% of al cases [20, 21].
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1.2.1 Ischemic Stroke
Figure 1.2 ilustrates how an ischemic stroke occurs. Basicaly, an artery inside or close
to the brain becomes clogged, thus preventing the bloodstream to correct flow to some
brain region. The brain cels beyond the clogged point die due to the lack of nutrients
and oxygen. Therefore, the function those dead cels were controling is now gone, even
the tissue is structuraly intact [22]. This tissue is known as the ischemic penumbra [9].
Figure 1.2: Representation of how an ischemic stroke occurs. An artery inside or
close to the brain become clogged, preventing the bloodstream to correct flow to some
brain region. The brain cels beyond the clogged point die from the lack of nutrients
and oxygen, leading to stroke.
Ischemic stroke is also divided into embolic or thrombotic. Embolic stroke occurs when
a blood clot or plaque fragments formed elsewhere in the circulatory system, usualy in
the heart or large arteries leading to the brain, break o↵and move towards the brain. In
the brain, the clot occludes a blood vessel, leading to stroke. In the case of thrombotic
stroke, the blood clot forms inside an artery already in the brain. The clot slowly
interrupts the blood flow, causing stroke. The main cause for that is atherosclerosis, a
hardening of arteries caused by cholesterol.
1.2.2 Hemorrhagic Stroke
In hemorrhagic strokes, a weak artery inside the brain eventualy ruptures, spiling
blood into or around the brain. The bleeding causes brain cels to die and the brain
part a↵ected stops working correctly. The most common mechanism that leads to a
hemorrhagic stroke is hypertension, which causes aneurysms, an excessive dilation of an
artery caused by a weakening of its wals (figure 1.3) that subsequently rupture [23].
More than 65% of patients with primary cerebral hemorrhage have either pre-existing
or newly diagnosed hypertension [24].
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Figure 1.3:Representation of how an hemorrhagic stroke occurs. A weak artery inside
the brain eventualy ruptures, spiling blood into or around the brain. The bleeding
causes brain cels to die, leading to stroke.
Hemorrhagic stroke is much more deadly than ischemic stroke, but fortunately, it is
much less frequent. There are also di↵erent kinds of hemorrhagic stroke, including in-
tracerebral and subarachnoid hemorrhage. Intracerebral stroke happens when a vessel
ruptures and bleeds into brain tissue. The bleeding causes brain cels to die. In sub-
arachnoid hemorrhage, a blood vessel bursts near of the brain surface, causing blood to
leak between the brain and skul. This blood may cause other nearby vessel to spasm
and reduce the blood flow to a certain brain region, leading to a stroke.
1.3 Socioeconomic Impact of Stroke
Stroke is responsible for 9% of al deaths worldwide [9]. It is a serious and disabling
global health-care problem that takes more than 4% of total direct health-care costs in
industrialized countries [18] and exorbitant amounts of money to the society every year:
around US$ 13 bilion in the United Kingdom, US$ 1.3 bilion in Australia and US$ 41
bilion in United States [9], where a stroke patient costs more than US$ 1,000 per day
in a hospital. Stroke occurrence is predominantly in older people, about 75% of stroke
patients are over 65 [25].
There are about 800.000 cases of stroke every year only in the United States [26], which
means that someone has a stroke every 40 seconds. Also in United States, stroke is
the third most common cause of death and the leading cause of long-term disability
[18, 27]. Around 80% of stroke victims wil survive the initial injury. Therefore, the
widely recognized problem caused by stroke is not death, but motor impairment, which
can be understood as loss or limitation in muscle control or a limitation in mobility [28].
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Stroke motor impairment usualy a↵ects movement control of the face, arm and/or leg
on one side of the body. Many patients loose the ability to walk independently and a
large number of patients do not regain their normal walking speeds [29]. Consequently,
gait impairment is one of the main contributors to long-term disability in daily living
of people that have been a↵ected by stroke [30]. This limitation in daily life activities
have a big e↵ect on patients and their families. Fortunately, with proper care and
rehabilitation most stroke survivors can resume their lives.
1.4 Stroke Rehabilitation
It is recognized that stroke rehabilitation presents specific chalenges [31]. Theories
of motor control and skils learning are crucial in the rehabilitation interventions [32].
However, neurophysiology supporting stroke rehabilitation is often poorly established
and interventions tend to be complex, containing several interrelated components [33].
The main principles for a successful rehabilitation after a stroke include a functional
approach targeting specific activities, intense practice and an early start few days after
the stroke [34]. Di↵erent mechanisms can improve function, thereby aleviating the
various impairments caused by stroke. Recovery of function in stroke patients typicaly
occurs within six months after onset, with larger improvements taking place in the first
three months [29]. Indeed, early start of training tends to yield better rehabilitative
outcomes [35–37]. Nevertheless, functional gains can stil continue in the chronic phase
of stroke [38, 39].
About 80% of stroke victims are a↵ected by motor impairment [18]. Therefore, one
primary goal of physical and occupational therapy is the recovery of functions a↵ected
by motor impairment. Function and motor impairment seems to be directed related, for
instance, the ability to walking (function) can be correlated with lower limb strength
(impairment) [29].
Functional recovery can occur via di↵erent mechanisms, as restitution or compensation
[40]. In the case of restitution, the function in the neural tissue that was initialy lost is
restored by finding alternative means to activate the same muscles used for a task prior to
injury. The movement is performed as it was before the injury [41]. Motor compensation,
instead, is associated with the acquisition by the neural tissue of a function that it did
not have before and the use of alternative muscles in compensatory strategies [42].
1.5 Gait Rehabilitation in Stroke Survivors
Stroke imparts several physical and cognitive disorders that produce disability [43–45].
Gait is one of the most important activities a↵ected in stroke survivors, leading to poor
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ambulatory activity [46]. Most victims experience significant sensory-motor impairments
[47, 48] and require rehabilitation to achieve functional independence again.
In this context, hemiparesis is a manifestation of stroke that a↵ects the contralesional
side of the body, and commonly impacts gait [29, 49]. A negative impact on output
forces, not just for the paretic leg, but also for the una↵ected leg, has been found in
stroke victims [50–53]. Nevertheless, walking velocity and endurance is greatly reduced
and patients usualy walk in a typical asymmetric manner, as they avoid to load the
paretic limb. Knee flexion is also reduced and most patients tend to compensate the
lack of knee flexion during swing, creating an abnormal compensatory movement in the
hip commonly known as hip hiking [54].
The rehabilitation process toward regaining mobility after a stroke can be divided into
three phases [55]:
1. Mobilization of bedridden patient into the wheelchair;
2. Gait restoration;
3. Improvement of gait in order to meet the requirements of daily mobility.
In the first phase, an early mobilization policy is generaly accepted. The patient at
the edge of the bed is transferred to a chair as soon as possible. Once the patient can
sit and tolerate verticalization for at least 10 minutes, the gait restoration training can
begin [20].
The approach used in the second phase of rehabilitation has seen major changes in
the last decade. The traditional methods used by physiotherapists have been replaced
by task-specific, repetitive gait training approaches. To help therapists during this
task, electromechanical devices can come into play, enabling patients to practice walking
over and over again. It has been hypothesized that the combination of machines and
physiotherapists can be more e↵ective than the latter alone, preventing many cases of
inability to walk [56].
1.5.1 Traditional Therapy
The theoretical bases assumed by the physical therapists to approach stroke rehabilita-
tion are diverse. Traditional methodology includes neuro-developmental training [57],
motor relearning programs, proprioceptive neuromuscular facilitation and the Rood ap-
proach [58]. However, the results of di↵erent kinds of training on gait have been shown
to be modest and independent of the methodology adopted [43].
Neuro-developmental training is the most usual rehabilitation approach [48, 59–61],
where the best wel-known stream is the Bobath concept. This therapy attempts an
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approach where social, emotional and functional problems are targeted, in addition to
sensory-motor deficits. The main objective is to suppress abnormal movement synergies
and move towards normal motor patterns [62]. It involves intensive preparatory train-
ing for walking in the sitting and standing positions. Despite the acceptance of Bobath
concept and other conventional techniques in stroke rehabilitation, there is stil a lack
of evidence demonstrating their e cacy [35, 63–68].
In gait rehabilitation, the task-specific repetitive approach is increasingly being used in
addition to conventional therapeutic approaches. The motor task to be learned should
be practiced as many times as possible [20]. Better outcomes have been attained with
the strategy of treadmil training with body weight support [67, 69–73]. With this
technique, patients walk on a treadmil with they body partialy supported by a harness
system. Physical therapists manualy assist patients in the correct way to move their
legs, providing some guidance based on patient’s disability level.
This type of therapy has the advantage of being task specific and repetitive, providing
a high degree of training. However, it is usualy very exhausting for therapists and, as
a result, the training duration is limited by the physical conditions of the therapists
themselves. Moreover, multiple therapists are required to assist the patient in both legs,
which can lead to poor coordination and synchronization of movements, and the cost of
multiple therapists for a single patient is not always covered by health care systems.
As a solution to these limitations, with the advance of the technology, therapies driven
by robotic machines were proposed as an addition to physiotherapy programs targeting
neurological impairment [74]. Gait therapy assisted by robotic actuators rather than
a therapist is becoming an increasingly prominent feature of rehabilitation worldwide.
More than aleviating the physical burden on therapists, robotic machines can accurately
apply repetitive training and more objectively measure patient’s outputs in terms of joint
kinematics and kinetics [44, 75].
1.5.2 Robotic Technology for Gait Rehabilitation
“Who wants to walk, has to walk” [76] has become a key concept for gait rehabilitation.
Towards this goal, robotic machines can alow more e↵ective training sessions, where
patients can train around 1000 steps within a typical training session (30 minutes in
average), whereas during manualy assisted training only approximately 100 steps per
session can be performed [55].
In the past years, di↵erent studies have been conducted in order to demonstrate the
ecacy of robot-based therapy over conventional, therapist-assisted training. Some
publications yield results in favor of conventional therapy [77, 78], others conclude that
robot-aided training is more e↵ective [79–82] and other studies find no significative
di↵erence in functional gait improvements between both [83–85]. One argument always
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in favor of the robotic approach is that it is roughly as e↵ective as the manual treadmil
therapy guided by therapists, but requiring much less e↵ort from therapists [79].
A recent Cochrane review [86] comprising 23 trials involving 999 patients investigated the
e↵ects of robotic-assisted gait training for improving walking after stroke. Results show
that patients receiving robotic-assisted gait training in combination with physiotherapy
are more likely to achieve independent walking than patients that do not train with those
devices. Also, a number of therapeutic benefits in gait training assisted by robotics in
stroke patients have been found in the literature: improvements in walking independence
and mobility [67, 87], functional walking ability [79, 88], muscle activation patterns
[80, 88], gait speed [80, 89] and joint range of motion [89].
In the folowing paragraphs it wil be reviewed the state of the art of the robotic technol-
ogy for gait rehabilitation. Rehabilitation robots can be broadly classified as stationary
devices and ambulatory exoskeletons, some of which are already available as commercial
products on the market.
1.5.3 Stationary Devices
The first machines developed for gait rehabilitation were not ambulatory. They are based
on a gait orthosis and a body weight support system in combination with a treadmil
[90]. Using predetermined movement patterns, they usualy do not alow variation in
the gait pattern. Sometimes those platforms also use virtual reality environments, in a
strategy to motivate and engage the patient to actively perform movements.
Stationary devices for gait training can be distinguished in two groups: end-e↵ector
systems and exoskeletons based solutions [91, 92]. End-e↵ectors simulate the stance and
swing phase during gait cycles, while the patient’s feet are placed on footplates. On
the other hand, exoskeleton-based systems consist of robots attached to subject’s limbs,
working in paralel with them.
1.5.3.1 Lokomat
Lokomat [74] is probably the most used stationary robotic machine for gait rehabilita-
tion in clinics nowadays. Lokomat is a commercialy available device manufactured by
Hocoma, a company in Zurich, Switzerland. The system, that uses a lower limb orthosis
coupled to a treadmil, was initialy developed for spinal cord injury treatment [93, 94].
It has an advanced body weight support system that can partialy lift the user during
the training. DC (Direct Current) motors are used for actuation of hip and knee joints
in the sagittal plane, while the ankle is kept passive. The motor’s drives are precisely
synchronized with the treadmil speed, assuring a precise match between the speed of
the gait orthosis and the treadmil. Figure 1.4 ilustrates the Lokomat.
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Figure 1.4:Lokomat is a commercialy available device that uses a lower limb orthosis
coupled to a treadmil for gait training. It has an advanced body weight support system
that can partialy lift the user during the training. DC motors provide actuation on
hip and ankle joints.
The first version of Lokomat was strictly a position controled device, but other control
algorithms have also been proposed [95, 96] to provide control methods that better
interact with the patient. Lokomat is the treadmil gait training device that has received
the most extensive clinical evaluation. Many studies, including randomized clinical trials
for stroke rehabilitation [77, 78, 84, 85, 97–100] were carried out using the Lokomat.
Also, spinal cord injury rehabilitation was targeted using Lokomat in clinical studies
[101–104].
Di↵erent studies about the ecacy of Lokomat when compared with traditional ther-
apy yielded di↵erent results, but a recent review [86] concludes that patients receiving
robotic-assisted gait training have higher probabilities to achieve an independent walk.
In this review, Lokomat was used in 13 of 23 total randomized clinical trials.
1.5.3.2 ALEX
ALEX (Active Leg Exoskeleton) [105, 106] is a motorized leg orthosis developed at the
University of Delaware, Newark, United States. It is intended for gait training and
rehabilitation of patients with walking disabilities. ALEX orthosis, see figure 1.5, has
a total of seven DOF (Degrees of Freedom) with hip and knee actuated in the sagittal
plane. The device is stationary and coupled to a treadmil. A force field control applies
forces on user’s feet to help the legs move on a desired trajectory. First experiments
performed on six healthy subjects walking on a treadmil have shown that a healthy
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person could be retrained in about 45 minutes with ALEX to walk on a treadmil with
a considerably altered gait [107].
Other studies with ALEX [108, 109] were conducted with two stroke survivors that
participated in fifteen sessions of gait training. The results show that by the end of the
training period, patients’ gait pattern improved and became closer to a healthy subject’s
gait pattern. Improvements were seen as a change in patients’ gait pattern by increasing
knee and ankle joint excursions and increasing their walking speeds on the treadmil.
ALEX mechanical structure and control strategy were redesigned in a new version,
ALEX-II [110]. This control strategy uses an assist-as-needed algorithm that provides
less encumbered motion for its users [111]. This new version was only tested with healthy
subjects. No further studies using ALEX or ALEX-II for stroke gait rehabilitation were
found in the literature.
After ALEX, the same group at the University of Delaware also developed a non-
motorized bilateral orthosis [112] that can be used to assist training of motor impaired
patients on a treadmil, such as patients with incomplete spinal cord injury. The device
design uses torsional springs at the hip and the knee joints to assist the swing motion.
The springs get charged by the treadmil during stance phase of the leg and provide
force propulsion to the leg during the swing. Simple dynamic models of walking in the
sagittal plane are used to optimize the parameters of the springs, so the foot can clear
the ground and have a desirable forward motion. The device was tested on a healthy
subject during treadmil walking for a range of walking speeds. Authors found that at
3.2 km/h the device was e↵ective in reducing the maximum hip torque requirement and
  
Figure 1.5:ALEX is motorized leg orthosis with a total of seven degrees of freedom.
Hip and knee joints are actuated in the sagittal plane, while the device is coupled to a
treadmil.
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the knee joint torque during the beginning of the swing. No results were shown with
impaired persons training with this non-powered device.
1.5.3.3 LOPES
LOPES (Lower Extremity Powered Exoskeleton) [113] is a lower limb exoskeleton cou-
pled to a treadmil developed at the University of Twente, Enschede, The Netherlands.
The device is ilustrated in figure 1.6. It combines a two dimensional actuated pelvis
segment with a leg exoskeleton containing three actuated rotational joints: two at the
hip and one at the knee. The actuators consist of a servomotor and a flexible Bowden
cable transmission [114, 115]. The joints are impedance controled based on a force
feedback loop to alow bidirectional mechanical interaction between the robot and the
training subject.
Di↵erent control approaches have been developed for LOPES. One approach, caled
Virtual Model Controler and presented in [116], tries to translate traditional gait re-
habilitation therapy programs into robotic rehabilitation therapy for selective control
of gait functions. In a subsequent work [117] this approach was tested in four healthy
subjects to control the step height, while leaving the remaining walking pattern unaf-
fected. The Virtual Mode Controler is also used in [118], as an alternative method to
support body weight, and in [119] to provide virtual support to the ankle and increase
foot clearance.
In the work presented in [120], a free walk mode of LOPES based on impedance control
is assessed. Results with healthy subjects showed that overal, walking with LOPES
Figure 1.6: LOPES combines a two dimensional actuated pelvis segment with a
lower limb exoskeleton containing three actuated rotational joints: two at the hip and
one at the knee. The actuators consist of a servomotor and a flexible Bowden cable
transmission.
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resembled free walking, although this required several adaptations in muscle activity. A
di↵erent approach presented in [121] was also implemented in LOPES: in this study, the
desired states of the disabled leg are generated online based on the movements of the
other leg. Results indicate that the interference of the robot is lower when compared
with a fixed reference trajectory, but no results were shown with impaired persons.
The study with LOPES in [122] tested the feasibility of providing assistance during foot
clearance by defining a virtual spring between the desired and the actual ankle height.
The algorithm automaticaly adapts the sti↵ness of the virtual spring, adapting the
amount of support to the experienced movement error in the previous steps. Results
were shown in four chronic stroke survivors, demonstrating that the training resulted in
improved foot clearance, which was accompanied by an increased walking speed.
In a recent study [123], ten individuals with chronic SCI (Spinal Cord Injury) partic-
ipated in an explorative clinical trial with LOPES. Participants trained three times a
week for eight weeks using an impedance based controler. Results showed that partici-
pants experienced significant improvements in walking speed and distance after training
and in eight weeks folow-up. It was concluded that the device is feasible in gait reha-
bilitation of chronic SCI individuals.
1.5.3.4 Gait Trainer GT I
The Gait Trainer GT I folows an end-e↵ector principle [91]. It was developed by Pro-
fessor Dr. Stefan Hesse and his team in Germany. In 1999 they established a company
in Berlin caled Reha-Stim focusing on technology for rehabilitation. Gait Trainer GT I
is a stationary machine with two footplates that simulates the phases of gait [124–126].
It consists of a double crank and rocker gear system, composed of two footplates posi-
tioned on two bars, two rockers and two cranks that provide the propulsion. Users are
secured in a harness and positioned on the two footplates, whose movements simulate
the stance and the swing phases. The machine controls the movement of the center of
mass in both the vertical and horizontal direction [88, 127]. A servo controled motor
assists gait movement by controling the gear velocity [128, 129].
Figure 1.7 ilustrates the Gait Trainer GT I, which was developed aiming to lower the
e↵ort of therapists in traditional gait training on a treadmil. In case reports [128, 129]
and a randomized crossover study [79], the authors found no di↵erence in e↵ectiveness
between treadmil training and the Gait Trainer GT I. However, they stated that the
Gait Trainer GT I helped to reduce manual guidance from the therapist and provided a
highly symmetric, more independent gait practice for non ambulatory participants.
Many studies were carried out with a large number of stroke patients using Gait Trainer
GT I. The study [82] comprised a non-blinded randomized trial with fifty stroke patients,
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Figure 1.7: Gait Trainer GT I folows an end-e↵ector principle. The stationary
machine has two footplates that simulates the stance and the swing phases of the gait.
which were recruited within six weeks after stroke onset. Results showed that partic-
ipants who trained on the robotic device with body weight support had a faster gait,
better mobility and improvements in functional ambulation compared to participants
who underwent conventional gait training. Other study in [87] evaluated 155 sub-acute
stroke patients in a randomized trial. Conclusion was that intensive locomotor training
plus physiotherapy resulted in a significantly better gait ability and daily living compe-
tence in patients compared with physiotherapy alone. The same conclusion was obtained
in [130], with a total of 48 participants with motor and gait dysfunction folowing sub-
acute stroke. Iosa et al [131] performed a study with twenty stroke subjects in order to
select the best parameters for the electromechanical Gait Trainer GT I.
In [132], Gait Trainer GT I was evaluated in combination with transcranial direct current
stimulation in thirty patients with chronic stroke. In this pilot study, it was found that
transcranial direct current stimulation had no additional e↵ect on robot assisted gait
training in patients with chronic stroke. The e↵ects of Gait Trainer GT I was also tested
with children with cerebral palsy [133]. The study evaluated the e↵ectiveness of repet-
itive locomotor training with eighteen ambulatory children with diplegic or tetraplegic
cerebral palsy. Results showed that Gait Trainer GT I may improve gait velocity and
endurance, as wel as spatiotemporal and kinematic gait parameters in patients with
cerebral palsy.
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1.5.3.5 HapticWalker
HapticWalker [134] was developed by the same team that developed Gait Trainer GT
I, as a successive machine. As improvements, HapticWalker has fuly programmable
trajectories, therefore enabling patients to train arbitrary gait trajectories and daily life
walking situations, as stair climbing up and down [76]. The device is ilustrated in figure
1.8.
HapticWalker comprises a translatory and rotatory footplate workspace, alowing per-
manent foot contact along arbitrary walking trajectories during al phases of gait. The
footplate dynamics were designed for smooth foot motions at moderate speeds and also
realistic simulation at higher speeds up to 5 km/h. The purpose for that was to enable
realistic simulation of gait perturbations like stumbling, sliding and other asynchronous
walking events [55]. The device is equipped with electrical direct drive motors and
six force/torque sensors mounted under each foot platform [135]. It is controled by
software and hardware based on industrial standards and interfaces. The software is
based on RTLinux and runs on an industrial computer [134]. The real-time motion
generator includes a Fourier-based algorithm for interpolation of natural cyclic walking
trajectories.
Di↵erently to Gait Trainer GT I, no randomized clinical trials were found using Hap-
ticWalker, but only a few studies with healthy users [136, 137].
Figure 1.8: HapticWalker is an end-e↵ector machine with fuly programmable tra-
jectories that enables patient to train arbitrary gait trajectories and daily life walking
situations, as stair climbing up and down.
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1.5.3.6 LokoHelp
LokoHelp [138] is another stationary device developed for improving gait after brain
injury. It is placed on a treadmil and fixed onto the band of the motor that driven the
treadmil, transmitting the movement to levers positioned on both sides of the device.
In this way, simulation of gait is achieved by tracking the levers that imitate the stance
and swing phases sequentialy. Step length is fixed at 40 cm and speed can be adjusted
from 0 to 2.5 km/h.
LokoHelp is a device that, in some way, lies between Lokomat and Gait Trainer GT
I approaches. It consists of a treadmil with body weight support system, like the
Lokomat, but the device itself consists of a pair of boots that guide the feet along
a fixed trajectory. Although it uses a treadmil, the device is considered end-e↵ector
based [91]. Figure 1.9 ilustrates the LokoHelp.
The first LokoHelp study [138] was a feasibility study recruiting six patients with im-
paired walking function. The intervention consisted of a training period of six weeks.
Results showed that LokoHelp may improve locomotor function and decrease the e↵ort
experienced by therapists carrying out the training. A later study [139] comprising six-
teen non-ambulatory patients after stroke, severe brain or spinal cord injury, concludes
that training with the device did not significantly improve gait when compared with
traditional training. However, the use of LokoHelp requires less therapeutic assistance,
reducing therapist discomfort.
Figure 1.9:LokoHelp is placed on a treadmil and fixed onto the band of the motor
that driven the treadmil, transmitting the movement to levers positioned on both sides
of the device.
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1.5.3.7 Other Stationary Devices
Other stationary devices have been developed around the world to improve gait training.
ARTHuR (Ambulation-assisting Robotic Tool for Human Rehabilitation) is an end-
e↵ector system where leg movements are controled via a moving coil [140]. The device
was designed to measure and manipulate human stepping on a treadmil.
A gait trainer developed in Korea, caled Walkbot [141], has been under investigation
to see the immediate e↵ects on knee joint sti↵ness with an individual with spastic hemi-
plegia. PAM (Pelvic Assist Manipulator) was developed to assist pelvic motion during
gait training in a treadmil [142]. POGO (Pneumaticaly Operated Gait Orthosis) was
designed as an attachment to PAM [143], providing assistance for leg swing. Both de-
vices are actuated by pneumatic cylinders. Autoambulator [144] is a treadmil device
exoskeleton-based with a body weight support system. It has four DOF corresponding
to flexion/extension of the hip and the knee. Robotic Gait Rehabilitation Trainer [54] is
a single actuator system that works on the pelvis, targeting the correction of secondary
gait deviations.
1.5.4 Ambulatory Exoskeletons
End-e↵ector gait machines as Gait Trainer GT I or LokoHelp lack a structure that
support the knee joint. The absence of such structure may be chalenging for some
stroke patients [145]. Furthermore, rehabilitation devices such as Lokomat, ALEX,
LOPES, Gait Trainer GT I and others, have to be physicaly instaled in specialized
hospitals or clinical centers due to their significant sizes and costs [146].
In addition, stationary devices may not be optimal for most patients in terms of en-
gagement for gait practice. For more e↵ective results in the rehabilitation process, it
is known that patient’s involvement and participation in voluntary movements of the
a↵ected limbs is critical [147, 148]. As an alternative to the static gait training o↵ered
by these platforms, some mobile robotic devices have been developed, providing the
capability of overground walking. These robotics devices are usualy caled wearable
exoskeletons or robotic exoskeletons.
Wearable exoskeletons consist of mechatronic structures attached to the subject’s limbs
and working in paralel with them, in order to assist, replace or enhance movements
[149]. Performance augmentation based on exoskeletons have been mainly sponsored
by DARPA (Defense Advanced Research Projects Agency) in the United States [150],
targeting the increase of capabilities of soldiers in the battlefield [151].
Exoskeletons for rehabilitation (movement assistance) or functional compensation (move-
ment replacement) are being developed by di↵erent groups around the world [90, 152,
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153]. Some robotic exoskeletons are also used in conjunction with FES (Functional
Electrical Stimulation) [154, 155].
In the folowing paragraphs it wil be reviewed the state of the art in lower limb robotic
exoskeletons for gait rehabilitation or gait compensation. From now on in this disserta-
tion, it wil be sometimes referred to wearable robotic exoskeletons as just exoskeletons.
1.5.4.1 HAL
HAL (Hybrid Assistive Limb) is an exoskeleton designed for rehabilitation, heavy labor
and rescue support. It is built in di↵erent versions: ful body, lower body and one
leg models are available [156]. A new version of this device, HAL5 (ful body) targets
paraplegic users [157].
HAL was developed at Tsukuba University, Japan, and it is marketed by Cyberdyne.
Research with this exoskeleton has been led and conducted by Dr. Sankai, a Professor of
the Tsukuba University. Cyberdyne does not sel HAL, instead, it rents it to hospitals
and medical facilities in Japan, for a monthly fee of about US$ 2,000. In February 2013
HAL has received a clearance for the European market, based on the requirements of the
Medical Device Directives in European Union. The device has not yet been certified as
a medical device in Japan neither have FDA (Food and Drug Administration) approval
in the United States.
The lower body model of HAL weights about 15 kg and the ful body model about
23 kg. It is battery operated and has an autonomy of approximately two and a half
hours. Hip and knee joints actuators are based on DC servo motors and Harmonic Drive
gearboxes, while the ankle joint is passively controled [156]. HAL has a control unit
that communicates to a remote monitoring computer by wireless Local Area Network
[158]. The lower limb model of HAL is represented in figure 1.10.
Two di↵erent control strategies are used with HAL, depending on the treatment pur-
pose and user’s capabilities [159]. The main actuation mechanisms are based on sEMG
(surface Electromyography) signals, which adjusts the robot torques for assistance de-
pending on the measured muscle activity. The second algorithm reproduces a stored
movement pattern based on acceleration and ground contact forces [160].
HAL has been used to conduct clinical trials in di↵erent hospitals [161–163]. In the
study carried out by Maeshima et al [162], with comprised sixteen stroke patients with
severe hemiplegia, four patients required gait assistance and twelve needed supervision
while walking. They have compared stride length, walking speed and physiological cost
index on wearing bilateral HAL suit and a KAFO (Knee-Ankle-Foot Orthosis). The
results showed that HAL suit increased the stride length and walking speed only in four
out of sixteen patients. The physiological cost index increased in twelve patients after
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Figure 1.10:HAL is an overground exoskeleton with actuation on hip and knee joints
and a passive ankle. The device is designed for rehabilitation, heavy labor and rescue
support.
the gait training, but removing the suit led to a decrease in the physiological cost index
values to equivalent levels prior to the use of HAL.
As authors conclude in their study, sEMG signals used to provide power assistance
can make it dicult for severely hemiplegic patients to perform activities using their
own muscles. This could lead to instability, consequently decreasing stride length and
walking speed. Also, the availability and quality of sEMG signals can vary from patient
to patient. Fragility and instalation requirements of electrodes can also be restrictive
outside the laboratory [164]. The system based on sEMG signal requires a process of
adaptation and adjustment to a specific user that can take up to two months [165].
Recent studies [163, 166] have demonstrated that locomotor training using the HAL
is feasible for rehabilitation of chronic and sub-acute stroke patients. However, the
e↵ectiveness of HAL-based rehabilitation over conventional therapies is stil unclear and
requires further studies.
1.5.4.2 ReWalk
ReWalk is a wearable motorized suit from Argo Medical Technologies Inc. developed
and patented by its inventor Dr. Amit Go↵er [167]. Go↵er became quadriplegic after
an accident in 1997 and was through his own personal experience in utilizing mobility
devices for people with SCI that he developed this exoskeleton. ReWalk has hip and knee
movements powered in the sagittal plane. It comprises a light wearable brace support
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suit, which integrates DC motors at hip and knee joints, rechargeable batteries, an array
of sensors and a computer control system [90]. The ankles are supported using simple
orthotic joints that have limited range of motion and spring assisted dorsiflexion [168].
The device is powered by rechargeable batteries intended for al-day use and overnight
charging. The batteries are located on a backpack carried by the user. The device is
customized and sized for each patient [169], see figure 1.11.
Changes in the user’s center of gravity are detected and used to initiate and maintain
the walking process. The user also has a remote control placed on his/her arm, similar
to a watch. With this interface, it is possible to start di↵erent tasks, such as sit-to-stand
or climbing stairs. ReWalk is intended for persons with lower limb disabilities that have
su↵ered injuries in the spinal cord. It cannot keep balance control, so the user should
always be supported by crutches for additional stability when walking, standing and
rising up from a chair.
ReWalk underwent clinical trial testing in some rehabilitation centers in the United
States, e.g. Moss Rehabilitation Hospital in Philadelphia [170] and Veterans A↵airs
Medical Center in Bronx, New York [171].
Argo Medical sels two models of its exoskeleton, caled ReWalk Rehabilitation and
ReWalk Personal. The first one in intended for clinical use and has been deployed in
rehabilitation centers across Europe, Israel and United States. Training with it alows
walking, standing, sitting and the capacity to ascend/descend stairs in the rehabilitation
center environment. The system can accommodate a range of heights from 1.6 to 1.9
meters and weights up to 100 kg. The key prerequisites to use ReWalk include the ability
Figure 1.11:ReWalk comprises a light wearable brace support suit, which integrates
DC motors at hip and knee joints, rechargeable batteries, an array of sensors and a
computer control system.
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to use hands and shoulders (walking with crutches), healthy cardiovascular system and
bone density.
ReWalk Personal was designed for everyday use as an assistive system. It is customized
and sized for each individual user. After a training period with the device and after
meeting requirements from a medical examination, the user can buy one to use it at
home. In 2012 Argo started seling ReWalk Personal model in Europe. In the United
States this personal model became the first exoskeleton with FDA clearance for use at
home and in the community on June, 2014. The device is now available throughout the
United States for personal purchase, at a cost of around US$ 70,000.
1.5.4.3 Ekso Bionics
Ekso Bionics (earlier Berkeley Bionics) is a North American company that originaly
developed exoskeletons for military use. In October 2010 they have unveiled an assistive
version caled eLEGS (Exoskeleton Lower Extremity Gait System) intended for patients
with complete and incomplete SCI [172]. In 2011 eLEGS was renamed as Ekso.
Ekso weights approximately 23 kg and has a battery life of an average of four hours. The
device uses DC motors for actuation of hip and knee joints in the sagittal plane and the
ankle is kept passive. Ekso system uses pressure sensors under the soles, potentiometers
and an accelerometer/gyroscope sensors [173]. The device can be commanded by a
user interface, controling Ekso step by step. The control strategy is based on position
control, relying on a standard walking trajectory and foot sensors to determine the
walking state. Ekso requires the use of crutches for patients to keep balance. The device
was primarily tested on four paraplegic patients [174] and on three stroke survivors with
chronic symptoms [175].
A recent study [176] has evaluated feasibility and safety of the Ekso when helping am-
bulation of individuals with SCI. Eight individuals with complete lesion participated in
the six week study. Conclusions are the device is safe for SCI patients in a controled
environment in the presence of experts. Ekso Bionics exoskeleton units (figure 1.12)
costs around US$ 150,000.
1.5.4.4 Vanderbilt Exoskeleton
The Vanderbilt exoskeleton is a prototype developed at the University of Vanderbilt
in Tennessee, United States, in the Center for Inteligent Mechatronics. The device
weights about 12 kg and has hip and knee joints actuated. Ankle and foot support are
not present on the device and it has to be used with an o↵-the-self AFO (Ankle-Foot
Orthosis).
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Figure 1.12:Ekso uses DC motors for actuation on hip and knee joints in the sagittal
plane, while the ankle is kept passive. Ekso system uses pressure sensors under the
soles, potentiometers, and an accelerometer/gyroscope sensors.
The device is powered by brushless DC motors through a 24:1 gear reduction, which
provides a maximum continuous torque of 12 Nm for hip and knee joints [177]. Addi-
tionaly, knee motors are equipped with electromechanical brakes that lock knee joints
in an event of power failure. Potentiometers are used as angular position sensors. A
lithium polymer battery of 29.6 VDC and 3.9 Ah brings one hour of autonomy for a
continuous walk with the device at a speed of 0.8 km/h [178, 179].
The control of the orthosis is based on postural information measured on the device,
that the authors claim, enables the user to control autonomously the device in a safe,
reliable and intuitive manner [180]. The device is designed to provide legged mobility
for people with paraplegia [181], including the possibility to aid paraplegic individuals
to ascend and to descend stairs [182]. It is modular and split into three pieces, which
makes it easy to dress on and o↵, even if the user is in a wheelchair. The device can
support people weighting up to 91 kg. In figure 1.13 a picture of Vanderbilt exoskeleton
is depicted. The authors indicated that a trade-o↵associated with the design of the
device is that it needs a custom fitting for each user of di↵erent sizes.
In October, 2012, the Vanderbilt University has signed an exclusive agreement with
Parker Hannifin Corporation for further development and commercialization. Parker
has named the exoskeleton as Indego and is planning to make the device available com-
mercialy in Europe in 2015 and in the United States in 2016. To date, Indego stil
does not have been submitted for FDA approval and stil does not have regulatory ap-
provals for European market. The device is currently undergoing clinical testing with
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Figure 1.13:The Vanderbilt exoskeleton is powered by brushless DC motors through
gear reductions that provides a maximum continuous torque of 12 Nm for hip and knee
joints.
SCI patients in di↵erent hospitals, but no further results have been published to date.
1.5.4.5 Rex
Rex Bionics is a company in New Zealand that manufactures the exoskeleton named Rex
(Robotic EXoskeleton). They have been working on the development and construction
of the device since 2003 [173]. Compared to other robotic exoskeletons, Rex is much
bigger and bulky, weighting about 52 kg. The advantage is that, to the best of the
author’s knowledge, Rex is the only exoskeleton that can balance itself, eliminating the
need of any additional supportive aid such as crutches.
Rex, shown in figure 1.14, is not intended for rehabilitation, but for functional compen-
sation in SCI patients that can operate hand controls. It is commanded by a joystick
alowing the user to sit, stand, walk at level ground and turn left or right. The maximum
speed that can be achieved by Rex is about 0.5 km/h. As such, Rex is obviously not a
complete replacement for the wheelchair at this stage, but instead it is a complementary
device with its own benefits.
Rex Bionics sels two models of its exoskeleton: one for personal use and other intended
for clinical rehabilitation. The main di↵erence between the two models is the possibility
of rapidly adjusting the rehabilitation model for multiple users who may vary in height,
weight and medical needs. The personal model is licensed for the European market,
seling for about US$ 150,000 plus servicing costs. Public research about the device and
clinical data have not been published to date.
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Figure 1.14:Rex is not intended for rehabilitation, but for functional compensation
in SCI patients that can operate hand controls. Rex can balance itself, eliminating the
need of any additional supportive aid such as crutches.
A version of Rex, caled NeuroRex, augmented with a brain-machine interface based on
EEG (Electroencephalography) for the control of the locomotion functions of Rex, has
been developed at the University of Houston [183–185]. NeuroRex is intended for use
by patients with SCI, and it is the first powered exoskeleton that can be controled by
the patient’s brain waves.
1.5.4.6 X1
The exoskeleton X1 [186] was developed by NASA (National Aeronautics and Space
Administration) in Texas, United States, in partnership with IHMC (Institute for Hu-
man and Machine Cognition) in Florida, United States. The technology used in X1 is a
combination derived from two di↵erent projects: the basic actuator design, safety sys-
tems, communication and control schemes are inherited from Robonaut2, a humanoid
robot developed to operate aboard the ISS (International Space Station) [187]; the se-
ries elastic actuation scheme was leveraged from the IHMC Mobility Assist Exoskeleton,
designed for assisted walking [188].
X1 is a tethered device with a backpack carried by the user, represented in figure 1.15.
The total weight of the device is about 26 kg. Actuation on the X1 is based on series
elastic rotary actuators for hip and knee on sagittal plane. Ankle has a passive degree
of freedom, as wel as hip abduction/adduction and internal/external rotation.
X1 exoskeleton has been developed for possible future use in the ISS. Since astronauts
need to exercise in space to keep bone density and muscle tone, X1 is planned as a
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Figure 1.15:X1 exoskeleton has been developed by NASA in partnership with IHMC.
The device is intended for possible future use in the ISS as a compact exercise tool for
astronauts.
compact exercise tool to be aboard of the ISS. Meanwhile, a recent study [189] has
tested X1 with two healthy subjects and one post-stroke victim. The objective was to
demonstrate the feasibility of implementing a neural interface with the X1, capable of
decoding lower limb movement during walking based on EEG signals. Authors pointed
out that actuation on the ankle joint would be very clinicaly relevant for stroke patients,
to counteract the foot drop problems.
1.5.4.7 Other Lower Limb Exoskeletons
A number of groups have published di↵erent works on lower limb exoskeleton devices
that are stil in the early stages of research and/or development. In the work presented in
[190], a di↵erent assistive concept with a combination of active orthosis, mobile platforms
and telescopic crutches are used. In [191], authors have developed an EMG-based lower
limb robot based on a neuro-fuzzy controler.
Mindwalker [192] is an exoskeleton developed at the University of Twente, The Nether-
lands, that targets SCI population. A recent study [193] shows the changes in EMG
patterns during the assisted walking with Mindwalker.
The IHMC in Florida, United States, has also developed di↵erent prototypes of exoske-
letons, as the IHMC Mobility Assist Exoskeleton [188] and Mina [194, 195], both with
actuation on the hip and the knee joints, intended for assistance in paraplegic persons.
A di↵erent approach to achieve more portability was developed at Sogang University in
Korea [196]. Researchers put together a lower limb exoskeleton and an active walker.
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The active walker has a handle and move on wheels, thereby providing support and
maintaining the patient’s balance. The walker also holds batteries, control unit and
motors, while power is transmitted by cables. The orthosis has 1 DOF active joint at
both hips and knees.
1.6 Conclusion
Stroke is a brain lesion caused by the lack of blood supply to the brain. The main
consequence of a stroke is a serious long-term disability, and it a↵ects a large number of
people around the world. Recovery after stroke is primarily based on physical therapy
and there have been some changes in the past decade. The most common rehabilita-
tion method is based on the task specific approach, with physical therapists manualy
assisting patients.
Gait is one of the most important daily life activity a↵ected in stroke victims and,
therefore, much e↵ort has been spent on gait rehabilitation. The physical work required
from therapists is one of the main limitation of the current methods for gait rehabilita-
tion. Moreover, multiple therapists are required to train only one patient and stil the
movement coordination of both legs is far from being synchronized.
In order to help physical therapists to improve the rehabilitation process, robotic devices
have been developed. The main devices for this purpose rely on stationary machines
that help patients to perform gait on a treadmil. Although these machines can aleviate
the physical e↵ort required from therapists and provide intensive training, motivation
and participation of patients are not always achieved. Active subject participation in
robotic gait therapy is vital to many of the potential recovery pathways and, therefore,
it is an important feature of gait training.
Ambulatory exoskeletons have emerged as a promising approach to restore gait and im-
prove motor function. Two main objectives are targeted with ambulatory exoskeletons:
gait compensation and gait rehabilitation. Most ambulatory exoskeletons target gait
compensation, which is understood as a replacement for lost movements. The main
attempt is to substitute the wheelchair with a device that can bring more benefits to
the user.
A few overground exoskeletons have shown the first results with patients. Although the
e↵ectiveness of these devices is stil unclear, the literature suggests that they are feasible
systems that can provide intensive training and superior motivation to patients.
Nevertheless, many chalenges remain. Actuation at the ankle, which is not present on
rehabilitation overground exoskeletons, would enable implementation of real-time strate-
gies that can better target foot drop problems in stroke victims. Assist-as-needed control
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strategies must also be implemented, leading to an active participation of the patient dur-
ing the rehabilitation task. This approach should be used to promote user involvement
by performing gait in a chalenging real environment. Lastly, clinical evaluation with
exoskeletons must be comprehensive, addressing gait performance and user-perception
through clinicaly validated functional scales and protocols.
1.7 Objectives and Organization of the Dissertation
1.7.1 Framework
The work presented in this dissertation was carried out at the Neural Rehabilitation
Group of the CSIC (Spanish Research Council). This section wil position this work in
the context of the several projects conducted by the Neural Rehabilitation Group. The
group has a large experience developing robotic devices for gait rehabilitation.
Developments started with the FP5 (Fifth Framework Programme) GAIT Project, which
aimed to provide an integrated approach to active functional compensation and biome-
chanical evaluation of lower limb joint disorders. To achieve this goal, GAIT designed a
KAFO which comprised sensors, actuators and an inteligent control system to regulate
joint functions during walking and other ADLs (Activity of Daily Living). The system,
ilustrated in figure 1.16, was also conceived as a biomechanical monitoring tool, for both
laboratory and daily use, capable of storing data and communicating wirelessly with a
software platform for medical analysis.
Figure 1.16:GAIT exoskeleton: a KAFO provided with sensors, actuators and an
inteligent control system to regulate joints functions during walking and other ADLs.
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Aiming at a population of polyo myelitis and young patients with cerebral palsy, the
GAIT Project approach had two main applications: improvement of the orthosis func-
tionality by means of compensation strategies during walking and ADLs; and tracking
of kinematics, kinetics and comfort data of interest for the patient, physician or physical
therapist during daily use and also at the laboratory.
After GAIT, the FP6 ESBIRRO Project was carried out aiming to develop Limit Cycle
control and biomimetic recovery reactions for the control of walking, in order to apply
these paradigms to design and construct an autonomous walking biped and a robotic
exoskeleton for gait (figure 1.17).
Limit Cycle controled robots exploit the dynamics of the mechanical systems (pendu-
lum behavior of the swinging leg), showing lower energy consumption, whereas walking
stability is comparable to the trajectory controled humanoid robots. Considering that
the starting point of the Limit Cycle robots was inspired on human gait, the ESBIRRO
Project proposes one step further in the evolution of such robots: implementation of
recovery reactions from perturbations that can be found in biological systems, e.g., hu-
man stumble reaction. These new generation robots can keep lower energy consumption
with improved stability. The modeling and control of a biped robot provide further
understanding of human gait, paving the way for novel actuated orthoses regarded as
robotic extensions of the human being: exoskeletons.
Subsequently, the REHABOT Project proposed research in the field of hybrid actuation
and control for rehabilitation of motor disorders, in particular to prove the concept of the
hybrid walking therapy for paraplegic individuals. The overal aim was to generate the
necessary knowledge to design a novel hybrid walking therapy with fatigue management
for incomplete spinal cord injured subjects. Research activities were conducted towards
Figure 1.17: Exoskeleton designed in the ESBIRRO Project that aims to develop
Limit Cycle control and biomimetic recovery reactions for the control of walking.
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Figure 1.18: Spinal cord injured patient using the REHABOT exoskeleton. The
device comprises a knee actuated exoskeleton working in close cooperation with FES
for gait rehabilitation.
the establishment of the required methods, hardware and software systems to proof the
concept with a pilot clinical evaluation.
A knee actuated exoskeleton was developed to work in close cooperation with FES in gait
rehabilitation, ilustrated in figure 1.18. Technicaly, assist-as-needed was implemented
over the basis of a compliant control of the exoskeleton and a closed-loop control of the
FES.
A clinical evaluation protocol in REHABOT alowed to assess the impact of the hybrid
walking therapy in paraplegic patients. Results demonstrate that the hybrid controler
adapts to patient residual function during walking and that the therapy is tolerated by
patients. Furthermore, the walking function of patients was improved after participating
in the study. In conclusion, the hybrid walking therapy holds potential for rehabilitate
walking in incomplete paraplegic patients, guaranteeing further research on this topic.
FP7 BETTER was the next project, that designed a new approach for gait retraining
post-stroke, in which existing and novel robotic technologies could be improved when
combined with non-invasive Brain/Neuronal Computer Interaction. BETTER proposed
a multimodal Brain/Neuronal Computer Interaction system that interacts with gait exo-
skeletons, implementing new control methods and monitoring functions. This concept
is represented in figure 1.19. The ultimate goal is to promote the active participation of
patients and to improve the functional outcome.
The project explores a top-down approach research in order to combine signals from
central and peripheral nervous systems with biomechanical data and provide a means
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Figure 1.19: Scheme that ilustrates the concept in the BETTER Project: closed
loop brain computer interface triggering an active AFO for inducing cortical neural
plasticity.
to evaluate the physical rehabilitation, its usability and acceptability. Furthermore,
BETTER provided means to assess patient’s compliance through the Brain/Neuronal
Computer Interaction, characterize the user involvement and modify the intervention at
the periphery with the robots. In this project a robotic AFO and KAFO were developed.
Each of these components are stand alone tools for earlier phases of stroke rehabilitation,
when patients are stil not able to control trunk and hence to walk. Di↵erent studies
were conducted in BETTER with the developed devices as a proof of concept for stroke
rehabilitation.
Subsequent work was developed in the HYPER Project (Hybrid Neuroprosthetic and
Neurorobotic Devices for Functional Compensation and Rehabilitation of Motor Dis-
orders), in which framework the work presented in this dissertation was carried out.
The research in HYPER project o↵ers a significant advance in investigating wearable
exoskeletons and neuroprostesics devices in close interaction with the human body. The
objective is both rehabilitation and functional compensation of motor disorders in ADLs.
HYPER focuses its activities on the development of novel configurations that aggregate
exoskeletons, neuroprostesics and virtual reality. These devices, by their combined ac-
tion, can enhance and help restore the latent capacities of patients su↵ering from stroke
or SCI.
The project aims to validate, both clinicaly and functionaly, the concept of developing
hybrid devices for rehabilitation and functional compensation of motor disorders, under
an assist-as-needed paradigm. It combines artificial and biological structures integrated
to restore motor function in patients. The main chalenges are to improve the outcome
of therapy and alow an early recovery, overcoming the major limitations of the current
rehabilitation solutions.
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Figure 1.20:H1 exoskeleton is the first version of a wearable exoskeleton developed
in the HYPER Project. The integration of wearable exoskeletons and neuroprosthetic
devices in this project aims to overcome the major limitations of current rehabilitation
solutions for stroke and spinal cord lesions.
In the framework of this project the author also obtained his Master Degree working on
the development of a first version of the lower limb exoskeleton, caled H1 and ilustrated
in figure 1.20. Based on experiments conducted with healthy subjects, we propose a new
version of the device, caled H2, with significant improvements when compared to the
H1. This dissertation wil present the H2 design, implementation and evaluation with
stroke patients.
H2 exoskeleton presented in this dissertation has been already integrated into a new
ongoing FP7 project caled BIOMOT. The main objective of BIOMOT is to improve
existing wearable exoskeletons by exploiting dynamic sensory-motor interactions and by
developing cognitive capabilities that lead to symbiotic gait behavior in the human-robot
interaction. BIOMOT proposes a cognitive architecture for robotic exoskeletons exploit-
ing neuronal control and learning mechanisms aiming to enable positive co-adaptation
and seamless interaction with humans.
1.7.2 Objectives
The main objective of this dissertation isto design, develop and validate a lower
limb robotic exoskeleton and an assist-as-needed therapy for gait rehabili-
tation in post-stroke patients. Around this main objective, several scientific and
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technical chalenges are addressed in this dissertation, which constitute the folowing
partial objectives:
1.First objective is to design a lightweight and ambulatory exoskeleton. Most state
of the art ambulatory exoskeletons include a backpack that should be carried by
the user, therefore resulting in a non-comfortable embodiment to the user. This
work focuses on designing a device that does not extend above mid-abdomen and
requires nothing to be worn over the shoulders and nothing above the lower back,
which presumably renders the user more comfort when using the device.
2.Another objective is the development of an adjustable device that can be used by
a broader range of patients. The adjustments should be simple and easy to be
performed by therapists, enabling a fast donning and do ng process when using
the exoskeleton in a clinical environment. This should lead to a reduced time from
the moment that patients arrive at the clinics to the moment they start practicing
walking.
3.Actuation on al three joints in both legs is another important aspect targeted in
the development. Ankle joint actuation is never addressed in overground rehabili-
tation exoskeletons, but it is very important to counteract the foot drop problems
in post-stroke patients. We envisioned a completed actuated device in the sagit-
tal plane, capable of providing the necessary torque to completely assist patients
through the walking process.
4.Further objective is the implementation of an untethered device with high auto-
nomy. The device should be battery powered with al electronic systems embed-
ded and wireless communications for data colection and user interface interaction.
This objective aims to give more freedom to the user while performing overground
walking, alowing intensive and repetitive gait training, freeing physiotherapists
from doing a laborious manual work.
5.A safe device is another objective and a main consideration in the development.
The design should account for safety features on the hardware and software, avoid-
ing any kind of dangerous situations that could lead to patient’s injury.
6.The development of a robust control approach that does not need manual adjust-
ments to each user is aimed. The exoskeleton should adapt to patient disabilities,
but without any sensors physicaly attached to human limbs. Al sensory infor-
mation should come from sensors placed on the exoskeleton. This wil lead to
robustness, more comfort and reliability.
7.Another important objective is the engagement and motivation of patients. Am-
bulatory exoskeletons that chalenge patients to perform movements in real envi-
ronments can be more e↵ective to reinstate neuroplasticity and to improve mo-
tor functions when compared with treadmil training. Performing gait in a real
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scenario may also help patients to improve others functions as weight shift and
balance.
8.Patient active participation in the rehabilitation process is another goal. This wil
be created by an assist-as-needed control algorithm that only applies the necessary
torque to complete the gait process, instead of fuly driving the lower limbs while
the patient remains passive. The exoskeleton should guide each patient’s joint in a
correct trajectory, only applying a restoring force when the patient deviates from
the correct trajectory.
9.A further objective is the development of an open architecture that wil alow the
exoskeleton to be integrated and/or commanded by third party systems. This fea-
ture alows the exoskeleton to be integrated into a more sophisticated rehabilitation
scenario and interface with external devices that can further engage patients. It
also generates the possibility of developing future therapies for retraining balance,
sit-to-stand, etc.
10.One last objective of this dissertation is the validation of al aspects related to
the usability and safety of the device with post-stroke patients. The validation
wil be a proof-of-concept of al design and implementation applied to a clinical
rehabilitation scenario. The clinical study should also generate feedback for further
implementation of a randomized clinical trial with a large cohort of patients.
1.7.3 Organization
This dissertation is organized in five chapters. Chapters 2 to 4 addresses specific top-
ics that relate to the development and validation of the lower limb exoskeleton, while
Chapter 5 presents the main conclusions of the work and provides future research and
development activities, proposed to improve the work presented in this dissertation.
Chapter 2 presents the mechanical and electronic design and the development of the
robotic exoskeleton. The chapter starts with the criteria for the mechanical design and
its implementation. Afterwards, the rationale for actuator selection is given and the joint
actuation implementation is explained. Power supply system and exoskeleton sensors
are detailed subsequently. Next, al the electronic development is detailed, including
the joint embedded electronics, the main controler board and the deterministic real-
time communication bus used to connect al joints to the main controler. Finaly, an
explanation about the safety systems incorporated on the exoskeleton is given.
Chapter 3 presents the development of al the software components implemented in the
exoskeleton. It starts with the software implemented at the actuation level, folowed by
the close loop controlers’ implementation. Subsequently, it is addressed a strategy for
implementing an assist-as-needed therapy for gait rehabilitation in a clinical scenario.
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The user interface developed for therapist interaction with the H2 is also presented.
Finaly, the chapter describes the open architecture of the device that alows it to be
integrated with third party devices, detailing the integration with a neural interface.
Chapter 4 presents the evaluation of safety and usability of the exoskeleton as a proof-of-
concept. First, experimental results about the use of the device with a group of healthy
subjects are presented. The experiment aims to validate the hardware and software
development prior to the clinical evaluation with post-stroke patients. With the clinical
study, it is validated the safety and usability of the device when applied to stroke victims
in a rehabilitation scenario. The study also investigates the e↵ects of the overground
walking therapy implemented to assist patients as needed.
Chapter 5 concludes the dissertation, gathering the main results and conclusions. Pub-
lications and patents originated from this dissertation are also summarized. Finaly,
future research and development activities originated in this dissertation are proposed.
Chapter 2
H2 Lower Limb Exoskeleton1
This chapter presents the H2 hardware design and implementation. The device is con-
ceived as a lower limb robotic exoskeleton for gait rehabilitation in stroke patients. The
chapter begins with a brief introduction about human walking, which gives background for
the exoskeleton mechanical design. It folows the rationale behind the actuators’ choice
and power requirements for designing an untethered device. As a result, the robotic
exoskeleton comprises active actuation on the hip, knee and ankle joints and it is pow-
ered by a lithium polymer batery for autonomous overground walk capabilities. Sensory
system of H2 includes di↵erent types of sensors placed on the exoskeleton, but not a sin-
gle sensor placed on the user’s body. This approach aims at improving user’s comfort,
system reliability and a fast and simple donning/dong process. Subsequent sections
detail the electronic architecture that was specificaly customized for H2. The architec-
ture comprises a distributed control system, designed to be more reliable and to avoid the
bulkiness and di culty of wiring sensor and actuator’s cables over the H2 mechanical
frame. Lastly, the chapter presents the safety features that have been implemented in
di↵erent levels to avoid possible injuries to patients during training.
1This chapter is partialy based on the folowing:
M. Bortole, A. del Ama, E. Rocon, J. C. Moreno, F. Brunetti, and J. L. Pons. Aroboticexoskeleton
for overground gait rehabilitation, in Proceedings of IEEE International Conference on Robotics
and Automation, pp. 3356–3361, 2013.
M. Bortole. Design and control of a robotic exoskeleton for gait rehabilitation, Master
Thesis, Universidad Carlos III de Madrid, 2013.
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2.1 Introduction
It is a general assumption that robotics wil play an important role in future activities
within rehabilitation of disabled people. The interest in rehabilitation robotics has grown
exponentialy in the last decade mainly due to the growing demand caused by increasing
numbers of stroke victims and the associate costs of rehabilitation [90]. As a result,
robotic-based therapies have been developed worldwide. However, the majority of the
existing robotic-based gait rehabilitation systems commercialy available are stationary.
Thus, patient’s displacement between two di↵erent places during training is not possible.
In an attempt to overcome this disadvantage, virtual reality systems have been applied
with the objective of to encourage and motivate patients [197].
However, motivation and engagement can be better achieved with exoskeletons capable
of overground walking. In these devices, actuators placed at the joints of the robot con-
trol patient’s joint motions, helping them to perform close to normal walking patterns.
Understanding the biomechanics of the human walking is essential to design such exo-
skeletons. Figure 2.1 represents a simplified diagram of the human gait. It is worth
to note that the event’s timing during the gait cycle labeled in the figure is approxi-
mate, slight varying across individuals and conditions. The gait cycle during human
walking is typicaly represented as starting and ending at the point of heel strike on the
same foot (represented from 0 to 100%). The heel strike on the adjacent foot occurs at
approximately 60% of the gait cycle.
In general terms, the human leg can be thought as a structure with seven DOF: three
rotational DOFs at the hip, one at the knee and three at the ankle. The sagittal plane is
Stance Phase Swing Phase
Heel Strike Heel StrikeOpposite Toe Of Opposite Heel Strike Toe Of
0% 10% 50% 60% 100%
Figure 2.1:Simplified diagram of the human walking through one cycle, beginning
and ending at the heel strike. Percentages showing contact events are given at their
approximate location in the cycle, since there is a slightly variation across individuals
and conditions. Adapted from [151].
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the dominant plane of motion during human locomotion. Joint movement in this plane
is simply referred to as flexion (positive direction) and extension (negative direction).
The practical implementation of an autonomous exoskeleton to assist human walk faces
a number of scientific and technological chalenges. Power supply, lightweight and ef-
ficient actuators and compliant control systems are among the many issues that a re-
searcher has to face. In an advanced exoskeleton development, o↵-the-shelf components
as actuators, batteries, electronics and other subsystems, usualy do not meet the low
weight, autonomy and high e ciency needed to accomplish the design objectives [151].
Consequently, most of the parts have to be developed and customized to fulfil the
implementation requirements.
This chapter presents a novel lower limb exoskeleton, caled H2, designed to drive the hu-
man legs during overground gait rehabilitation. It is shown that designing a customized
actuation structure, power supply system and al electronic architecture can result in a
more lightweight, compact and e cient system. Also, the right choice of the joints that
should be actuated is very important, as wel as the number of degrees of freedom. Too
many actuated joints can result in a bulky and heavy device with a much more complex
control system. However, lack of actuation in some important joints can lead to some
drawbacks, as missing actuation on the ankle joint, which is clinicaly relevant for stroke
patients to counteract the foot drop problems.
The design of the H2 robotic exoskeleton is based on the background presented in Section
1.7. With the stroke population in mind, it was developed a lower limb exoskeleton with
six actuated joints (hip, knee, ankle on both legs) in the sagittal plane, since this is the
main plane of motion during human walking.
This chapter starts by presenting the rationale for the design and the mechanical im-
plementation of the exoskeleton in Section 2.2, with a description of the structure, ad-
justments, degrees of freedom and range of motion of the device. Section 2.3 describes
the rationale behind the actuators’ choice and the mechanical implementation on the
H2 joints. Section 2.4 presents the power supply system developed for running H2.
Subsequently, the electronic control architecture is presented in Section 2.6. Section 2.7
explains the safety mechanisms implemented in the hardware and software of the H2.
The chapter ends with conclusions that summarize the major results of the design and
development of this exoskeleton.
2.2 Mechanical Design
H2 exoskeleton is designed for gait rehabilitation of adults between 1.50 and 1.95 meters
in height, with a maximum body weight of 100 kg. The device is primarily intended for
rehabilitation of stroke victims, but it can also be used for gait compensation in patients
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who have paralysis of the lower limbs folowing spinal cord injuries. It is conceived for
overground gait training in a clinical environment as a bilateral wearable device. The
H2 has six DOF, in which hip, knee and ankle are powered joints.
One novel characteristic in the H2 is the actuation on the ankle joint. Existing exoske-
letons for rehabilitation (please refer to Section 1.5.4) are constructed without actuated
foot segments and patient’s ankle joints are not controled. Usualy, patients move
their feet freely or the feet are lifted during the swing phase of walking using passive
mechanisms as elastic straps, springs or passive orthoses. However, the ankle plantar
flexors play a key role in propulsion, body-weight support and swing initiation during
walking [198]. After a stroke, propulsive impulses delivered by plantar flexors muscles
are often highly asymmetric. Push-o↵asymmetry results in increased metabolic energy
consumption and slow walking speeds [199–201]. Also, actuation of ankle joint can be
very clinicaly relevant to counteract the foot drop problems that typicaly a↵ect stroke
survivors [189].
H2 mechanical design is a totaly improved version of the exoskeleton H1 developed by
the author on his master thesis and published in [202]. Improvements in the H2 with
respect to the H1 account for a stronger and simpler actuation structure on the knee
and the ankle joints, a more durable and reliable knee joint mechanism and a more
lightweight hip joint. The H2 electronic architecture and control software is totaly new
and wil be presented in Chapter 3.
Various criteria informed the H2 mechanical design. As pointed out in the literature
[203], an exoskeleton design should be ergonomic, comfortable, lightweight, safe, with a
strong structure and adaptable to di↵erent users. Low mass is an important aspect, since
inertia cannot be easily compensated during training [204]. Therefore, aluminum 7075
is primarily used in the mechanical structure in consideration of mechanical resistance
and lightweight. The final device weights about 12 kg including its battery pack. The
exoskeleton frame has bilateral uprights for the thigh and the shank, hinged hip, knee
and ankles and articulated footplates (distaly) and a waist support (proximaly).
The mechanical structure is designed to alow active and passive movements in the
sagittal plane for hip, knee and ankle joints. In the frontal plane, hip ab/adduction
is accommodated by compliance embedded into the hip segment. Such compliance is
intended to provide stability to the wearer, admitting passive movements of about twenty
degrees, which alows for turns while walking. Figure 2.2 (a) ilustrates the anatomical
planes of human body used as reference. H2’s ROM (Range of Motion) in actuated
joints is mechanicaly limited for safety reasons. The maximum ROM possible across al
joints is shown in table 2.1. These values were chosen based on normal gait on healthy
subjects [205], also alowing users to perform sit-to-stand and stand-to-sit movements.
To be consistent with the reference used by clinicians, flexion was considered the positive
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Figure 2.2:a) Representation of the anatomical planes of human body. b) Diagram
of the exoskeleton leg in the rest position (al joints at 0 degree) and positive direction
of movement indicated. The positive direction represents flexion and it is in accordance
with clinicians’ definition.
Table 2.1:H2 degrees of freedom and range of motion across al joints.
Joint Degree of Freedom Actuation Range of Motion
Hip Flexion/Extension active 100 /20
Hip Ab/Adduction passive 10 /10
Knee Flexion/Extension active 100 /3
Ankle Dorsi/Plantar Flexion active 20 /20
direction of movement and extension the negative direction. Figure 2.2 (b) ilustrates
the reference adopted.
The length of the thigh and the shank of the exoskeleton can be adjusted by a mechanism
of two telescopic bars that are pushed one inside the other, and are securely fixed in
di↵erent positions by screws. The same mechanism is used to change the position of
the footplate relative to the exoskeleton’s ankle. The size and position of the adjustable
rounded leg braces with Velcro straps alow for customization to individual requirements.
H2 mechanical structure is shown in figure 2.3. Foam pads are used to minimize pressure
against the skin and prevent damage. The exoskeleton supports its own weight through
the mechanical frame to the ground, so the users do not feel any extra weight on their
trunks or lower limbs.
Importantly, the H2 design is modular, particularly relevant for stroke rehabilitation.
Mechanical design was conceived in such way that al segments of the device can be
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Figure 2.3:Aluminum 7075 is primarily used in the mechanical structure of the H2
in consideration of mechanical resistance and lightweight. Hip, knee and ankle joints
are actuated in the sagittal plane.
used independently in a very simple way. The H2 o↵ers means of using unilateral Hip-
Knee-Ankle, Knee-Ankle or just one joint versions of the device, alowing customized
treatment protocols to each patient’s specific needs.
2.3 Actuators
Most types of actuators used in robotics cannot be used in exoskeletons, since for this
application high torques are required while operating at higher speeds that most actu-
ators can provide [206]. Main candidates available for use as actuators on exoskeletons
are electric, pneumatic, hydraulic and SEAs (Series Elastic Actuator). The design and
selection of the H2 actuators were based on the average torque and power of each joint
during normal gait (not pathological) at normal speed [205]. A study of di↵erent possible
candidates was evaluated. The most relevant criteria to select the actuation technology
to drive the human joints were the specific power (ratio of actuator power to actuator
weight) and portability.
Hydraulic and pneumatic actuators have high power density. Hydraulic actuators have
been used in military exoskeletons such as BLEEX [207, 208] and Sarcos [165]. Pneu-
matic actuators were applied to some stationary devices for rehabilitation, such as PAM
[142] and POGO [143]. The main drawbacks of hydraulic and pneumatic actuators are
that they are bulky, which can make their use prohibitive on lightweight overground
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exoskeletons. They also present problems of internal friction and leakage [207], which
could not be acceptable in devices used in clinical environments.
SEA actuation is based on a elastic element, usualy a spring, placed in series with the
actuator output, where the force is calculated based on its compression [188]. They have
been used in some rehabilitation devices [209], but they stil face a common limitation
about the fixed spring constant of the elastic element. The smooth coordination of force
and position between patient and exoskeleton can be di cult between di↵erent subjects
[210].
Electric motors have been used in most ambulatory exoskeletons [156, 169, 172, 177]. The
literature suggests that the use of electric motors provide a reduction in power consump-
tion during gait [207]. DC motors meet the criteria of necessary power with a compact
and portable solution for wearable devices. Within the DC motors category, brushless
motors o↵er several advantages for wearable devices, including higher eciency, more
torque density, increased reliability, reduced noise, longer lifetime and reduction of elec-
tromagnetic interference. To meet the chalenging goal of using a lightweight actuator
and, at the same time, e cient and able to provide enough torque, BLDC (Brushless
Direct Current) motors were chosen as actuators for the H2 joints. Moreover, flat type
motors were selected, which brings the possibility of placing the motors coaxialy with
the joints and maintaining a smal volume paralel to the user’s legs.
As the exoskeleton joints need more torque and lower speed than BLDC motors can
provide directly, a possible solution for increasing torque and reducing the speed is
coupling a gearbox to the motor shaft output. To achieve a lightweight and a smal
volume solution, strain wave gears were selected as a gearbox. Strain wave gears are
a special type of mechanical gear system, usualy known as “harmonic drive”, because
they are produced by the Harmonic Drive. The main advantages of this type of gearbox,
when compared to traditional gearing systems, include: no backlash, compactness, high
gear ratios, high torque capability, coaxial input and output shafts, good resolution and
excelent repeatability when repositioning inertial loads [211, 212].
A 100 W flat BLDC motor (EC60-100W, Maxon) is used in al six joints. This motor
has a rated nominal voltage of 24 VDC and nominal torque of 220 mNm. Furthermore, a
strain wave gear (CSD20-160-2A, Harmonic Drive) with a gear ratio of 160:1 is coupled
to each motor shaft and gives to the joints a continuous net torque of 35 Nm and
peak torques of 180 Nm. According to [93], an average torque of 35 Nm for the hip
actuator is presumed to be adequate enough for most patients. Based on experiments
with the previous version of the exoskeleton, it was concluded that 35 Nm is enough for
driving knee and ankle joints as wel. Moreover, the human gait cycle does not require
a continuous torque, but higher torques in specific moments, which wil be provided by
the peak torque of the actuators that can reach up to 180 Nm.
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Motor Strain wave gear
Figure 2.4:a) BLDC motor used in the H2 joints. b) Strain wave gear used in the
H2 joints. c) Exploded view of one knee joint, which can provide 35 Nm of continuous
net torque. Al six joints use similar design and actuation system.
Therefore, we designed the three joints with the same actuation system. In figure 2.4 is
shown an exploded view of the knee joint, as wel as the Maxon motor and the Harmonic
Drive gearbox used in the H2.
2.4 Power Supply
The power supply can be one of the most limiting factors for an untethered exoskeleton
embodiment. Although the H2 exoskeleton is designed to be used in a clinical setting, a
tethered device can lead to some drawbacks when performing overground walking. Thus,
the exoskeleton was developed as an autonomous device. Di↵erent types of energy
sources have been used to power exoskeletons [206]. With improvements in battery
technologies over the years, a compact and high capacity battery pack can provide
enough power for running an exoskeleton.
Autonomy also has to do with the performance of the actuators. The developed ex-
oskeleton was designed with high e ciency motors and gearboxes, and state-of-the-art
electronic drives with very low dissipation. Additionaly, a compact lithium polymer
battery pack was specificaly designed to power the H2. The pack has a nominal voltage
of 22.5 VDC and a capacity of 12 Ah. The battery pack is integrated with the mechan-
ical frame and placed at the hip level, providing a comfortable embodiment for the user
and no extra weight on the trunk or lower limbs.
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The battery pack was designed to run the exoskeleton for an average of four hours of
continuous walking. Also, since the battery pack is detachable from the mechanical
frame, it is very easy to replace an empty one with a fuly recharged pack for continuous
work. An external charger was also developed to charge the H2 batteries.
2.5 Sensors
The interaction between user and exoskeleton is very important for user’s comfort and
safety in a wearable robotic device [213]. Also, when sensors have to be physicaly
placed on human limbs, several issues, specialy related to safety, comfort, reliability
and donning/do ng process need to be expected and appropriately dealt with.
In terms of physical interface with the human user, H2 is designed in such a way that
there are no sensors physicaly attached to the human. Al sensory information comes
from sensors placed on the exoskeleton: 6 potentiometers, 25 Hal E↵ect sensors, 24
strain gauges and 4 foot switches are used to determine parameters such as angular
position and velocity, force and interaction torque, motor torque and foot ground contact.
Each joint is equipped with a precision industrial potentiometer (157S103MX, Vishay
Spectrol) used as an absolute angular position sensor. It exhibits a tight linearity of
±0.25% and long rotational life. Its stainless steel shaft is coupled to a toothed puley
and a toothed belt is used to transmit the joint’s motion. This avoids slippage and
therefore a loss of reference position. The position sensor placement at the joint is
represented in figure 2.5.
Potentiometer
Strain Gauge
Figure 2.5:H2 joint ilustrating the position sensor placement, as wel as where the
strain gauges are attached to the mechanical link, in order to measure the interaction
torque between user and exoskeleton.
44 Chapter 2 H2 Lower Limb Exoskeleton
Strain gauges attached at each exoskeleton’s link are used as force sensors. These sensors
are designed to measure the torque produced by the interaction between the user’s limb
and the exoskeleton. Four strain gauges are connected in a ful Wheatstone bridge
configuration to enhance the measurement accuracy and insensitivity to temperature
variations. The bridge is excited with 5 VDC and a custom-made electronic circuit
balances the bridge for nul point measurement, also amplifying the output 500 times.
Thus, the output signal is in a range that alows torque measurements from –50 to +50
Nm. This range was chosen based on the maximum torque of the actuators with a safety
factor for peak torques. A calibration constant was obtained using a set of calibrated
weights and minimized with a least squares algorithm.
Figure 2.5 ilustrates the place where the strain gauges are attached to the mechanical
link. After the attachment to the links, strain gauges are covered and protected by a
hard resin. This avoids humidity and external contamination that can cause damage to
the strain gauges or interfere with measurements.
Besides the interaction torque between the subject and the exoskeleton, the system can
also measure the actuator’s torque. This task is carried out using a Hal E↵ect sensor
that measure the motor’s current, which is directly related to the motor’s torque. The
system also uses the Hal E↵ect sensors inside the motors to compute the actuators’
angular speed.
The footplate of the exoskeleton is equipped with two foot switches based on resistive
sensors, which binary detect the contact between subject’s foot and the ground. These
sensors are located under the heel and the toe, and their main goal is to detect the
di↵erent phases during gait segmentation. The H2 exoskeleton, its actuators and sensors
are shown in figure 2.6.
2.6 Control Architecture
The H2 control architecture is represented in figure 2.7. The electronic hardware is
composed of three main parts:
1. The main board, responsible for running al controlers and synchronizing the
joints’ movements;
2. The motor drives, dedicated to sensor data acquisition and actuator control of
each joint independently;
3. The data bus, a real time network connecting the main board and the motor drives.
Modularity is an important consideration when designing an exoskeleton control archi-
tecture. When the device has to deal with complex tasks and/or have many DOFs, a
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Figure 2.6:Ilustration of the H2 exoskeleton, its actuators and sensors. Al sensory
information comes from sensors placed on the exoskeleton: 6 potentiometers, 25 Hal
E↵ect sensors, 24 strain gauges and 4 foot switches.
centralized control architecture would not be e↵ective anymore [214]. Therefore, a dis-
tributed architecture is implemented in the H2. It also makes easy to use each segment of
the device independently in a very simple way. Unilateral Hip-Knee-Ankle, Knee-Ankle
or only one joint versions of the device can be easily applied in customized treatments
depending on the therapy goals.
2.6.1 Main Board
The main controler is based on a customized electronic board caled H2-ARM, designed
specificaly for real-time control of the H2. The smal size of the H2-ARM board (56 x
44 mm) alows it to be placed on the exoskeleton frame, reducing the bulk, as wel as
complexity and diculty of wiring and connections. Moreover, it eliminates the need of
a backpack being carried by the user, as most lower limb exoskeletons have. Figure 2.8
depicts the board and its electronic architecture.
H2-ARM computational power relies on an ARM (Advanced Risk Machine) microcon-
troler (STM32F405, STMicroelectronics) running at 168 MHz. The board has two
independent CAN (Control Area Network) transceiver channels for real time communi-
cation: one is used to connect to al six motor drives (H2-Joint) boards, receiving sensory
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Figure 2.7:Representation of the H2 control architecture. Modularity is an important
characteristic in the architecture design of an exoskeleton that has to deal with complex
tasks.
information and commanding the six joint’s actuators; the other channel is intended to
connect to external devices.
The board also has two more communication ports, both wireless: Bluetooth and Wi-Fi.
Bluetooth communication is intended to connect to a user interface on a smartphone
or tablet. The user interface is an application that alows physical therapists to change
some parameters as needed within the H2 during rehabilitation. The user interface wil
be discussed in detail in Section 3.6. Wi-Fi link is used to send data wirelessly via UDP
(User Datagram Protocol) to a laptop, where the data and information generated in the
exoskeleton can be visualized in real time and stored for o✏ine analysis. Wi-Fi link can
also be used to connect to external devices.
H2 presents an open architecture that alows it to be integrated with and/or to be
controled by external devices or systems. Both the CAN channel and the Wi-Fi link
are interfaces present on the device for this purpose. This feature open means for
combined studies, alowing integration or augmentation of the H2 with distinct types of
devices. The open architecture wil be detailed in Section 3.4.
The H2-ARM board is powered by 3.3 VDC generated by a high e cient switched
voltage regulator connected to the battery power. Two LEDs (Light Emitting Diode)
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Figure 2.8: a) The H2-ARM electronic board has a smal size of 56 x 44 mm. b)
Scheme of the H2-Joint board that is designed specificaly for real-time control of the
H2.
are used to report the H2 state: LED 1 turns on in green color when H2 is switched on.
LED 2 turns on in blue color if any failure occurs in the communication with the motor
drives. If this happens, the joints’ power is turned o↵for safety reasons. The H2-ARM
also monitors the battery level of the H2.
2.6.2 Motor Drives
H2 is a multi-DOF device with a large number of sensor inputs and control outputs.
The classic approach in robotic design to route al sensor and actuator signal wires to a
central processor would mean tens of wires along the H2 mechanical frame. By creating
a network structure and distributing nodes in each joint, it is only required four wires:
two for distributing the power supply and two for routing al sensors’ and actuators’
information.
Taking advantage of the distributed approach, the six H2 joints are equipped with an
H2-Joint board (numbered from 1 to 6) developed specificaly for the H2 application.
Two main tasks are carried out by the H2-Joint1⇠6 boards: sensors’ data acquisition
and control of joint’s motor. Figure 2.9 ilustrates the electronic board mounted on its
aluminum case and its functional scheme.
The H2-Joint1⇠6 boards are located at the hip, knee and ankle joints at motor’s side.
The boards include a power management module, a computation module, a MOSFET
(Metal Oxide Semiconductor Field E↵ect Transistor) drive module, a communication
transceiver, the signal conditioning and the sensors’ interface.
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Figure 2.9:a) The H2-Joint electronic board mounted on its aluminum case of 58 x 30
mm. b) Scheme of the H2-Joint board that is responsible for sensors’ data acquisition
and control of joint’s BLDC motor.
The power management module receives the power supply voltage coming from the H2-
ARM board and convert it to 5 VDC using switching regulators for e cient conversion.
The 5 VDC powers the computation module, the communication transceiver and the
amplifiers used for signal conditioning. The computational module consists of a 64 MHz
DSP (Digital Signal Processor) microcontroler (DsPIC30F4011, Microchip), with a 48
kB FLASH memory and 2 kB of RAM, with a very low power consumption (less than
350 mW).
H2-Joint1⇠6 boards are in charge of the data acquisition of al joint’s sensors: angular
position, interaction torque, motor torque, joint velocity and foot-ground contact (this
last one only for the ankle joints). H2-Joint1⇠6 contain al the circuitry of the analog
filters for each joint sensor and the amplifiers for the strain gauges. The sensor’s analog
input are converted to a digital value with 10 bits of resolution by the computational
module, after the filtering and amplifying process. A smal data packet of six bytes
aggregates the sensor’s information on each joint and is sent to H2-ARM board every
one milisecond through the communication transceiver that connects al the joints to
the main controler. Detailed information about sensors’ data transmission wil be given
in Section 3.2.
The BLDC motor’s drives are embedded directly into the H2-Joint1⇠6 boards. The
DSP microcontroler controls the joint’s motor via six high speed MOSFETs connected
in a three phase bridge configuration. The MOSFET bridge are controled by PWM
(Pulse Width Modulation) at a frequency of 32 kHz. This approach ensures very low
dissipation and high e ciency in the motor control. The MOSFETs maximum voltage
is 40 VDC and maximum current is 31 A, which make them suitable for controling the
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100 W motor at 24 VDC. Adequate heat dissipation is provided by an aluminum case,
in which the MOSFETs are internaly attached.
H2-Joint⇠6 boards are very compact and lightweight, smal enough to be mounted
directly on the motor’s side in the exoskeleton’s frame. This approach decreases the
amount of electromagnetic noise and the number of wires on the exoskeleton. Moreover,
the drives are designed in a four-quadrant mode configuration, which alows them to
regenerate power when an external force moves the exoskeleton joint. The regenerated
energy is stored back into the battery.
2.6.3 Data Bus
The data bus used on the H2 consists of a network structure with a deterministic real-
time communication based on CAN technology running at 1 Mbps. In this design, only
two serial wires between any two consecutive nodes are required to form a complete
network. This topology is particularly useful when cabling a network where al nodes
are physicaly oriented on a line, as on the H2 legs.
The data bus was designed to enable the H2 main controler (H2-ARM) to interact with
distributed sensors and actuators, reduce the bulk, complexity and di culty of wiring
and achieve high-speed real-time control. Figure 2.10 ilustrates the network topology,
where the six H2-Joints nodes are serialy connected to the H2-ARM. The network alows
an unlimited number of nodes (limited only by the electrical load on the bus) and does
not require any alteration to add or remove nodes. A simple loop-back terminator is
used in both sides of the network in the last node (the ankle boards).
Bus nodes are not addressed in this network protocol. Instead, the address information
is contained in the messages that are transmitted. This is done by an identifier, which
also indicates the message priority. The lower the binary value of the identifier, the
higher the priority of the message.
The network is flexible in terms of configuration, automaticaly avoids data colision and
corrects data packets errors in the transmission. Bus arbitration is based on CSMA/CA
(Carrier Sense Multiple Access with Colision Avoidance), which is a non-destructive
arbitration. If a node wants to transmit a message across the network, it first checks
if the bus is in the idle state (Carrier Sense), i.e., no node is currently transmitting.
In the case of two or more nodes start a transmission at the same moment (Multiple
Access), colision of the messages is avoided by bitwise arbitration mechanism (Colision
Avoidance), and the node with the higher priority becomes the dominant node and sends
its message. Al other nodes wil automaticaly stop transmission and switch to receive
mode. After correct reception of the message, which is acknowledged by each node, the
message is stored when required for that node, otherwise, it is discarded.
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Figure 2.10:Ilustration of the H2 network topology, where the six H2-Joints nodes
are serialy connected to the H2-ARM board. The network runs at 1 Mbps.
Each communication cycle in the network protocol involves passing a message from the
H2-ARM node to al H2-Joint⇠6 nodes in the network. The message payload consist
of six bytes preceded by an ID of eleven bits. Each message data packet also includes
bits that indicate start of the frame, data length, CRC (Cyclic Redundancy Check),
acknowledgment and end of the frame.
As the message travels on the bus, each H2-Joint⇠6 reads its assigned actuator command
data byte by looking the message ID and the payload message (H2-Joint1 reads byte
1, H2-Joint2 reads byte 2 .. H2-Joint6 reads byte 6). The MSB (Most Significant Bit)
represents the motor rotation direction and the remain seven bits give the voltage level
that should be applied to the motor joint (in increments of 0.78%). After reading the
command actuators message, each H2-Joint⇠6 returns one message back to H2-ARM
node with a specific ID and its localy colected sensor data.
The control scheme on the H2-ARM controler runs at 1 kHz. At this frequency, one new
message is sent to al H2-Joint⇠6. Since the communication cycles occur at a fixed rate,
this protocol alows for deterministic control. Also, it provides built-in network error
detection as, for every message received, each H2-Joint⇠6 has to return data information
to the H2-ARM. As a result, H2-ARM has a robust means to determine the integrity of
the network and the correct operation of the joint’s actuators. If some failure occurs on
the network that cannot be corrected automaticaly (for instance, a cable disconnection),
H2-ARM instantly stops the exoskeleton and shuts o↵the joints power for safety reasons.
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To ilustrate the whole hardware and electronic architecture of the H2, figure 2.11 links
a video of the final system working. The software running on the H2-ARM board and
on each one of the H2-Joint⇠6 boards wil be detailed in Chapter 3.
Figure 2.11:Click here or scan this code to see a demonstration video about the H2
exoskeleton.
2.7 Safety
Safety is one of the most important features in robotic exoskeletons. Since the device
is attached to the humans limbs, it should be very compliant with user’s movements.
Specialy in exoskeletons for clinical applications, where patients can have some physical
limitations or weakness, safety features should be incorporated in di↵erent levels, includ-
ing the exoskeleton control system. Very few exoskeletons consider the safety aspect in
the control system [164]. Most of them only implemented safety in the mechanical
design.
H2 has multiple safety features, including the mechanical design, the control system, the
data bus protocol and the software. The first aspect is the mechanical limitation in the
range of motion in actuated joints. The maximum range of motion across al joints is
shown in table 2.1, which is shorter than the human limits. Therefore, the H2 actuators
cannot damage the human legs by applying over extension or over flexion movements.
The second safety aspect is an extend of the ROM limitation. The H2 ROM can be
individualy shortened and limited by software when necessary. In case of patients with
reduced extension and/or flexion movements due to spasticity (very common in stroke
patients) or any other reason, the maximum joint range can be simply reduced in anyone
or a combination of the six joints.
Two more safety mechanisms rely on the protocol used on the H2 data bus. The pro-
tocol based on CSMA/CA guarantees at hardware level data error and data colision
avoidance. The sensors’ data and joints’ actuation commands exchanged between H2-
ARM and H2-Joint1⇠6 are protected against errors, being checked by al nodes in the
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network. If any node detects an error in a message transmitted, the message is auto-
maticaly discarded and repeated by the sender. The second mechanism avoids data
colision in the bus without destroying messages being transmitted. The node with less
priority transmitting a message can recognize that another node with higher priority is
transmitting at the same time. The lower priority node then automaticaly switches to
receive mode without interfering in the message being transmitted. When the higher
priority node finishes its transmission, the other node wil proceed with its data. This
protocol guarantees strict determinism for real time communication, ensuring stability
of the control system.
Safety is also implemented in the high level software control in the H2-ARM. The assist-
as-needed control, that wil be detailed in Section 3.5, implements safety strategies in
the coordination of the joint movements, avoiding, for instance, H2 to perform two
consecutive steps with the same leg.
Another important issue on the exoskeleton is the controler stability. In general, insta-
bilities can be caused by high-frequency and/or high-amplitude external perturbation
induced by robot-human interaction or overshoots in controler’s response. These insta-
bilities were considered and avoided by adequate sensor’s signal filtering and controler
parameters’ adjustments, thus avoiding oscilations or vibration in actuators’ perfor-
mance.
Furthermore, one last safety feature is implemented on the H2-ARM board. The software
determines the integrity of the network by monitoring the frequency of the data received
from al joints. For each actuator command sent by H2-ARM, H2-Joint⇠6 boards have to
acknowledge the message reception by returning their sensor data information. If some
failure occurs in any joint or in the network, H2-ARM instantly stops the exoskeleton
by shutting o↵the joints power. The mechanical impedance of the joints is enough to
stabilize the patient if this occurs. This failure is reported to the therapist by a LED
status.
2.8 Conclusion
This chapter described the mechanical design and the development of the H2 exoskeleton,
as wel as the electronic hardware that was specificaly customized to the H2. The device
is a powered lower limb exoskeleton for rehabilitation of post-stroke patients that need
gait training in order to recover their impaired motor function. H2 has a total mass of
12 kg including its battery pack, which fulfils the first objective of this dissertation: an
ambulatory exoskeleton with a lightweight design.
The H2 exoskeleton can be easily adjusted to be worn by persons from 1.5 to 1.95 meters
in height, achieving objective number 2, which accounts for a device that can be used
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by a broader range of patients. Moreover, the H2 provides assistive torques at both
hip, knee and ankle joints, also achieving objective number 3, by means of a completed
actuated device in the sagittal plane. The device is capable of providing continuous joint
torques of 35 Nm to al six joints.
A custom distributed embedded electronic architecture was designed with power being
provided by a lithium polymer battery which provides power for running the device
untethered. This approach fulfils objective number 4, which is the implementation
of an autonomous exoskeleton. Also, H2 does not extend above mid-abdomen and
requires nothing to be worn over the shoulders and nothing above the lower back, which
presumably renders the user more comfort when using the device. The compact design of
the exoskeleton is greatly facilitated by the customization of al single electronic boards
and by the development of a distributed control system integrated with the mechanical
structure.
Moreover, the battery pack is integrated with the mechanical frame and placed at the
hip level, providing no extra weight on the trunk or lower limbs of the user, thereby
creating a much more comfortable embodiment. The battery pack is detachable and
very easily replaced with a fuly recharged one for continuous work. Also, looking for
comfort and reliability, H2 is designed with no sensors physicaly attached to the user.
Al sensors are integrated in the exoskeleton, thus facilitating the dressing on and o↵
process with patients.
Finaly, many features were implemented in the exoskeleton hardware and software for
increased patient’s safety, fulfiling objective number 5. In the mechanical design, lim-
itation in the ROM of each joint guarantees that H2 wil never exceed humans range
of motion. Stil, each range of motion can be individualy shortened by software if
necessary. The electronic hardware uses a CAN data bus that guarantees a correct com-
munication between al nodes and in case a failure that cannot be automaticaly fixed
by software, powers o↵the H2.

Chapter 3
Assist-As-Needed Control
Strategy
This chapter presents the software development for the H2 robotic exoskeleton, as wel as
the integration of the device with a neural interface. The software was developed in a lay-
ered architecture, with three di↵erent levels. This approach makes easy the development
of new therapies or control strategies without rewriting al the code. The chapter begins
with the description of the software implemented to control each H2 joint actuator. It
folows the description of the middle layer of software, which was implemented to syn-
chronize the movement of al joints and to provide close loop control based on position,
torque or sti↵ness. Each joint can be independently controled by the high level control
layer, where the therapies are implemented. The high level control can be implemented
on the H2-ARM board and directly interface the middle layer or can be implemented
on external devices and communicate to the middle layer by means of UDP or CAN
protocols. For the experiments presented in this thesis, a therapy intervention based on
assist-as-needed control strategy was implemented on the H2-ARM board. Also, for the
same experiments, H2 was integrated with a neural interface intended for monitoring
brain changes during the rehabilitation period.
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3.1 Introduction
The main considerations when designing an exoskeleton control is how to achieve the
best control performance, best user interaction, high stability and safe operation. How-
ever, other important issues have to be considered when designing control strategies for
patient’s rehabilitation. For inducing motor learning, studies have shown that training
is only e↵ective if associated with task-oriented movements involving e↵ort by the pa-
tient [215]. This approach is thought to be an essential requirement to achieve e↵ective
cortical reorganization.
Therefore, simply having an exoskeleton imposing physical therapy by rigidly moving
patient’s limbs wil have limited success, especialy when the patient is passive and not
contributing to the exercise. To achieve ful neurorehabilitation, the brain must work in
association with the motion of limbs to promote corticospinal rehabilitation.
In order to accomplish this, researchers have implemented di↵erent control approaches on
their exoskeletons. HAL, the overground exoskeleton with more studies in rehabilitation
of post-stroke patients [161–163, 216], uses sEMG signals for adjusting the joints’ torque.
However, stroke a↵ects the normal function of the brain, and the EMG signal, which
is a further downstream in the neurological pathway, gets a↵ected as wel. Therefore,
sEMG to torque conversion method wil be a more chalenging task that may need a
long time for adaptation and adjustments [165].
A di↵erent strategy, which has been implemented in stationary gait trainers or upper
limb rehabilitation devices [108, 217–220] to promote user participation, is the so caled
assist-as-needed controler. This approach modulates the robot assistance according to
parameters measured during task execution. It seems to be suitable for hemiplegic post-
stroke patients because the emphasis is more on guidance towards a correct pattern than
on a simple rigid repetition.
The H2 control approach implements an assist-as-needed algorithm based on a force field
control, where the joint torque is generated based on the trajectory deviation, resulting
in a corrective proportional force that guides patient’s limb. This algorithm concept has
the benefit that the controler wil always generate enough torque to stabilize both, the
a↵ected and una↵ected leg, without the need of any model of the exoskeleton or the
user.
The assist-as-needed control of the H2, together with the overground capability, is in-
tended to create a highly motivated environment for patients, leading to a faster recovery
and higher gains in motor functions. Moreover, the use of this robotic tool wil facili-
tate the work carried out by physical therapists, alowing a more intensive training for
patients without fatiguing therapists.
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Another novelty in the H2 software is the open architecture developed for H2 augmen-
tation or integration with third party devices. The software architecture was developed
in such way that it alows H2 to be externaly controled by means of wired and wireless
communication interfaces present on the device.
This chapter presents the development of al H2 software components and its open
architecture integrated with a neural interface. Section 3.2 in this chapter presents
the software design implementation of the H2 at actuator level, responsible for motor
control and sensor data acquisition. Section 3.3 describes the second software layer that
comprises three type of close loop controlers actuating on each joint independently:
position, torque and sti↵ness. Section 3.4 describes the H2 open architecture and the
interfaces present on the device intended for integration or augmentation with external
systems. Section 3.5 presents the implementation of a therapy intervention that provides
assistance based on patient’s impairment level. Section 3.6 explains the user interface
designed to help therapists adjust H2 parameters during training sections. Section 3.7
describes the H2 integration with a neural interface intended to track cortical changes
over the rehabilitation time. The chapter ends with conclusions that summarize the
major achievements of this software implementation.
3.2 Actuator Control
The H2 software was designed with a layered architecture containing three di↵erent
levels. Figure 3.1 associates the software layers with the electronic hardware presented
in Section 2.6. This structure makes easy the development of new therapies or control
strategies without rewriting al the code. Only the top layer needs to be replaced with
the new therapy software.
The first software layer implemented on the H2, caled “Actuator Control” on figure 3.1,
runs on the H2-Joint1⇠6 electronic boards. The software was written in C language
and compiled with the CCS Compiler (PCWHD, CCS Inc.) to be embedded into the
DSP microcontroler. The objective of this firmware is to read and digitalize al sensors’
information and to control the BLDC motor on each joint.
A timer routine is used to read al sensors each 300 microseconds, which includes the
position sensor, the interaction torque sensor, the motor torque sensor and the temper-
ature sensor. In the ankle joints, the foot ground contact sensor is also included. An
analog to digital conversion with 10 bits of resolution is performed and the digital values
are stored in a local bu↵er. When the H2-ARM board request the data (each 1 ms),
an average of the last three analog values are performed and a mathematical function is
used to convert the values to the physical variables that they represent, before sending
the data to the main controler.
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Figure 3.1:Association of the software layers with the H2 electronic hardware. Ac-
tuator Control software runs on H2-Joint1⇠6 boards. Low Level Control and Assist-
as-Needed Therapy algorithms run on the H2-ARM board.
The potentiometers signals are converted to degrees, based on the range of motion
of each specific joint. Interaction torques signals measured by the strain gauges are
proportionaly converted to Nm. Actuator torques are measured with the current sensor
on the MOSFET bridge and proportionaly converted to Nm. The ground contact
detected by the foot switches are converted to a binary signal. A hysteresis comparison is
used to avoid noise in the process of detecting the gait cycles. Temperature information
is the only data not sent to the H2-ARM board. Instead, this information is used
as safety measure in the H2-Joint board: if the temperature rises up more than 70
degrees, the microcontroler disables the MOSFET bridge to prevent it to be damaged.
A notification message is sent to the H2-ARM controler.
The second task carried out by this software layer is the BLDC motor control. A BLDC
motor have three windings on the stator and the rotor is a permanent magnet. To
make the rotor turn, there must be a rotating electric field in the stator, that is created
by exciting two windings at a time. The excitation on the stator must be sequenced
in a specific manner, while knowing the exact position of the rotor magnets. Position
information comes from the three Hal E↵ect sensors inside the motor. There are six
distinct regions or sectors in which two specific windings are excited. By reading the Hal
E↵ect sensors, the microcontroler obtains a 3-bit code value ranging from 1 to 6 that
represents a sector in which the rotor is presently located. Each code, therefore, gives
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information on which windings need to be excited. Thus, a lookup table is implemented
in the program to determine which two specific windings need to be excited based on
sensors’ information.
The three Hal E↵ect sensor outputs are connected to input pins of the DSP microcon-
troler, enabled along with an interruption. If a change occurs on any of these three pins,
an interrupt is generated. Then, the program reads the Hal E↵ect sensor values and
uses them to generate an o↵set in the lookup table for correctly driving the windings of
the BLDC motor. Figure 3.2 represent the sequence commutation of the three phases
of the BLDC based on the rotor location.
Using the above explained method, it is possible to get ful speed rotation of the motor.
However, to be able to control the speed of the BLDC motor, it is necessary to apply
a variable voltage to the terminals of the windings. By varying the voltage across the
windings of the motor, we can directly control the speed of the motor. A PWM approach
is an ecient way to digitaly control the motor speed. Variation of the motor voltage
can be achieved by changing the duty cycle of the PWM signal. Six PWM channels are
implemented in the DSP and connected to the three-phase MOSFET bridge that drive
the motor. The digital command to control motor direction and speed is received from
the H2-ARM main controler. Figure 3.3 ilustrates this control scheme running on the
H2-Joint1⇠6 electronic boards.
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Figure 3.2:Representation of the three phases MOSFET bridge and the commutation
sequence of the BLDC motor. By reading the Hal E↵ect sensors, the microcontroler
obtains the information on which sector the rotor is presently located and, therefore,
information on which windings need to be excited.
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Figure 3.3: Representation of the Actuator Control scheme running on the H2-
Joint1⇠6 electronic boards. The DSP microcontroler receives a command from the
main controler and generates six PWM channels to control the three-phase MOSFET
bridge that drive the BLDC motor.
3.3 Low Level Control
The actuator control firmware is the lowest software layer implemented for H2. A next
software layer, caled low level control, is implemented in the H2-ARM board. The main
objectives of this layer are the implementation of di↵erent types of real time close loop
control and the synchronization of al joint movements.
The low level software layer was programmed in C language and compiled with the
MikroC Compiler (MikroC Pro for ARM, MikroElektronika Ltd.) to be embedded into
the ARM microcontroler. This software receives the sensor information from al joints
in a digital format by means of the H2 data bus. This software layer can control each
exoskeleton actuators in position, torque or sti↵ness independently, which means that
di↵erent types of control can be applied to di↵erent joints at the same time. The H2-
ARM can switch between the di↵erent control modes in execution time.
The idea behind the implementation of the low level software is to guarantee actuators
real time control and make it transparent for a superior software layer. Therefore, a
superior layer wil be responsible for implementing therapy interventions, sending high
level commands to this inferior layer. The folowing subsections explain the implemen-
tation of the low level controlers.
3.3.1 Position Control
The interaction between the exoskeleton and the user’s limb should be as smooth as
possible, avoiding abrupt movements that can cause discomfort and/or instability to the
user. For this reason, the position controler should avoid oscilations in the trajectory
and overshoot response. This behavior can be achieved through the correct tuning of a
PID (Proportional-Integral-Derivative) controler.
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The output referenceu(t) of a PID controler is given by:
u(t)=Kpe(t)+Ki
Zt
0
e(⌧)d⌧+Kdddte(t) (3.1)
where:
•Kpis the proportional gain, a tuning parameter;
•Kiis the integral gain, a tuning parameter;
•Kdis the derivative gain, a tuning parameter;
•eis the error between the set point and the actual condition;
•tis the instantaneous time (the present);
•⌧is a variable of integration that takes values from time 0 to the present.
A discretization process is required in order to design a digital implementation of a PID
controler. Equation (3.1) can be adapted to a discrete function for a digital controler,
based on the sample time4t, which in the present work is 1 ms. The integral term can
be discretized as folows:
Zt
0
e(⌧)d⌧=
kX
n=1
e(n)4t (3.2)
The derivative term can be approximated as a first order function:
d
dte(t)=
e(k) e(k 1)
4t (3.3)
Based on equations (3.2) and (3.3), the digital PID is given by:
u(k)=Kpe(k)+Ki
kX
n=1
e(n)4t+Kde(k) e(k 1)4t (3.4)
wherekis the present sample time. In order to tune the PID controler, the parameters
Kp,KiandKdhave to be calculated. For H2 position controler it was used the Ziegler-
Nichols tuning method [221]. This tuning method is performed by settingKdandKi
gains to zero and increasingKpgain until the control loop oscilates with a constant
amplitude. This ultimate gain, caledKu, and the oscilation periodTuare used to set
the PID gains as indicated in table 3.1.
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Table 3.1:Ziegler-Nichols tuning parameters for adjusting a PID controler.
Kp Ki Kd
0.6Ku 2.0Kp/Tu KpTu/8.0
For a practical application in a rehabilitation scenario, overshoot and oscilations in the
actuator’s response are characteristics to be avoided, for the sake of safety and stability
when using the exoskeleton. To fulfil with these requirements, after calculating the PID
gains, an empirical correction is applied to the parametersKp,KiandKd, in order to
avoid overshoot and oscilations in each actuator’s response.
A scheme of the position controler implemented for H2 is ilustrated in figure 3.4. The
controler also takes into account the ROM limitation for each joint. By default, the
algorithm uses the values presented in table 2.1, but these values can be independent
shortened. Moreover, a program routine was created to reset the integral part of the
PID when H2-ARM switch to a di↵erent control mode. Otherwise, the controler keeps
the integration process and would go unstable next time H2-ARM switches back to it.
Position
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Position Feedback
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  ROM
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Limb PositionSet Point
Figure 3.4:Representation of the position control scheme running on the H2-ARM
board. Position feedback is received from the H2-Joint board that acquires joint sensors’
signals.
3.3.2 Torque Control
The second low level control implemented in H2-ARM is based on torque close loop
control. Two feedback possibilities exist for this control: interaction torque between the
H2 and the user and the actuator torque. Figure 3.5 ilustrates the scheme implementa-
tion that control the torque delivered to each joint independently. The implementation
uses a digital PID controler as presented in equation (3.4) and a similar design strategy
presented for position control, except for tuning the parametersKp,KiandKd.Dueto
the fact that torque control is to a great extent dependent on the environment [222], the
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Figure 3.5: Representation of the torque control scheme running on the H2-ARM
board. The two torque feedbacks are received from the H2-Joint board that acquires
joint sensors’ signals.
parameters are tuned empiricaly through bench testing while the actuators link interact
with the user.
When the interaction torque feedback is selected, the controler keeps the desired output
level of torque in each joint based on the H2 and the user interaction. This control scheme
has a special application in lowering the mechanical impedance of the exoskeleton when
the desired output torque is set to zero. In this scenario, the controler wil actuate at
the joints in such way that the user feels very low (idealy zero) resistance when moving
their limbs attached to the exoskeleton.
The mechanical impedance is known as the relationship between the force exerted in
the exoskeleton actuators and the resulting motion [223]. A low impedance behavior is
also known as backdriveability [224]. Good backdriveability has important advantages
in robotic therapeutic systems [140], including the ability to act as a passive actuator
to capture movements [225].
The users would not feel any resistance when moving their limbs if the mechanical
impedance of the exoskeleton could be zero. This zero impedance can only be achieved
theoreticaly, due to inertia and friction of the actuators and the controler time delay
[226]. However, low impedance can be achieved if the controler drives the motors
based on the interaction with the user. Thus, to make the exoskeleton act as a passive
actuator, this control strategy uses the torque applied by the user to the exoskeleton
links and move the joints trying to maintain at a minimum value the resistance felt by
the user. The controler should be very stable, avoiding high frequency oscilation that
can cause patients to lose balance. Since the interaction torque signal usualy exhibits
high frequency components, a digital Butterworth low-pass filter (5 Hz, 4th order) is
applied to the torque signal in the feedback loop of the controler.
An important application of the low impedance mode is the possibility for the exoskele-
ton to capture user’s movements to create a strategy caled learning mode. A learning
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mode strategy requires that the movement of the legs should not be hindered, and thus,
the mechanical impedance of the exoskeleton should be minimized. However, since the
actuators used in H2 have a high mechanical impedance output, this control strategy
has to be used to make it compliant with user’s motion. The physical therapist is now
able to manualy assist the movements of the patient, while the high level control can
record the joints trajectories. After the task is completed, for example, a sit-to-stand
movement, the high level control can use the recorded data to replicate the movement
actively.
3.3.3 Sti↵ness Control
Sti↵ness is defined as the rigidity of an object, i.e., how much deformation an object
withstands in response to an applied force [227]. In case of an articulated joint, sti↵ness
can be defined as how much the joint deviate from its reference position based on a
certain amount of torque applied at the joint.
For a wearable exoskeleton, which is attached to the patient’s limbs, compliance with
user’s movement is very important. Otherwise, the exoskeleton may cause injuries to
the patients by applying too much torque on their joints in specific occasions. Sti↵ness
control can be implemented to make the exoskeleton’s joints more compliant with user’s
movement and not as rigid as when controled in position. This control is, in some way,
equivalent to a torque limitations into the motors.
The sti↵ness control was implemented aiming to drive the joints with a variable sti↵ness
from 0 to 100%. If the joint sti↵ness is set to 0, the joint controler does nothing and
the joint is free to move, only limited by the intrinsic mechanical impedance of the joint.
With a sti↵ness value of 100% the joint is alowed to use ful torque power to reach a
given position. Therefore, the behavior in this particular condition is similar to position
control. Between these two extremes, the joint is more or less compliant proportionaly
to the selected sti↵ness level. When trying to reach a desired position, the controler
wil apply a limited torque. If the provided torque is not enough, since the user apply
higher opposite torque, the joint does not reach the target position.
Figure 3.6 represents the sti↵ness close loop controler. It was implemented by means
of a digital PD (Proportional-Derivative) controler, given by the equation (3.5), that
derives from equation (3.4):
u(k)=Kpe(k)+Kde(k) e(k 1)4t (3.5)
whereuis the controler output,Kpis the proportional gain,Kdis the derivative gain,
eis the error between the set point and the actual condition,kis the present sample
and4tis the sample time. Similar to the PID controler, the parametersKpandKd
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Figure 3.6:Representation of the sti↵ness control scheme running on the H2-ARM
board. Position feedback is received from the H2-Joint board that acquires joint sensors’
signals.
have to be calculated in order to tune the PD controler. The Ziegler-Nichols tuning
method was also used for this controler. With the parameterKdset to zero,Kpgain
was increased until the control loop oscilates with a constant amplitude. This ultimate
gainKuand the oscilation periodTuare used to set the PD gains as indicated in table
3.2.
Table 3.2:Ziegler-Nichols tuning parameters for adjusting a PD controler.
Kp Kd
0.8Ku KpTu/8.0
For the same reasons as discussed in the implementation of the position controler, after
calculating the PD gains, an empirical correction is applied to the parametersKpand
Kd, in order to avoid overshoot and oscilations in each actuator’s response.
Two set points are defined for the sti↵ness controler. The first one represents the desired
position that the joint should reach and the second one is the sti↵ness percentage, which
is an indication of the maximum torque that the actuator should provide. Variations
in the sti↵ness value wil proportionaly changes the parameterKp. As a result, the
controler outputu(k) is reduced, proportionaly reducing the torque generated by the
actuator.
3.4 Open Control Architecture
Most, if not al, robotic machines for rehabilitation have a close architecture, which
means that they cannot be easily integrated with other devices or externaly controled.
H2, however, presents an open architecture that alows it to be integrated with other
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devices or systems and to be externaly controled. The architecture was developed in
such way that not only permits it to be externaly controled, but make the task simple
by means of both wired and wireless communication interfaces present on the device.
The wired interface is based on a CAN bus working at 1 Mbps. Through this interface,
an external device can access the low level controlers of the H2, being able to control
each joint of the device independently in real time. The external system can control H2
joints in position, torque or sti↵ness. Also, al the kinematic and kinetic data generated
in the exoskeleton is sent by the same bus to the external devices connected to the bus.
Since CAN communication protocol alows an unlimited number of nodes connected
to the same bus, multiple devices can receive the H2 data and send commands to it
simultaneously.
A message protocol was created to be used when connecting with external devices by
using CAN. Four types of commands are defined. Each command is based on a standard
CAN message with a unique ID and six data bytes. Table 3.3 summarizes commands
accepted and their functions. Table 3.4 represents kinematic and kinetic data sent by
the H2 in three messages of six bytes each.
Table 3.3:CAN messages format accepted by the H2 from external devices.
Message Joint Control Min Angles Max Angles Start/Stop
ID 70 75 80 85
Byte 1 Motor ID Right hip Right hip Start/Stop Data
Byte 2 Type of control Right knee Right knee Reserved
Byte 3 Pos/torque set point Right ankle Right ankle Reserved
Byte 4 Sti↵ness set point Left hip Left hip Reserved
Byte 5 Reserved Left knee Left knee Reserved
Byte 6 Reserved Left ankle Left ankle Reserved
The commandJoint Controlcan be used to control each one of the six joints indepen-
dently.Motor ID values means: 1 = Right Hip; 2 = Right Knee; 3 = Right Ankle; 4 =
Left Hip; 5 = Left Knee; 6 = Left Ankle.Type of Controlvalues means: 1 = Position
control; 2 = Sti↵ness control; 3 = Torque control; 4 = Motors disabled; 5 = Motors
stopped. WhenPosition Controlis used, byte 3 is the set point for that joint and bytes
4, 5 and 6 are not used. ForTorque Control, byte 3 is the set point for that joint and
bytes 4, 5 and 6 are not used.Sti↵ness Controluses byte 3 as the set point for position
and byte 4 as the percentage of sti↵ness for that joint (where the value 0 means no
sti↵ness and the value 100 means the maximum possible sti↵ness).
The commandsMin Angles andMax Angles can be used to set the minimum and
maximum angles accepted as set point forPositionandSti↵ness Control, shortening
Chapter 3 Assist-As-Needed Control Strategy 67
Table 3.4: Kinematic and kinetic data sent by the H2 through CAN to external
devices.
Message Joint Angle Joint Torque Foot Switch
ID 110 120 130
Byte 1 Right hip angle Right hip torque Right heel foot switch
Byte 2 Right knee angle Right knee torque Right toe foot switch
Byte 3 Right ankle angle Right ankle torque Left heel foot switch
Byte 4 Left hip angle Left hip torque Left toe foot switch
Byte 5 Left knee angle Left knee torque Battery voltage
Byte 6 Left ankle angle Left ankle torque Reserved for future use
the ROM of the joints. The commandStart/Stopis used to start or stop sending data
via CAN (byte 1 = 1 starts data; byte 1 = 0 stops data).
In order to make the integration task with external devices even easier, H2 features a
wireless communication port based on Wi-Fi. When turned on, the H2-ARM board cre-
ates an Wi-Fi spot that alows any Wi-Fi enabled device to connect to its network. The
H2-ARM automaticaly assigns an IP (Internet Protocol) address to devices connected
to the network. Through UDP protocol, similar commands are implemented in packets
of 8 bytes. Table 3.5 summarizes commands structure accepted by the H2 and table 3.6
represents kinematic and kinetic data sent back.
Table 3.5:UDP data frame accepted by the H2 from external devices.
Message Joint Control Min Angles Max Angles Start/Stop
Byte 1 115 (Start frame) 115 (Start frame) 115 (Start frame) 115 (Start frame)
Byte 2 70 (Message ID) 75 (Message ID) 80 (Message ID) 85 (Message ID)
Byte 3 Motor ID Right hip Right hip Start/Stop Data
Byte 4 Type of control Right knee Right knee Reserved
Byte 5 Pos/torque set point Right ankle Right ankle Reserved
Byte 6 Sti↵ness set point Left hip Left hip Reserved
Byte 7 Reserved Left knee Left knee Reserved
Byte 8 Reserved Left ankle Left ankle Reserved
3.5 Assist-As-Needed Therapy
During rehabilitation, assisting patients only when they need is, amongst others, a
prominent aspect to make robotic rehabilitation successful [220]. In the rehabilitation
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Table 3.6: Kinematic and kinetic data sent by the H2 through UDP to external
devices.
Byte Data Byte Data
Byte 1 115 (Start frame) Byte 12 Left knee torque
Byte 2 Right hip angle Byte 13 Left ankle torque
Byte 3 Right knee angle Byte 14 Right heel foot switch
Byte 4 Right ankle angle Byte 15 Right toe foot switch
Byte 5 Left hip angle Byte 16 Left heel foot switch
Byte 6 Left knee angle Byte 17 Left toe foot switch
Byte 7 Left ankle angle Byte 18 Battery voltage
Byte 8 Right hip torque Byte 19 Reserved
Byte 9 Right knee torque Byte 20 Reserved
Byte 10 Right ankle torque Byte 21 Reserved
Byte 11 Left hip torque Byte 22 120 (End frame)
process it is important to activate e↵erent motor pathways and a↵erent sensory pathways
simultaneously. Fuly assisting patients by imposing fixed limb trajectories can lead the
motor cortex to habituate to the repetitive activation of the same sensory pathways,
thus limiting the motor function recovery [228].
There are di↵erent possibilities to increase human involvement in the therapy and, thus
avoiding bounding the person to a fixed reference trajectory. The two general approaches
are either adding more compliance to the robot or adapting the reference trajectory to
the individual movements of a person [229]. The extent of robotic assistance depends on
the purpose of the rehabilitation program. In the acute phase of stroke more guidance is
necessary, while after a certain progress of therapy, when the person is able to generate
own e↵ort, less guidance and more freedom are desirable.
Di↵erent methods have been used in robotic rehabilitation to provide assist-as-needed
therapy, sometimes caled by di↵erent names, as “patient-cooperative” or “subject-
driven” [95, 228]. The idea behind the assist-as-needed concept is that the assistance
provided by the robot should be su cient to guide and complete the desired physiolog-
ical movements, while chalenging patients to provide maximal own e↵ort [230, 231]. In
this way, neuroplasticity can be stimulated and motor learning regained.
For this reason, we have proposed a control approach that extends the assist-as-needed
concept to al lower limbs joints. This control is applied to the H2 to implement a
gait rehabilitation therapy designed to stroke victims. The general algorithm consists
in the generation of a symmetric gait pattern, an automatic adaptation of this reference
pattern to each subject and a force field control that assist patient’s movements when
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performing this trajectory. Patient’s joint are individualy assisted to keep the leg on its
trajectory. Deviations from the adapted trajectory wil result in corrective forces. The
magnitude of the forces depends on the extent of the trajectory deviation.
3.5.1 Pre-Recorded Gait Pattern
The human musculoskeletal and neural-motor system is highly optimized for e cient
biped locomotion [232, 233]. The e ciency is because muscles do not power the joints
independently, but often span multiple joints and transfer power from one joint to an-
other. A 75 kg human consumes only approximately 165 W of metabolic power during
level-ground walking [207, 234].
The human gait is a cyclic movement pattern mainly executed in the sagittal plane of
the body. One gait cycle is defined as the period between two consecutive heel strikes
of the same foot with the ground. Each cycle comprises a stance phase (when the foot
is in contact with the ground) and a swing phase (when the foot is o↵the ground)
[205, 235, 236].
A chalenge when implementing gait training using robotic exoskeletons is the generation
of the gait trajectory. A study with healthy subjects in [121] suggests that the desired
states of the disabled leg can be generated online based on the movements of the other leg.
However, stroke greatly impacts the output forces, not just for the paretic leg but also for
the una↵ected leg [50–53], and stroke victims walk in an asymmetric manner avoiding to
load the paretic limb. Therefore, the una↵ected leg also has an abnormal compensatory
gait pattern, and reflecting it to the paretic leg wil not lead to improvements on the
gait of post-stroke patients.
Other works in the literature [178, 195] suggest that gait patterns can be predefined
trajectories based on o✏ine simulations or gait data captured from healthy subjects.
This last approach was chosen to be used in the H2 gait implementation, since symmetry
of gait is of special importance to stroke recovery. The reference trajectory was recorded
using a motion system capture based on high speed infrared cameras (Vicon Motion
Systems Ltd, United kingdom). During the data colection, the subject uses special
markers attached to the body segments of interest, both lower limbs in this case. These
markers reflect the infrared light. Thus, the motion system can track the markers
online using a system with multiple cameras. Then, the performed trajectory can be
reconstructed o✏ine, and hip, knee and ankle angles are obtained for both legs. In
taking advantage that the human gait is a cyclic process, we just need to acquire and
store the angles for one step. A lookup table is then generated with the six joints angles
and stored in the microcontroler memory in the H2-ARM board.
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3.5.2 Force Field Controler
Position or trajectory control is a widely implemented robotic strategy [93, 143, 223,
237, 238]. In this control approach, a position controler guides the patient’s limb to a
fixed reference path, while receiving the joint angles as a feedback. For the lower limbs,
the reference trajectory can be the pre-recorded gait pattern from a healthy subject.
However, some previous works suggest that position control strategies do not su ciently
chalenge patients to actively move their limbs during gait training assisted by robots
[239]. A better technique to regain motor control skils in stroke survivors is the use
of force fields that guide patient’s movements during goal-oriented therapy [240]. The
force field provides haptic feedback that is processed by the patient, thus leading to a
continuous improvement of motor performance and retraining of motor functions.
This force field strategy is implemented in the H2 algorithm, which is responsible to
assist the patient’s gait based on their disability level. To achieve this, the first step is
the generation of an adjusted trajectory. The reason for this is that the gait pattern
di↵ers slightly between individuals. Therefore, there are some disadvantages to the
implementation of a trajectory control based on a pattern of another individual. In
order to alow for a more compliant operation, the algorithm takes into account an
sti↵ness gain to generate an adjusted trajectory for the gait assistance.
The algorithm scheme is ilustrated in figure 3.7. The maximum value that the adjusted
trajectory can deviate from the pre-recorded trajectory can be adjusted using the gain
Gint, which is a normalized gain value between 0 and 1. The gain value 1 (meaning
100%) alows no deviation from the reference trajectory and the value 0 gives a totaly
free trajectory. With the user interface, physical therapists can change this gain value
ad-hoc for each patient when necessary.
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Figure 3.7:Control scheme for the assist-as-needed gait therapy. A pre-recorded gait
pattern from a healthy subject is used as reference. Based on this reference, a force
field controler guides the patient limbs, applying the necessary torque to complete the
gait in each joint independently.
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The adjusted trajectory output is converted to an input to the torque controler. Con-
sequently, the H2 provides an output torque to the actuators that is proportional to
the trajectory deviation. This algorithm creates a force field control that guides pa-
tient’s limb in a correct pattern, only assisting the patient when he/she deviates from
the trajectory. Because al joints on the exoskeleton have their own dedicated electronics
and control parameters, each actuator can be independently controled. This alows the
algorithm to generate specific assistance for each joint separately. Specialy for hemi-
paretic stroke patients, who have asymmetric functioning across both lower limbs, this
exoskeleton can adapt its functionality in real time based on each individual patient’s
needs, without requiring a manual adjustment for each patient.
Figure 3.8 depicts a scheme that ilustrates the concept of this control method. A virtual
tunnel is created around the reference trajectory. The actuator torque act as a spring,
alowing a proportional deviation from reference, but keeping the trajectory inside the
defined tunnel.
The implemented algorithm can also control the walking speed of the exoskeleton. Speed
selection is available to the physical therapists by means of a user interface. During
training they can adjust the H2’s gait speed across 10 di↵erent possible speeds, approx-
imately between 0.5 to 1.8 km/h, to personalize the training for each patient. Since the
H2 adapts the pre-programmed reference trajectory, the absolute final speed is, in some
way, user-dependent.
Reference
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Figure 3.8:Concept representation of the force field controler. A virtual tunnel is
created along the reference trajectory. The actuator torque act as spring, alowing a
proportional deviation from the reference, but keeping the trajectory inside the tunnel.
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3.6 User Interface
The H2 exoskeleton is designed in such way that its operation by physiotherapists is very
simple. Al the complexity in the control scheme is carried out by the embedded software
and is transparent to the operator. In order to facilitate even more the operation, a
simple mobile and wireless user interface was developed.
Figure 3.9 represents a screenshot of the interface developed to operate the H2. It is
programmed in Java and runs in a smartphone or tablet with Android operating system.
The interface communicates with the H2 by a Bluetooth link. When the application is
started, it first checks the communication link with the exoskeleton and informs the user
about the success or not in establishing communication.
Once the communication is successfuly established, therapists can start or stop the
exoskeleton gait sequence by simply pressing a button. Furthermore, using the interface
during training, physical therapists can also adjust the H2’s gait speed, as previously
discussed, to personalize training for each patient.
Another feature of the interface is the possibility of adjusting the gainGintfor each leg
independently. Ten possible levels are used to adjust how much the adjusted trajectory
can deviate from the recorded trajectory, where the value 10 (meaning 100%) alows no
deviation from reference trajectory and the value 0 gives a totaly free trajectory. With
Figure 3.9: Screen ilustration of the interface developed to operate H2. It alows
therapist to start and stop the gait process, change gait speed and adjust maximum
deviation of the pre-recorded trajectory.
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this interface, physical therapists can change the gain value ad-hoc for each situation
based on the patient’s disability.
One last feature of the interface is the possibility of choosing the gait sequence. The
default setting corresponds to a continuous walk, where the exoskeleton starts walk-
ing when the start button is pressed and only stops when the stop button is pressed.
However, to train some patients that are too weak to walk continuously, a step-by-step
strategy is also implemented. In this mode, when the walking button is pressed, H2
performs only one step and automaticaly stops. When the therapist presses the button
again, H2 performs a step with the other leg and stops again. This strategy is also useful
at the first training session to get the patient familiarized with the use of the device.
3.7 Neural Interface Integration
The experiments with stroke patients to validate the use of the H2 exoskeleton (detailed
in Chapter 4) were performed in Houston, United States. This was a colaboration study
with the laboratory of Noninvasive Brain-Machine Interface Systems at the Department
of Electrical and Computer Engineering at the University of Houston together with the
TIRR Memorial Hermann Hospital.
For this colaboration study, the open architecture of the H2 was integrated with a neural
interface developed at the laboratory of Noninvasive Brain-Machine Interface. When
associated to exoskeletons, neural interfaces can be used for correlating the aspects of
learning during rehabilitation, as wel as creating brain-machine interfaces that further
engage the patients [241].
Whole-head 64-channel active EEG were colected using a wireless system (BrainAmpDC
with Acticap, BrainProducts Inc.), depicted in figure 3.10, and labeled in accordance
with the extended 10-20 international system. The EEG data was acquired during each
training session, sampled at 1 kHz and referenced to FCz. The system is totaly non-
invasive and only requires a smal portion of water-based gel between each electrode and
the scalp of the patient.
To synchronize the EEG and the H2 colected data, an external trigger circuit was
developed to label the start and stop of data colection during training session with pa-
tients. The trigger signal was transmitted wirelessly using two 2.4 GHz radio transceivers
(Wixel, Pololu Corporation). One transceiver is placed together with the EEG set and
has a button that alows the experimenter to manualy place trigger labels. The other
transceiver is placed together with the H2-ARM control board to receive the manual
triggers sent by the experimenter.
EEG data were recorded in order to characterize neural correlations of user-H2 interface
interaction and learning, as wel as to develop algorithms for creating a brain-machine
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Figure 3.10: Whole-head 64-channel active EEG cap used to acquire brain signals
from the scalp. The data is sampled at 1 kHz and send wirelessly.
interface for the H2 in future rehabilitation applications. Further discussion about the
EEG data and the neural interface system are outside of the scope of this dissertation
and is left as future work.
3.8 Conclusion
This chapter presents the design of the H2 control architecture. The control relies on a
structure of layers, where the lowest level is responsible for controling the actuators and
acquiring the sensors’ information. This software layer is implemented on the electronic
boards placed on each H2’s joint. The second software layer implement three di↵erent
close loop controlers for each joint: position, torque and sti↵ness control. The objective
of this layer is to serve as an open architecture that alows other systems to control
the H2. In this way, di↵erent therapies can be implemented in a higher level layer, by
abstracting the H2 hardware level, which is controled in real time by the main processor
in the H2-ARM board.
To validate to device in a real scenario of gait training, one therapy was also implemented
in the high level software layer. This is an assist-as-needed control that was designed
to help patients to actively participate in the gait training assisted by the exoskeleton.
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The algorithm behind this therapy relies on a pre-recorded normal gait trajectory. When
necessary, this trajectory is adjusted in real time to the patient wearing the exoskeleton.
The patient’s gait is then guided through this trajectory. The guidance has a main ob-
jective of providing torque only when patient deviates from the correct trajectory. Each
joint is independently controled, to better provide the correct level of assistance. This
normal gait pattern provided by the H2 aims to correct the asymmetric gait developed
by post-stroke patients.
To validate the hypothesis that this algorithm can provide assistance to retrain gait, we
design a pilot clinical study where post-stroke volunteers train with the H2 along several
sessions of physical therapy. This clinical study to validate the H2 exoskeleton and the
assist-as-needed algorithm is presented in the next chapter.
This chapter has presented results that fulfil objectives 6, 7, 8 and 9 stated in Section
1.7.2. Objective number 6 is fulfiled with the development of a control approach that
adjusts gait patterns to a specific subject without prior training. Moreover, the algorithm
does not need any sensor physicaly attached to the subject’s body.
Folowing, objectives number 7 and 8 are achieved by the implementation of an assist-as-
needed therapy with gait training performed overground in a real environment. This can
further motivate patients in the rehabilitation process, that guarantee patient’s active
participation. The developed algorithm, instead of fuly driving the lower limbs while
patient remains passive, provides assistance by only applying a restoring force when
patient deviates from the correct trajectory that they should folow.
Objective number 9 is the design of an open architecture for H2. This is achieved by
the so-caled middle software layer that alows external systems to command or to be
integrated with the exoskeleton. A neural interface was already integrated with the H2
to be used during the experiments with post-stroke patients. These experiments are
detailed in the subsequent chapter.

Chapter 4
Functional and Usability
Evaluation1
The preceding chapters of this dissertation have presented in detail the theoretical and
technological developments required to design and construct a lower limb robotic ex-
oskeleton. This chapter presents the experimental evaluation of the device, including its
hardware and the assist-as-needed walking therapy. The evaluation comprised experi-
ments performed with healthy subjects first, aiming to debug and optimize hardware and
software of the device and validate its safety and control approach prior to testing with
patients. The second and most extensive part of the evaluation consisted of a usability
and clinical pilot study with post-stroke patients. In this study, H2 functionality, safety
and usability were evaluated on six post-stroke hemiparetic users during four weeks of
ambulatory gait training. This evaluation analyzed several aspects: the H2 control per-
formance, patients atitudes and motivation towards the use of the device, patients’ safety
and tolerance to the intensive robotic training and the preliminarily impact of the robotic
training on the walking function of the patients. Results shown that the device is safe and
easy to use. The patients tolerated the walking therapy very wel and were motivated by
training with the device. These results motivate further research on overground walking
therapy for stroke rehabilitation with the H2 exoskeleton.
1This chapter is partialy based on the folowing manuscripts:
M. Bortole, A. Venkatakrishnan, F. Zhu, J. C. Moreno, G. E. Francisco, J. L. Pons, and J. L.
Contreras-Vidal. The H2 robotic exoskeleton for gait rehabilitation after stroke: Early
findings from a clinical study, Journal of NeuroEngineering and Rehabilitation. Submitted on
August 30th, 2014.
M. Bortole, F. Zhu, A. Venkatakrishnan, Z. Hernadez, J. L. Pons, and J. L. Contreras-Vidal.
H2 NeuroExo: Integration of the H2 lower body powered exoskeleton and mobile brain
monitoring to improve gait rehabilitation, International Workshop on Wearable Robotics, 2014.
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4.1 Introduction
The innate ability for reorganization in the nervous system raises questions about the
best rehabilitation scenario, in order to maximize gains from brain plasticity. Literature
suggests that repetitive, specific task training is more e↵ective for cortical and task
learning reorganization [242, 243]. Most improvements wil be seen with respect to
the specific task that is trained. Therefore, when conducting gait therapy with post-
stroke patients, the number of footsteps practiced per training session, i.e., the training
intensity, appears to be very important. The physical work expended by therapists
helping patients to practice a large number of steps is, however, di cult to carry out
unaided. To accomplish this objective, robotic devices can be used, since they enable
the patient to practice walking over and over again. Robotic devices do not replace the
physiotherapist, but can act like a tool that, in combination with the physiotherapist,
is more e↵ective than the therapist alone [76].
But more important than repetition, active subject participation in gait therapy is vital
to many of the potential recovery pathways [147] and it is, therefore, an important feature
of gait training. Higher levels of subject participation and chalenge could be promoted
through designs of robotic assist-as-needed therapies and performing overground walking
in a real environment. Assist-as-needed control strategies focus on the idea that when
patient moves along a desired trajectory, the robot should not intervene. If the patient
deviates from the desired trajectory, the robot should create a restoring force, that
increase proportionaly with the trajectory deviation [244].
To evaluate al aspects of the H2 lower limb exoskeleton presented in the preceding
chapters of this dissertation, we proposed a clinical pilot study in order to validate the
functionality, safety and usability of the device in a real rehabilitation scenario. Large-
scale randomized and controled trials are hard to conduct for a specific therapy or
patient group. The reasons for that are, first, because of the di culty of recruiting
patients and, secondly, because of the heterogeneity of functional disturbances after
stroke, like the site and extent of lesions and severity of neurological deficit [20]. On
the other hand, smal-scale trials can help to validate new concepts and devices for
rehabilitation, pointing to the correct direction to be folowed in a more specific and
larger study.
The organization of this chapter is as folows. First, Section 4.2 presents the experimen-
tal protocol designed to be used with healthy subjects and post-stroke patients. Section
4.3 describes the experimentation with healthy volunteers and validate the safety and
control approach of the device to be used with post-stroke patients. Section 4.4 presents
the clinical study with six post-stroke patients, with a discussion of each case study
separately. The results are presented in Section 4.5. The discussion about results ob-
tained with the H2 in gait training is given in Section 4.6. Finaly, Section 4.7 draws
the conclusions and main findings.
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4.2 Experimental Protocol
The experimental protocol, including al procedures with stroke patients and healthy
subjects were approved by the IRB (Institutional Review Board) at the University of
Houston. Appendix A presents the document with the approval details, under the Ap-
plication ID number 14107-01(4838). The study protocol is also registered and available
at ClinicalTrials.gov, under the reference number NCT02114450. Al subjects enroled
on this study provided informed consent prior to participation. Appendix B presents
a copy of the consent form signed by participants before to be enroled in the study.
Eligible participants for this study were adult healthy subjects with no history of neuro-
logical, neuromuscular or physical disability and post-stroke hemiparetic subjects, both
groups including volunteers between 18 and 75 year olds.
4.2.1 Inclusion and Exclusion Criteria
Inclusion criteria for healthy subjects participating in the study with the H2 were male
and female able-bodied adults aged between 18 and 75 years. Regarding the post-stroke
participants, it was included in the study both male and female adults who met the
folowing criteria:
•Age between 18 and 75 years old;
•Individuals with unilateral stroke resulting in hemiparesis;
•Sub-acute or chronic stroke, i.e., interval of at least 3 months or interval of at least
6 months from stroke onset to time of enrolment, respectively;
•Cognitive ability to assimilate and participate actively in the treatment protocol
(Mini Mental State Examination score>24 points, within a total of 30 points
indicating normal cognitive ability);
•Ranchos Los Amigos Level of Cognitive Functioning VI (with stage VIII being
the highest level of cognitive function);
•Mild-moderate functional disability post-stroke (Rankin Scale scores between 2
and 4);
•Modified Ashworth Scale of Spasticity score2 (range is 0 to 4, where 4 reflect
maximum spasticity);
•Height range between 1.50 to 1.95 meters (H2 adjustment limitations);
•Maximum weight of 100 kg (H2 adjustment limitations);
•No skin integrity issues;
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•Su cient passive range of motion at the hip (at least 90 degrees flexion, 15-20
degrees extension), knee (90 degrees flexion, complete extension) and ankle (15
degrees dorsiflexion, 15 degrees plantarflexion);
•No contraindications to standing or walking;
•Good physical conditioning to alows the treatment;
•Adequate familiar and social support.
Exclusion criteria for healthy subjects were any history of neurological, neuromuscular
or physical disability. Exclusion criteria for post-stroke participants were:
•Severe cognitive and/or visual deficit;
•Hemi neglect;
•Severe sensory deficit;
•Joint contracture of any extremity that limits normal range of motion during
ambulation with assistive devices;
•Skin lesions that may hinder or prevent the application of exoskeleton;
•Uncontroled angina;
•Severe chronic obstructive pulmonary disease;
•Severe osteoporosis;
•Cardiac contraindications for exercise;
•Alergy to the materials used;
•Any other medical contraindications;
•Any medical co-morbidities that would prevent standard rehabilitation;
•Changes in behavior that prevent treatment: no cooperation or aggression.
Determination if patients meet or not the necessary requirements to participate in this
study were based on clinical examination by clinical doctors colaborating in this study,
as listed in the IRB Approval document in the Appendix A.
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4.2.2 Usability and Clinical Study Design
The usability and clinical study consists of four weeks of gait training, in a total of twelve
sessions per patient, in conjunction with two assessment sessions, one before and one
after the training period. The objectives of this study design are: 1) to assess patient
walking function before training; 2) to apply four weeks of gait training assisted by the
H2, aiming to evaluate the safety and usability of the device; 3) to assess patient walking
function after training, in order to look for possible improvements after training with
the H2.
The training period accounted for four consecutive weeks, three sessions per week in
separated days. In this pilot clinical investigation, the study design consisted of an open-
label assignment of participants to H2 robot-assisted gait training. After patient arrives
at the clinical training place, the first step was to proceed with the EEG system setup.
This included instrumenting the patient with the EEG cap containing 64 electrodes and
applying a smal portion of gel in each contact point between the electrodes and patient’s
scalp. Then, the final step was the H2 donning process, which basicaly consisted on the
correct attachment of the robot to patient’s legs and waist. The H2 was prior adjusted
to the patient anthropometric measures.
During each training session, subjects were asked to perform an overground walking
task guided by the H2 in assist-as-needed mode with a self-selected gait speed along
a 50-meter circular or 120-meter linear path. After wearing the exoskeleton, patients
were instructed to walk as much as they were able, without exceeding 40 minutes of net
walking. During training, patients were encouraged to take rest breaks as necessary.
Figure 4.1 ilustrates a patient wearing the H2 and the EEG cap at the beginning of a
training session. An experienced physical therapist folowed patients during the whole
training period. At least two more persons were present during training sessions and
folowed patients to ensure patient safety. The gait start and stop process was controled
by the patient using two hand buttons placed on a walker, which was used as a balance
assistive device during training. If the patient was not able to press the button by
him/herself, he/she gave verbal commands and the physical therapist started or stopped
the gait process.
Patients were alowed to change the walking speed in real time during continuous walking
from level 1 (approx. 0.5 km/k) to 10 (approx. 1.8 km/h) based on their comfort level.
Based on patient feedback, the therapist used the smartphone interface to adjust gait
speed as necessary.
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Figure 4.1:Patient wearing the H2 and the EEG cap at the beginning of a training
session. The gait start and stop process was controled by the patient using two hand
buttons placed on a walker, which was used as a balance assistive device during the
training.
4.2.3 Clinical Outcomes
Pre- and post-training assessment sessions were based on standard clinical outcomes and
were performed by an independent rater, i.e., a second physical therapist that did not
participated in the robotic training. The assessment sessions took place in separated
days and the protocol was equal for pre- and post-sessions for al patients.
The walking assessment tests were performed by the patients using their regular assistive
devices for walking, like AFOs and/or canes, if any. Thus, results from these tests ought
to reflect patient walking ability in a daily basis. These assessments were included to
help document any clinicaly relevant behavioral changes that may occur in response
to training with the H2 powered exoskeleton. The folowing assessment scales were
included:
•Berg Balance Scale[245, 246]: It is a psychometricaly sound measure of bal-
ance impairment for use in post-stroke assessment and the most commonly used
assessment tool across the continuum of stroke rehabilitation [247]. The ease with
which the Berg Balance Scale can be administered makes it an attractive measure
for clinicians, since it requires minimal equipment and space. It measures both
static and dynamic aspects of balance and risk for fals through direct observation
of patient’s performance. The 14 items comprised by the scale are scored from 0
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to 4, with a score of 0 representing an inability to complete the task and a score
of 4 representing independent item completion. A global score is calculated out
of 56 possible points. Scores of 0 to 20 represent balance impairment, 21 to 40
represent acceptable balance, and 41 to 56 represent good balance.
•Functional Gait Index[248]: The Dynamic Gait Index was originaly developed
to assess postural stability during gait in people older than 60 years of age at risk
for faling [249]. The scale consists of 8 tasks with varying demands, such as
walking at di↵erent speeds, ambulating over and around obstacles, walking while
turning the head, ascending and descending stairs and making quick turns. The
Functional Gait Index consists of a 10-item gait test that comprises 7 of the 8 items
from the original Dynamic Gait Index and 3 new items. The 3 new tasks include
gait with narrow base of support, ambulating backwards and gait with eyes closed.
These new tasks have been added because it was noted that these particular tasks
are di cult to be performed by people with vestibular disorders [250]. Performing
gait with eyes closed is probably the most informative task because the person
must rely on vestibular and somatosensory inputs in order to maintain postural
control. Each one of the 10 items in the Functional Gait Index is scored in a scale
from 0 to 3, with a maximum possible score of 30 points.
•6 Min Walk Test[251]: The 6 Min Walk Test is safer, easier to administer,
better tolerated, and better reflects activities of daily living than other walk tests
[252]. The test has the guidelines standardized by the American Thoracic Society.
The primary measurement of this test is the distance walked by the patient during
6 minutes. When performing the 6 Min Walk Test, the patient should walk alone
and not assisted by clinicians. However, they are alowed to use their usual walking
aids during the test (cane, walker, etc.). Patients should perform overground walk,
as opposed to walking on a treadmil. The 6 Min Walk Test is a useful measure of
functional capacity, targeted at people with at least moderately severe impairment.
•Timed Up-and-Go Test[253]: The Timed Up-and-Go Test is a simple balance
test that is commonly used to assess a person’s functional mobility in the com-
munity. The test measurement consists of the time needed for a patient to stand
up from a regular chair, walk 3 meters in a straight line, turn around, walk back
and sit down. Elderly who are able to complete the test in less than 20 seconds
have been shown to be independent in transfer tasks of daily living and walk at
gait speeds that should be su cient for community mobility. In contrast, a person
completing the test in 30 seconds or longer tends to be more dependent in activities
of daily living.
•Fugl-Meyer Lower Extremity[254]: The Fugl-Meyer assessment is a cumu-
lative numerical scoring system for evaluation of balance, motor function, joint
function and some sensation qualities in hemiplegic patients. The test was con-
structed assuming that motor function recovery folows an obligatory sequence
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[255]. A score from 0 to 2 is applied to each item of the test, where: 0 means it
cannot be performed, 1 means it can be partialy performed and 2 means it can be
fuly performed. The maximum motor score for the lower extremity is 34 points
in total.
•Barthel Index of Activities of Daily Living[256, 257]: The Barthel Index
measures functional disability by quantifying patient performance in activities of
daily life, that are grouped according to self-care and mobility tasks. The test
was first developed in 1965 by Mahoney and Barthel [256] and later modified by
Granger et al [258]. The original test comprises 10 activities of daily life, but a
short form including 5 items is also available [259]. A score from 0 to 4 is applied
to each item, with a maximum possible score of 20 points. Lowest scores represent
more dependent patients. The Barthel Index is considered easy to use, reliable
and sensitive to change.
4.2.4 Data Acquisition
During al training sessions, kinematic and kinetic data generated by the H2 were ac-
quired for o✏ine analysis. The data included angular position, interaction torques and
motor torques for left and right hip, knee and ankle joints, toe and heel ground contact,
H2 walking state (right step, left step or stopped), battery voltage and current. Al data
were sampled at 100 Hz by the H2-ARM board and sent wirelessly via Wi-Fi. Data
were colected using a Simulink program developed to store and visualize the data in a
laptop. Matlab was used to process al colected data.
In addition, for this study, the open architecture of the H2 was integrated with a neural
interface, as detailed in Section 3.7. Whole-head wireless 64-channel active EEG was
acquired during each training session, sampled at 1 kHz. The H2 and the EEG data
were synchronized by means of a manual trigger sent to both systems. The EEG data
were recorded in order to characterize neural correlates of user-H2 interface interaction
and learning, as wel as to develop algorithms for creating a brain-machine interface for
the H2 for future rehabilitation applications. As stated in Section 3.7, the EEG data
and the brain-machine interface are not discussed in this dissertation.
Al data were transmitted wirelessly, including the H2 and the EEG data. This aspect
provides much more freedom to the patients to perform the overground walking therapy.
The main goal was to engage patients and motivate them to participate actively during
the training.
In addition to the H2 and the EEG data, patient’s attitudes towards H2 training were
captured by using a Likert scale. Patients were asked to rate the ease of use of the H2 at
the beginning and at the end of al training sessions, ranging from 0 (very hard to use)
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to 10 (very ease to use). Further, relevant comments from patients were documented
during the training sessions.
4.3 Study With Healthy Subjects
This section presents the experimental validation of the H2 exoskeleton integrated with
the EEG system on healthy subjects. In more detail, the experiments aim to validate the
hardware and software presented in Chapters 2 and 3 respectively, as wel as to evaluate
the usability and safety of the device in experiments in a real walking scenario. These
experiments also aim to test the whole system operation and synchronization with the
EEG system, thus validating the protocol prior to testing with stroke patients.
4.3.1 Experiments
Five healthy subjects with no history of neurological, neuromuscular or physical dis-
ability participated in the experiments. The experimental protocol mainly consisted of
walking guided by the H2 while wearing the EEG system. Prior to start the experiment,
the subjects signed the informed consent. The H2 lengths were adjusted to match sub-
ject’s height prior to donning, and subjects were first instructed about how the system
works. Then, the first step was to set up the EEG system, putting the EEG cap on the
subject’s head and applying a smal portion of gel on each contact point between elec-
trodes and the scalp. After checking the correct functioning of the EEG system, the last
step was the H2 donning process, which basicaly consisted of the correct attachment of
the exoskeleton around subject’s legs and waist.
At the beginning of the experiment, the H2 speed was adjusted to the lowest speed
value (about 0.5 km/h). Subject used the walker buttons to start and stop the gait
process. During the experiments, subjects were folowed by another person for safety
reasons. This person was also in charge of adjusting the H2 gait speed with the mobile
user interface, according to subject comfortable speed.
During the experiments, subjects were instructed to folow the H2 guidance through
the walking process. They were free to start walking when they felt comfortable and
instructed to stop at least every five minutes, to better simulate the functional ability
of the target stroke population. The walking trial consisted of walking with H2 for
about 20 minutes in a 50 meters circular or 120 meters linear path. Subject’s skin under
the leg braces of the exoskeleton was inspected after the walking trial, as wel as the
exoskeleton, its cables and connections.
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4.3.2 Results
Al subjects completed the walking experiment. Operation of H2 was wel tolerated and
was perceived as comfortable. No dangerous situations were reported. After removing
H2 at the end of the experiment, some subjects using short pants revealed some red
skin points that disappeared within 10 minutes. This was generated due to some H2 leg
braces attachment, but was not observed in subjects using long pants. Furthermore, no
adverse e↵ects were reported during or after the experiments.
A few problems were identified in the experiments regarding the H2 operation. A soft-
ware bug was preventing the correct synchronization of the H2 and the EEG data at
the first experiments. The problem was solved for future data colection. It was ob-
served malfunction in some interaction torque and foot ground sensors. The sensors
were recalibrated and/or replaced to solve the problem. It was also observed that the
EEG wireless data transfer presented a reduced range in some occasions, due to some
environment interference. To avoid this problem in the future, its was decided to use a
mobile cart equipped with the EEG receptor and the laptop, alowing the experimenter
to folow the subject more closely if necessary.
To ilustrate the H2 operation during walking experiments, results from one subject are
shown in figure 4.2. The figure depicts the reference trajectories and the trajectories
performed by the subject during the walking. For a better representation, trajectories
are shown in the cycle domain based on the stride length, with an average of al steps
performed during the whole session.
It can be observed from the results that the H2 can successfuly guide the joints through
the gait pattern, with a smal compliant deviation. Transitions amongst stance and
swing phases were smooth during the experiments and no jerky movements were noticed.
Subjects needed around five to ten minutes to get used to the H2 operation. After this
period, subjects were able to walk without any aid to keep their balance. They were
also able to rapidly increase their walking speed.
4.3.3 Conclusion
The study with healthy subjects presented in this section aimed to verify the correct
operation of the H2. In addition, it was also aimed to test the protocol to be used
with stroke patients, in order to prepare it for clinical experimentation. Results have
shown that the developed robotic exoskeleton and its control approach are able to assist
the locomotor activity. This has been confirmed by experiments with healthy subjects.
However, the application in a clinical study with stroke patients is further investigated
in Section 4.4.
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Figure 4.2:Hip, knee and ankle trajectories performed by the healthy subject. Blue
lines are the reference trajectories that subject is guided through by means of a force
field. Red lines represent the average trajectories performed by subject during the
experimental test.
Walking velocity of the H2 exoskeleton (max. 1.8 km/h) could be considered slow for
healthy subjects, after a period of training with the device. However, post-stroke patients
present a reduced strength [50, 51] and consequently, lower gait speeds when compared
to healthy subjects. Therefore, the H2 walking speed range is expected to be suitable
for post-stroke rehabilitation.
Tests with healthy subjects prior to patients could ensure system stability and integrity,
besides fine tunning the control methods. Minor problems were detected and solved. In
conclusion, the H2 proved to be safe to use and able to assist gait training. Donning and
do ng process was simple and fast, and users were able to get used to the exoskeleton
in a short period of time.
From experimentation with healthy subjects it was noted that some temporary skin
irritation could occur when subject used short pants. Since this e↵ect did not occur
when using long pants, this aspect was taken in consideration for future tests, including
patients. However, it does not create any limitation, since H2 do not use any sensors
attached to subject’s body.
Experiments with stroke patients have to confirm the usability and safety of the system
when applied to a clinical study.
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4.4 Study With Stroke Patients
This section presents the case studies for each patient, comprised by the experimental
results of the gait training and patient’s feedback about H2 (Sections 4.4.1 to 4.4.6).
Six patients were recruited to participate on the clinical study. Al six participants were
chronic stroke patients and were not receiving any additional gait training or physical
therapy during this period of experimental training. Patients are named here SA01,
SA02, SA03, SA04, SA05 and SA06. There was only one dropout, i.e. subject SA03.
After completing three training sessions, this patient had his medicine prescription for
blood pressure changed by his doctor, which frequently caused him to feel dizzy when
standing or walking, preventing him to continue the walking therapy. The remaining
five patients completed the study protocol of four weeks of training. Due to personal
schedule conflicts, some patients missed one or two training sessions.
4.4.1 Case Study 1
Patient SA01 is a male, 58-year old, 1.92 meter tal and weights 84 kg. He had a stroke
five years prior to participation in the study. In consequence of the stroke, SA01 has
his left body side a↵ected. He is able to walk without any assistive device, but present
an asymmetric gait pattern, reduced left knee flexion and a compensatory movement at
hip, known as hip hiking. He was not receiving any physical therapy but exercised his
walking regularly.
SA01 completed twelve sessions of training plus the two assessment sessions. He was
able to complete 30 to 40 minutes of gait training per session with just a few breaks
for rest. Table 4.1 presents the clinical outcomes related to this patient. After the
four weeks of training with the H2, he improved his scores in the Berg Balance Scale
and Fugl-Meyer for lower extremity. There was no variation in Barthel Index and he
decreased his performance in the 6 Min Walk Test, Functional Gait Index and Timed
Up-and-Go Test.
Table 4.1:Pre- and pos-assessment data for SA01.
Clinical Outcomes Scale Pre-assessment Post-assessment
Berg Balance Scale 0 to 56 47 49
Functional Gait Index 0 to 30 22 20
6 Min Walk Test meters 328 213
Timed Up-and-Go Test seconds 16.2 17.9
Fugl-Meyer Lower Limb 0 to 34 25 26
Barthel Index ADL 0 to 20 18 18
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Figure 4.3: Left side plot corresponds to the number of total steps performed in
each session by SA01, which is direct related to the walking distance. Right side plot
corresponds to the number of steps per minute in each session, which relates to the gait
speed.
SA01 was very motivated about training with the H2. He had only some di culty at first
session to keep his balance, which is considered normal because al users need a training
time to get used to the device. This was expected and happened even with healthy
subjects. After 10 to 15 minutes of training, he was more confident and able to walk
guided by the symmetric gait pattern generated by the exoskeleton. The number of steps
performed in each session (see figure 4.3), which reflects the walking distance, increased
over al sessions for patient SA01. Also, as it can be seen in figure 4.3, the number of steps
per minute, which reflects the walking speed, increased along the therapy. Both walking
distance and speed are dependent on patient’s condition and mood on the training day,
which generate inter-session variation.
Lastly, figure 4.4 represents the average trajectories performed by each joint of the
patient when using the exoskeleton. For comparison, we plot the reference trajectory
and the average trajectory of al steps performed in the first and last training sessions
with the H2. Trajectories are represented in the cycle domain, based on the stride length
percentage, from heel strike to the next heel strike. As it can be observed in the results,
patients guided by the force field are being able to perform a more symmetric gait
pattern. Additionaly, knee flexion on the paretic leg is being improved with training.
4.4.2 Case Study 2
Patient SA02 is a male, 45-year old, 1.78 meter tal and weights 88 kg. He is the less
chronic patient participating on the study. His stroke onset occurred six months prior
to starting the training with the H2. As a consequence of the insult, SA02 has his left
body side a↵ected. He is able to walk but with the assistance of a passive AFO on
the a↵ected leg. SA02 presents an asymmetric gait pattern, reduced left knee flexion,
hip hiking movement and he was stil taken some medication for stroke treatment, but
without participation in any physical therapy. It is worth to note that SA02 was invited
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Figure 4.4:Hip, knee and ankle trajectories performed by the patient SA01. Blue
lines are the reference trajectories that patient is guided through by means of a force
field. Red lines represent the average trajectories performed by the patient in the first
training session. Black lines represent the trajectories performed at the last session.
to participated in a similar study with another ambulatory exoskeleton before training
with the H2, but he performed only one session and dropped out. He explained that
the device was cumbersome and the device’s backpack that he had to carry was causing
him low back pain.
When invited to participate of the H2 study, SA02 completed ten sessions of training
plus the two assessment sessions. He only missed two training sessions due to a personal
conflict schedule with the training. SA02 stated that the H2 was simpler and lighter to
use. During pre- and post-assessment sessions, he was alowed to used his AFO as he
does in a daily basis. During the training sessions, he was not using the AFO since H2
can completely replace its function and, moreover, with an active actuation.
Table 4.2 presents the clinical outcomes related to the patient SA02. After the four weeks
of training with the H2, he improved his scores in the 6 Min Walk Test, Timed Up-and-
Go Test, Fulg-Meyer and Barthel Index. Berg Balance Scale and Functional Gait Index
scores did not present any variation, possibly because the patient has scores close to
ceiling and the outcome measures are not sensitive enough to capture the variations.
SA02 had almost no di culties to use the H2, even at the first session. He was able to
use the walker properly to keep his balance and started and stopped the gait process
on his own, by using the hand buttons placed at the walker. The number of total steps
performed by SA02 in each session and the number of steps per minute, both represented
in figure 4.5, increased during training time.
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Table 4.2:Pre- and pos-assessment data for SA02.
Clinical Outcomes Scale Pre-assessment Post-assessment
Berg Balance Scale 0 to 56 54 54
Functional Gait Index 0 to 30 28 28
6 Min Walk Test meters 274 290
Timed Up-and-Go Test seconds 11.8 9.3
Fugl-Meyer Lower Limb 0 to 34 27 28
Barthel Index ADL 0 to 20 17 18
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Figure 4.5: Left side plot corresponds to the number of total steps performed in
each session by SA02, which is direct related to the walking distance. Right side plot
corresponds to the number of steps per minute in each session, which relates to the gait
speed.
Figure 4.6 represents the average trajectories performed by each joint of patient’s leg
when using the exoskeleton. For comparison, we plot the reference trajectory and the
average trajectory of al steps performed in the first and the last training session with
the H2. Trajectories are represented in the cycle domain, based on the stride length
percentage, from heel strike to the next heel strike. Similar to SA01, SA02, when guided
by the force field, is able to perform a more symmetric gait pattern. Additionaly, knee
flexion on the paretic leg is being improved as wel.
4.4.3 Case Study 3
Patient SA03 is a male, 68-year old, 1.83 meter tal and weights 82 kg. He had his
stroke two and a half years before participating on the study and got the right side of
the body disabled. SA03 has reduced ambulation and uses a wheelchair for locomotion.
He is able to walk only if assisted and at low speeds. He used a four contact point cane
when walking. SA03 presents an asymmetric gait pattern, reduced right knee flexion,
hip hiking movement and reduced strength in both legs.
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Figure 4.6:Hip, knee and ankle trajectories performed by the patient SA02. Blue
lines are the reference trajectories that patient is guided through by means of a force
field. Red lines represent the average trajectories performed by the patient in the first
training session. Black lines represents the trajectories performed at the last session.
SA03 was excited about training with the H2. His weakness caused him to need some
extra assistance to keep balance at the beginning of the training. He was improving his
performance over the training period, but after three sessions he had to drop out the
study. He explained that after this period, he had his medicine prescription for blood
pressure changed by his doctor, which frequently caused him to feel dizzy when standing
or walking, preventing him to continue the walking therapy. Table 4.3 presents clinical
outcomes related to patient SA03 pre-assessment. Post-assessment was not performed
since the patient dropped out.
Even with reduced ambulation, which is confirmed by the poor performance in the Timed
Table 4.3:Pre- and pos-assessment data for SA03.
Clinical Outcomes Scale Pre-assessment Post-assessment
Berg Balance Scale 0 to 56 32 -
Functional Gait Index 0 to 30 10 -
6 Min Walk Test meters 200 -
Timed Up-and-Go Test seconds 52.0 -
Fugl-Meyer Lower Limb 0 to 34 11 -
Barthel Index ADL 0 to 20 16 -
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Up-and-Go Test, added to low scores in the Berg Balance Scale, Functional Gait Index
and Fugl-Meyer measurements in the pre-assessment, subject SA03 was improving his
performance with the training. Guided by the H2 during only three training sessions, he
was being able to perform a more symmetric gait pattern and to improve knee flexion
on the paretic leg, which is ilustrated on figure 4.7.
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Figure 4.7:Hip, knee and ankle trajectories performed by the patient SA03. Blue
lines are the reference trajectories that patient is guided through by means of a force
field. Red lines represent the average trajectories performed by the patient in the first
training session. Black lines represent the trajectories performed at the last session.
4.4.4 Case Study 4
Patient SA04 is a male, 43-year old, 1.88 meter tal and weights 99 kg. He is the second
youngest participant and second closest participant to the stroke onset, which occurred
eleven months prior to participation on the study. SA04 has his left body side a↵ected by
the stroke. He is able to walk but uses a cane as assistance and presents an asymmetric
gait pattern, reduced left knee flexion and hip hiking movement. He was not receiving
any physical therapy and was very motivated about training with the H2 exoskeleton.
He even comment that he wished to have a robotic device like H2 at the beginning of
his training just after the stroke onset.
SA04 completed twelve sessions of training as wel as the two assessment sessions. He
was able to complete 30 to 40 minutes of gait training per session with just a few
breaks for rest. Table 4.4 presents the clinical outcomes for SA04, who achieved a great
improvement. He improved his walking distance by about 76% after the four weeks of
training and reduced the Timed Up-and-Go Test for about 20%. The Berg Balance Scale
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Table 4.4:Pre- and pos-assessment data for SA04.
Clinical Outcomes Scale Pre-assessment Post-assessment
Berg Balance Scale 0 to 56 56 56
Functional Gait Index 0 to 30 25 26
6 Min Walk Test meters 134 237
Timed Up-and-Go Test seconds 13.2 10.7
Fugl-Meyer Lower Limb 0 to 34 25 26
Barthel Index ADL 0 to 20 18 18
was at maximum score for pre- and post-assessment. Functional Gait Index and Fugl-
Meyer scores presented improvements too. There was no variation on Barthel Index,
which is also close to the ceiling score.
SA04 presented only a few di culties at the first session to get used to the device. In
al sessions the subject performed the training with very high level of balance, which
is corroborated by his maximum score on the Berg Balance Scale. At the end of the
training, SA04 was very confident and was able to walk guided by H2 without any
additional device to keep his balance. He increased the number of steps performed in
each session and the number of steps per minute, both ilustrated in figure 4.8. He was
able to walk at the maximum speed with the H2, around 1.8 km/h at the last training
session.
Lastly, figure 4.9 represents the average trajectories performed by each joint of the
patient when using the exoskeleton. The assist-as-needed algorithm generating the force
field helped SA04 to perform a more symmetric gait pattern and to improve the knee
flexion on his paretic leg.
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Figure 4.8: Left side plot corresponds to the number of total steps performed in
each session by SA04, which is direct related to the walking distance. Right side plot
corresponds to the number of steps per minute in each session, which relates to the gait
speed.
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Figure 4.9:Hip, knee and ankle trajectories performed by the patient SA04. Blue
lines are the reference trajectories that patient is guided through by means of a force
field. Red lines represent the average trajectories performed by the patient in the first
training session. Black lines represent the trajectories performed at the last session.
4.4.5 Case Study 5
Patient SA05 is a male, 40-year old, 1.80 meter tal and weights 84 kg. He is the youngest
subject participating on the study, but the most chronic stroke patient, since he had a
stroke fourteen years prior to participation on the study. SA05 has the right side of body
a↵ected by the insult. He is able to walk but with the assistance of a passive AFO on
the a↵ected leg. SA05 presents an asymmetric gait pattern, reduced right knee flexion
and hip hiking movement. He was not participating in any physical therapy but walked
regularly in a daily basis.
SA05 completed ten sessions of training, plus the two assessment sessions. Similar
to SA02, he missed two training sessions due to a personal conflict schedule with the
training. During pre- and post-assessment, he was alowed to used his AFO as he
does normaly. During the training sessions he was not using the AFO, since H2 can
completely replace its functionality in an actuated manner.
Table 4.5 presents the clinical outcomes related to the patient SA05. After the four
weeks of training with the H2, he greatly improved his score in the 6 Min Walk Test and
improved four points in the Berg Balance Scale. The Functional Gait Index, Timed-Up-
and-Go Test and Fugl-Meyer scores also presented improvements. The Barthel Index
score was close to ceiling and did not presented variation.
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Table 4.5:Pre- and pos-assessment data for SA05.
Clinical Outcomes Scale Pre-assessment Post-assessment
Berg Balance Scale 0 to 56 49 53
Functional Gait Index 0 to 30 19 22
6 Min Walk Test meters 289 386
Timed Up-and-Go Test seconds 10.5 9.6
Fugl-Meyer Lower Limb 0 to 34 16 18
Barthel Index ADL 0 to 20 19 19
As the other subjects, SA05 had some di culty at the first session to keep his balance
assisted by the walker. After the first training session, he was more confident and able to
walk folowing the symmetric gait pattern generated by the exoskeleton. The number of
total steps performed in each session and the number of steps per minute are presented
in figure 4.10. Patient SA05 increased a lot the number of steps per minute and was
able to complete 30 to 40 minutes of gait training per session with just a few breaks for
rest. In the session number seven, the reduced number of performed steps is due to the
H2’s footplate, that broke during the training session. The mechanical structure of the
footplate was fixed and reinforced for the next training sessions.
Lastly, figure 4.11 represents the average trajectories performed by the subject when
using the H2. Trajectories are represented in the cycle domain, based on stride length
percentage, from the heel strike to the next heel strike. As results show, gait pattern
has become more symmetric and knee flexion on the paretic leg is being improved with
the robotic assisted training.
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Figure 4.10: Left side plot corresponds to the number of total steps performed in
each session by SA05, which is direct related to the walking distance. Right side plot
corresponds to the number of steps per minute in each session, which relates to the gait
speed.
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Figure 4.11:Hip, knee and ankle trajectories performed by the patient SA05. Blue
lines are the reference trajectories that patient is guided through by means of a force
field. Red lines represent the average trajectories performed by the patient in the first
training session. Black lines represent the trajectories performed at the last session.
4.4.6 Case Study 6
Patient SA06 is a female, 67-year old, 1.60 meter tal and weights 62 kg. She is the
only female participating on the study. Her stroke occurred six and a half years prior
to participation on the study, letting her with the left side of the body a↵ected. She
was the weakest participant in the study, almost unable to walk. When walking, she
was only able to do it at very low speed. Moreover, she used her passive AFO on
the a↵ected leg and a four contact point cane to assist her walking. SA06 presents an
asymmetric walking pattern, reduced left knee flexion and high level of weakness on both
legs. Moreover, she presents hyper-extension on the a↵ected knee joint, which diculty
her walk and causes her to constant loose balance.
SA06 completed the twelve sessions of training plus the two assessment sessions within
the scheduled time. During pre- and post-assessment, she was alowed to use her AFO
as wel as her cane to assist her walking. During the training sessions, she was not using
the AFO, since H2 can completely replace its function actively and, to avoid her knee
hyper extension, the H2 left knee ROM was limited in software to 10 degrees higher
than normal maximum extension.
Table 4.6 presents the clinical outcomes related to patient SA06. With the four weeks
of training with the H2, she improved her scores in the Berg Balance Scale, 6 Min Walk
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Table 4.6:Pre- and pos-assessment data for SA06.
Clinical Outcomes Scale Pre-assessment Post-assessment
Berg Balance Scale 0 to 56 38 39
Functional Gait Index 0 to 30 10 10
6 Min Walk Test meters 54 67
Timed Up-and-Go Test seconds 49.3 41.7
Fugl-Meyer Lower Limb 0 to 34 21 21
Barthel Index ADL 0 to 20 18 18
Test and Timed Up-and-Go Test. The Functional Gait Index, Fulg-Meyer and Barthel
Index did not present variation.
Due to her weakness and di cult to keep balance, SA06 had diculties to use H2 at the
first session, performing only a few steps. With the constant training with the device,
she was able to increase her strength and the number of steps walked in each session,
reaching almost a 1000 steps at the final training session (see figure 4.12). She also
increased her walk speed, represented by the number of steps per minute in the figure
4.12.
Figure 4.13 represents the average trajectories performed by patient SA06 when using
the H2. She also achieved a more symmetric gait pattern and improved her knee flexion
on the paretic leg with the training.
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Figure 4.12: Left side plot corresponds to the number of total steps performed in
each session by SA06, which is direct related to the walking distance. Right side plot
corresponds to the number of steps per minute in each session, which relates to the gait
speed.
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Figure 4.13:Hip, knee and ankle trajectories performed by the patient SA06. Blue
line is the reference trajectory that patient is guided through by means of a force field.
Red line represents the average trajectory performed by the patient in the first training
session. Black line represents the trajectory performed at the last session.
4.5 Results
Hereby are presented the general results gathered from the six post-stroke patients par-
ticipating on this pilot clinical study, related to the gait intervention, safety and usability
of the H2 when applied to clinical rehabilitation.
4.5.1 Gait Intervention
In this pilot clinical study, the usability and safety of using the H2 for robot-assisted gait
training in stroke patients has been evaluated and validated. Five from six participants
with stroke were able to finish twelve sessions of training over a period of approximately
four weeks. Subject SA02 and subject SA05 completed ten sessions only as they had to
miss two sessions due to a personal schedule conflict with the training. Subject SA03
dropped out the study after three sessions of training due to reasons not related to H2
training.
At the first session, al participants started at the lowest walking speed (around 0.5
km/h) and were able to increase the gait speed across sessions as training progressed.
Figure 4.14 links a video of a post-stroke patient during a rehabilitation session with
the H2. The deviant gait pattern of the stroke patients could be retrained into a more
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Figure 4.14:Click here or scan this code to see a video of a post-stroke patient during
a rehabilitation session with the H2.
symmetric pattern during the training time. Symmetry of gait is of special importance to
stroke recovery because the a↵ected side promotes a persistent, uneven walking pattern.
Further, the number of steps walked, a measure indicative of walking distance, increased
across sessions for al participants. The average number of steps performed by patients
in each training session was around 900 steps, whereas during manualy assisted train-
ing only approximately 100 steps per session can be performed [55]. Thus, H2 alows
intensive gait training with much less e↵ort from therapists.
Additionaly, clinical outcome scores show improvements in al but one patient partic-
ipating on the training. Al participants were chronic stroke survivors and were not
receiving any additional therapy. Since patients were in a stable phase of recovery after
the stroke, the functional gains can be probably attributed to the robotic training itself.
4.5.2 H2 Safety and Usability
The time needed for donning and setup the H2 and the EEG system was short, around
twenty minutes elapsed from the time participants arrived before gait training could
start. The dong process was even faster, less than two minutes. It is worth to note
here that about 80% of required donning time was related to the EEG system setup,
which included to apply a smal portion of gel in al contact points of the 64 electrodes
with the patient’s scalp. H2 donning took no more than five minutes in general.
No adverse e↵ects were observed during training, including no skin irritation or redness,
no sore spots, any pain or discomfort during or after the training.
H2 also demonstrated significant autonomy in the context of battery power. A totaly
charged battery pack could run the exoskeleton for about nine training sessions of, on
average, 40 minutes each session. Considering that in each session, a participant walked
30 minutes on average, H2 could run for more than four hours of continuous walking with
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a single battery charge. Also since the battery pack is detachable from the mechanical
frame, it is very easy for a therapist to replace an empty one with a fuly charged battery
pack.
The H2 exoskeleton tested in the experiments was the first device built and thus, is-
sues might have been expected. Remarkably, the H2 robot-assisted gait training was
conducted without any major problems. Only minor technical issues occurred without
impacting user’s safety and were easily fixed. Amongst those minor problems, we include
the mechanical connection between the footplate and ankle joint that ruptured and was
replaced with a reinforced one; some interaction torque sensors and foot ground contact
sensors were not working property and were replaced for new ones.
Lastly, patients participating on the study were very motivated about training with the
device. When asked to evaluate the ease to use of device in each session on a Likert scale,
the average rating for the six patients in al twelve sessions were 7, where 0 indicates
“extremely hard to use” and 10 indicates “extremely easy to use”. The main positive
feedback received from patients when training with H2 was: “the device is lightweight”;
“wearing it is fast and simple”; “I can feel that it helps my knee flexion”; “it is more
exciting walking overground with this device than my previous treadmil training with
manual assistance” and “I wish I had access to this device when I was in the hospital
for inpatient rehabilitation after my stroke”. The main negative feedback received from
patients was: “it felt weird at the first moment and took me some time to get used to
it in my first training session, since I have never used a robotic device like this”.
4.6 Discussion
The pilot clinical study conducted with post-stroke patients have presented the first
evidence for safety and usability of the H2 wearable robotic exoskeleton in the context of
post-stroke gait rehabilitation. The main finding of this work is that the H2 exoskeleton
provides a means for safe and intensive gait training in hemiparetic stroke survivors.
Across four weeks of training in six stroke subjects, the H2 exoskeleton proved to be
easy to use, with a fast donning and dong process and was very wel accepted by
patients as a potential rehabilitation device.
Importantly, the results from this pilot clinical study indicate that the H2, operated in
assist-as-needed control mode, alows reshaping of the asymmetric, deviant hemiparetic
gait in stroke survivors through a relatively short period of training. It is important to
note that in most stroke victims, the lack of knee flexion during swing creates an ab-
normal compensatory movement in the hip, commonly known as hip hiking. Also, most
patients do not rely on their paretic leg, hence, they do not shift weight equaly on both
lower limbs during walking. This behavior creates an asymmetric gait pattern where the
stance phase on the paretic leg is shorter than the una↵ected leg. The gait assistance
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force field implemented in H2 guided patients in a correct gait pattern, creating a stance
phase that is equal across both lower limbs and consequently preventing compensatory
hip hiking. As a result, while using H2, patients are being trained to the correct pattern
of weight shifting between lower limbs and knee flexion.
Actuation at the ankle was another important aspect of H2 design. During training
it helped avoid foot drop and could help patients to work on dorsiflexion movements.
The H2’s control algorithm, therefore, helps these patients relearn a symmetric gait
pattern across both lower limbs by providing assistance as needed at the appropriate
limb segments and joints. Importantly, the ability to perform this training in a functional
context such as overground walking is of major clinical significance. Furthermore, it is
very interesting to note that this training is stimulating and chalenging even for the
participant with chronic stroke (fourteen years ago). Coupled with the motivational
component of training provided by a novel robotic gait training regimen, the H2 alows
these participants to experience kinesthetic feedback of near-normal gait patterns in
overground walking. Since the six participants in this study were able to increase walking
speed and distance across training sessions, it would appear that H2 robot-assisted
training can potentialy recruit extant neuroplasticity and promote improved motor
control in these patients.
However, these findings must be considered with the caveat that this study is limited to a
smal subgroup of patients that is not representative of the entire stroke population and
therefore, conclusions cannot be drawn regarding gait improvements after the use of the
H2. Furthermore, as seen from the patient demographic data and functional outcome
scores, the subgroup of stroke participants included in this study is also heterogeneous
in terms of time at which H2-assisted training was provided with regards to their stroke
onset as wel as their individual functional impairments. This is an important factor to
be considered as this population is very diverse, and therefore, no two patients are alike
in terms of their impairments.
Therefore, it is critical that H2 robot-assisted training be personalized to each individual
based on his/her needs. In this regard, further modifications can be implemented in the
control algorithm to provide variable resistance once the user has reached a certain
threshold in terms of torque generation and/or joint angular position/velocity. This
wil help ensure progressive, adaptive changes to the training regime and is a clinicaly
significant issue that warrants further investigation.
Notably, the modular design of the H2 is particularly relevant for stroke rehabilitation.
Since various segments of the device can be used independently, H2 o↵ers promising
means of using unilateral Hip-Knee-Ankle, Knee-Ankle or just one joint versions of
the device, customizing treatment protocols to each patient’s specific needs. These
questions need to be addressed in future research, in order to help develop optimal control
algorithms to use these modular components of the H2 for individualized rehabilitation.
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Similarly, appropriate intervention durations and frequency of training, i.e., “dosing
schedules”, are stil not wel established for such wearable robotic rehabilitation proto-
cols, which also needs to be examined in careful detail in further clinical investigations.
Furthermore, in order to fuly utilize the functionality of the lightweight wearable H2
device, future training protocols can also include other functional tasks such as sit-to-
stand, stand-to-sit and stair climbing.
The lack of major changes in clinical outcomes precludes any conclusions about func-
tional improvements when training with the H2 in this study. The author believes this is
primarily because while the participants in this study had qualitative gait asymmetries
and impairments, this is not captured by the granularity of the standard clinical out-
come measures. Further, in some of the items such Berg Balance Scale and Functional
Gait Index, if participants achieve scores closer to the ceiling, it is impossible to track
any further qualitative improvement using those items. This brings to light the impor-
tance of developing novel metrics or outcome measures that are sensitive and capable
of tracking behavioral changes quantitatively and qualitatively in robotic rehabilitation
paradigms. However, it is important to study the relationship of these novel metrics
to standard clinical outcomes, in order to describe the functional domain that is being
assessed.
Finaly, the factors discussed above such as inadequate “dosing” in terms of frequency
and duration of training may have prevented su ciently progressing treatment for each
participant based on their functional levels. These questions need to be addressed in
a clinical investigation with a larger population, along with comparison of H2 robot-
assisted training to conventional physical rehabilitation regimes. A future work, there-
fore, is focusing on a controled clinical study in a larger sample of participants with
stroke.
4.7 Conclusion
In summary, this chapter fulfils the objective number 10, by presenting the evaluation
of H2, a novel lower limb robotic exoskeleton for rehabilitation of stroke survivors. The
device is lightweight and battery-powered, thereby alowing for gait training in func-
tional contexts such as overground walking in comparison to more traditional tethered
or treadmil-based robotic rehabilitation devices.
Further, the control of H2 is based on a custom assist-as-needed algorithm that creates
a force field along a desired trajectory, proportionaly applying torque only when patient
deviates from the pre-programmed correct pattern. This force field control, therefore,
helps restore a symmetric gait pattern in hemiparetic stroke survivors, by assisting only
the segments that need it and preventing undesired compensatory movement patterns,
such as hip hiking.
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Additionaly, a customized mobile-based user interface alows the therapist to person-
alize and adjust the maximum alowed deviation from the reference based on a specific
patient’s condition.
Finaly, we also present early findings from a clinical evaluation of the H2 for gait
rehabilitation in six participants with post-stroke hemiparesis. Participants have shown
adaptive improvements in their gait trajectories across the training sessions over four
weeks. These results are encouraging and provide the first evidence for safety and
feasibility of using the H2 for functional gait training in stroke patients. A future work
aims to evaluate the therapeutic benefits of active training with the exoskeleton in
restoring gait function in a larger population of stroke patients.
In summary, the developed H2 device opens up future research avenues to study methods
to optimize rehabilitation protocols that can be customized for individuals with gait
impairments folowing neurological injuries and with the capacity to deliver high dosage
and high intensity therapies. Taken together, these advances can have a huge clinical
impact by helping accelerate recovery and improve functional independence and quality
of life in these patients.
Chapter 5
Conclusions and Future Work
This last chapter summarizes the main conclusions of this dissertation and how they
contributed to achieve its objectives. In addition, it also presents the technical and
scientific contributions resulting from this work. In the last part, this chapter describes
the future work that can give continuity to the research presented here. Two main areas
are identified for further research, which are new control approaches for the exoskeleton
and randomized clinical studies with a large cohort of post-stroke patients. The design
of new control approaches is already being carried out in a new project that uses the H2
exoskeleton. Randomized clinical trial studies wil aim to validate the e↵ectiveness of
the robotic therapy compared with conventional therapy.
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5.1 Conclusions of the Dissertation
Stroke results from a disturbance on the blood supply that flows to the brain. As a
consequence, the contra-lateral side of the body is a↵ected, leading to lost or diminished
motor functions. Stroke is among the most common causes of adult disability, and
hemiparesis, the main manifestation of stroke, leads to a poor walk ability. Most patients
walk to slowly to participate in the community activities. Gait disability is common after
stroke and it is one of the main complains from patients who su↵ers a stroke insult.
Recovery after stroke has been based on physical therapy focusing on task specific ac-
tivities. The translation of neuroscientific research into care, associated to the advance
of the technology, has led to new approaches in rehabilitation. In order to help physical
therapists to improve the rehabilitation process, robotic exoskeletons can come into play.
These robotic devices have emerged as a promising approach to restore gait and improve
motor function on impaired stroke victims.
Helping therapists to improve the outcomes of gait rehabilitation through robotics exo-
skeletons has been the main motivation for the research on this dissertation. The overal
aim was to generate the necessary knowledge to design, develop and validate a novel
lower limb robotic exoskeleton and an assist-as-needed therapy for gait rehabilitation
in post-stroke patients. Research activities were conducted towards the development
of the hardware and the control methods required to proof the concept with a clinical
evaluation.
Several partial objectives were proposed in Section 1.7.2 and accomplished with the work
presented in Chapters 2 to 4. The first five partial objectives were achieved by designing
and implementing the H2 lower limb exoskeleton, a lightweight robotic device capable of
overground walking. The device, weighting no more than 12 kg, provides a comfortable
embodiment to the user, by not extending above mid-abdomen and requiring nothing to
be worn over the shoulders or above the lower back. Furthermore, the robotic exoskeleton
can be easily adjusted to fit adults between 1.50 and 1.95 meters in height. Taken
together, these characteristics enabled a fast donning and dong process, facilitating
therapist’s work and increasing the training time.
The H2 exoskeleton was envisioned as a completely actuated device in the sagittal plane,
including the hip, knee and ankle joints. Actuation on the ankle joint, which is never
addressed in overground rehabilitation exoskeletons, was very important to counteract
the foot drop problems in post-stroke patients, improving their dorsiflexion movements.
Additionaly, the H2 exoskeleton presented a great autonomy powered by battery. The
device was designed with high e ciency motors and gearboxes, integrated with cus-
tomized electronic drives presenting very low dissipation and able to regenerate power.
As a result, the H2 could run for more than four hours of continuous walking with a
Chapter 5 Conclusions and Future Work 107
single battery charge. When empty, the battery pack is easily replaced by a fuly charged
one.
Partial objectives 6 to 9 were achieved by implementing a control approach that assist
the patient only when needed. This method creates a force field that guides patient’s
limbs along a correct trajectory. In this way, the robotic exoskeleton only applies forces
when patient deviates from the trajectory, therefore, helping them to relearn a symmetric
gait pattern across both lower limbs. Importantly, H2 has the ability to perform this
training therapy overground in a real environment, which can greatly motivates patients
to actively participate on the training.
Finaly, research was conducted to evaluate the robotic exoskeleton and its control ap-
proach in a study with six post-stroke patients, achieving the last partial objective. This
clinical study aimed to be a proof-of-concept of al design and implementation applied
to a real clinical rehabilitation scenario. Several aspects were evaluated: the robotic ex-
oskeleton control performance, patients attitudes and motivation towards the use of the
device, patients’ safety and tolerance to the intensive robotic training and the impact of
the robotic training on the walking function of the patients.
Patient’s attitudes towards the use of the device were very positive. Al patients were
motivated to train with the exoskeleton. No adverse e↵ects were observed neither during
nor after the training sessions. Typical training sessions lasted for about 40 minutes,
with 30 minutes of net walking time. Most patients were able to complete the training
sessions with just a few brakes for rest, and the number of steps walked on each session
increased over al sessions for al patients, as wel as the gait speed.
The results from this usability and clinical study shown that the H2 operated in assist-as-
needed control mode can help the deviant hemiparetic gait in stroke survivors to become
more symmetric. The gait assistance force field guided patients in a correct gait pattern,
creating a stance phase that is equal across both lower limbs. Therefore, while training
with the H2, patients are working on the correct pattern of weight shifting between lower
limbs, as wel as improving the knee flexion. Furthermore, it is also notable that training
with the H2 was motivating even for the participants that have a stroke long time ago.
Since the six participants in this study were able to increase walking speed and distance
across training sessions, it seems that H2 training can recruit exiting neuroplasticity and
lead to better motor control in post-stroke patients.
The main findings of the usability and clinical study are that the H2 exoskeleton is safe
and easy to use by experienced therapists in a rehabilitation set, besides enabling high
intensive and repetitive gait training. Some factors as training frequency and duration
may have prevented higher progress of functional level on participants. Although the
study is limited regarding the validation of the H2 e↵ectiveness compared to traditional
gait therapy, the findings can guide furthers studies in this respect. A future work,
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therefore, is to focus on a controled clinical study in a larger cohort of post-stroke
patients.
Lastly, the H2 and the neural interface integration during the clinical study has generated
a large database of kinematic and kinetic data synchronized with EEG data. The open
architecture of the H2 resulted in a simple way to integrate with third party systems.
Based on the synchronized data colected during the clinical study, new algorithms are
being developed to create a brain-machine interface to improve the H2 control. Future
use can provide the patients with a more natural way to control the exoskeleton during
gait training.
5.2 Contributions
This dissertation has contributed to the scientific knowledge with the design and devel-
opment of a lower limb robotic exoskeleton intended for gait rehabilitation in post-stroke
patients. Di↵erent aspects developed on this thesis were novel enough to give rise to a
national design patent:
•J. L. Pons, J. C. Moreno, F. Brunetti,M. Bortole. “Exoesqueleto de miembro
inferior”. Patent Reference: Registered Design, Acta Notarial 546/2013.
The patented technology resulting from the work presented in this dissertation
has been transferred to a spin-o↵company, which is now commercializing the H2
robotic exoskeleton in di↵erent countries as a research tool to be used in clinical
studies.
The work described in this thesis has also produced a number of published scientific
contributions:
•M. Bortole, A. Venkatakrishnan, F. Zhu, J. C. Moreno, G. E. Francisco, J. L.
Pons, and J. L. Contreras-Vidal. “The H2 robotic exoskeleton for gait rehabilita-
tion after stroke: Early findings from a clinical study”,Journal of NeuroEngineer-
ing and Rehabilitation. Submitted on August 30th, 2014.
This manuscript describes the H2 assist-as-needed algorithm to provide gait as-
sistance to post-stroke victims, as wel as the clinical pilot study with patients.
The training was wel tolerated and the findings demonstrate that the H2 is safe
and easy to use in clinical rehabilitation. The overground training employed as a
means to enhance active patient engagement proved to be chalenging and exciting
for patients. This topic has been addressed in Chapter 4.
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•M. Bortole, F. Zhu, A. Venkatakrishnan, Z. Hernadez, J. L. Pons, and J. L.
Contreras-Vidal. “H2 NeuroExo: Integration of the H2 lower body powered ex-
oskeleton and mobile brain monitoring to improve gait rehabilitation”,Interna-
tional Workshop on Wearable Robotics, 2014.
This paper presents the augmentation of the H2 robotic exoskeleton with a mo-
bile brain imagining technology, based on scalp EEG, and algorithms to alow the
tracking of changes in cortical activity patterns emerging from a robotic gait in-
tervention in stroke patients. Synchronization and use of both systems provide a
window to study cortical adaptation during robotic rehabilitation. This topic has
been addressed in Chapter 3.
•A. Venkatakrishnan, F. Zhu,M. Bortole, Z. Hernadez, J. Kung, S. Chang, G. E.
Francisco, J. L. Pons, and J. L. Contreras-Vidal. “H2 NeuroExo: A clinical study
in post-stroke gait rehabilitation”,International Workshop on Wearable Robotics,
2014.
In this work is presented the development of an algorithm to decode walking intent
as wel as to systematicaly characterize the nature of neural adaptation in terms
of changes in cortical dynamics during user-H2 interaction. Taken together, the
findings from this clinical study can help advance the clinical translation of the
H2 exoskeleton for stroke rehabilitation. This topic has been partialy addressed
in Section 3.7.
•M. Bortole, A. del Ama, E. Rocon, J. C. Moreno, F. Brunetti, and J. L. Pons.
“A robotic exoskeleton for overground gait rehabilitation”,in Proceedings of IEEE
International Conference on Robotics and Automation, pp. 3356–3361, 2013.
This paper presents the exoskeleton hardware and software development. The de-
vice is a bilateral exoskeleton with six degrees of freedom and is designed to gait
training in stroke survivors. Experimental results have shown that the exoskeleton
can adapt a pre-recorded gait pattern for the gait pattern of a specific user. This
topic has been partialy addressed in Chapter 2.
•M. Bortole, and J. L. Pons. “Development of an exoskeleton for lower limb reha-
bilitation”,in 2012 International Conference on NeuroRehabilitation: Converging
Clinical and Engineering Research on Neurorehabilitation, pp. 85–90, 2012.
This paper presents the first version of the robotic exoskeleton designed to assist
overground gait, as wel as the first experiments with a healthy subject. The re-
sults have shown that the robotic exoskeleton can replicate a normal gait pattern
for walk assistance. This topic has been partialy addressed in Chapter 2.
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•E. Urendes, R. Ceres,M. Bortole, and J. L. Pons. “External support forces
during assisted walking in a new rehabilitation system”,in 2012 International
Conference on NeuroRehabilitation: Converging Clinical and Engineering Research
on Neurorehabilitation, pp. 805-809, 2012.
In this work is described a novel system for rehabilitation of patients with limited
motion capabilities. The approach is based on a combination of an exoskeleton
to assist gait combined to a mobile platform to partialy support body weight.
An analyses of user-system interaction forces is performed in order to extract gait
parameters. This topic is related to the use of the exoskeleton in another rehabil-
itation project.
•M. Bortole, and J. L. Pons. “Arquitectura de control distribuida para un ex-
oesqueleto de rehabilitaci´on de marcha”,in VII Congreso Iberoamericano de Tec-
nolog´ıas de Apoyo a la Discapacidad, 2013.
This paper presents the distributed control architecture of the robotic exoskeleton
designed to assist overground gait. The architecture is based on nodes and con-
nected by means of a deterministic bus that guarantees real time operation. This
topic has been partialy addressed in Chapter 2.
•M. Bortole, J. L. Pons, and E. Urendes. “Integraci´on de una plataforma h´ıbrida
para rehabilitaci´on y compensaci´on funcional de la marcha”,in XXXIII Jornadas
de Autom´atica, 2012.
This paper describes the integration of a hybrid platform in order to improve the
rehabilitation process of patients su↵ering from stroke or spinal cord injury. The
platform is composed by an exoskeleton, a neuroprotesis and virtual reality. A
first prototype of the lower limb exoskeleton already integrated with the platform
is presented. This topic has been partialy addressed in Section 3.4.
•A. J. del-Ama,M. Bortole, A. Garza-Cervantes, J. C. Moreno, A. Gil-Agudo,
and J. L. Pons. “Actuadores multimodales para compensaci´on de la marcha de
personas con patolog´ıa neurol´ogica”,in XXXIII Jornadas de Autom´atica, 2012.
It is presented in this paper the design of two exoskeleton actuators, one for the
ankle and one for the hip. The design is based on the analysis of the gait biome-
chanics of the subjects with incomplete spinal cord injury. The actuator design
aims to minimize the weight of the final actuator and to provide the ability to
implement various control strategies, based on position and torque. This topic has
been partialy addressed in Section 2.3.
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•E. Urendes,M. Bortole, J. L. Pons, and R. Ceres. “Influencia de la descarga
parcial de peso en la lateralidad de la marcha humana”,in XXXIII Jornadas de
Autom´atica, 2012.
This paper presents a gait rehabilitation system with partial body weight support.
In a first phase of the validation of the system, this work describes a study about
the influence of weight discharge on the lateral component during gait. This topic
is related to the use of the exoskeleton in another rehabilitation project.
5.3 Future Work
The research conducted in this thesis together with the results obtained, could serve as
proof of concept to validate the safety and usability of the H2 exoskeleton when applied
to post-stroke rehabilitation. To achieve this, a study with post-stroke individuals was
carried out. However, this study was not intended to prove the e↵ectiveness of the
device when used in gait rehabilitation. Although patients have shown improvements in
their gait functions, this study is limited in this aspect and further research has to be
conducted to validate the e↵ectiveness of H2 when compared to traditional therapy.
The knowledge and experience acquired during the clinical experimentation can be ap-
plied in future clinical trials with a large cohort of patients. Di↵erent aspects can be
improved when carrying out a new rehabilitation study with the H2 exoskeleton. Here
it is discussed some aspects based on the results and the feedback received from the
therapists participating on the study.
The first further goal is to study the H2 e↵ectiveness in gait rehabilitation. To this end,
a randomized clinical trial with a large cohort of patients is proposed. This clinical study
should compare the H2 training with a control group of patients receiving conventional
therapy. Additionaly, appropriate intervention durations and frequency of training are
stil not wel established for such wearable robotic rehabilitation protocols. This aspect
also needs to be examined in careful detail in further clinical investigations.
Participants on the study carried out were al chronic post-stroke individuals. However,
sub-acute patients are likely to benefit more from the training, since most gains in motor
functions are seen in this phase of recovery. Furthermore, sub-acute patients are usualy
weaker and with reduced ambulation capability, causing them to need more assistance
from therapists. The H2 can better assist them, with higher degree of movement coordi-
nation, besides to aleviate therapist’s physical e↵ort. Also, in order to fuly utilize the
functionality of the lightweight wearable H2 device, future training protocols can also
include other functional tasks such as sit-to-stand, stand-to-sit and stair climbing.
The use of a zero gravity harness system could be helpful in future clinical experimenta-
tion. It can better guarantee patient’s safety during the ambulatory training, specialy
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the most impaired ones. The system has a harness that is placed around the subject and
then attached to an overhead track by means of ropes, eliminating the risk of fals. As
the subject ambulates, the system quietly slides along the overhead track, maintaining
its position above the individual, making it nearly imperceivable to the patient. If the
patient loses their balance and fals at any time, the zero gravity system wil catch them,
preventing any injury.
It was also noted from the clinical tests that the walker used to help patients to keep their
balance could not be the best option, since it may prevent the patients to perform larger
steps sometimes. Instead, the use of paralel bars as an aid for balance could better help
the patients, encouraging them to perform larger steps and walking at higher speeds.
In addition, one last future work proposed from the results of this dissertation is the
design of new control approaches to the H2 exoskeleton. It is critical that H2 robot-
assisted training be personalized to each individual based on his/her needs. In this
regard, further modifications can be implemented in the control algorithm to provide
variable resistance once the user has reached a certain threshold in terms of torque
generation and/or joint angular position/velocity. This wil help ensure progressive,
adaptive changes to the training regime and is a clinicaly significant issue that warrants
further investigation.
In terms of developing new control methods, H2 has been already adopted as the ex-
perimental platform for the BIOMOT Project. The main objective of BIOMOT is to
improve existing wearable exoskeletons by exploiting dynamic sensory-motor interac-
tions and by developing cognitive capabilities that lead to a symbiotic gait behavior in
the human-robot interaction. BIOMOT proposes a cognitive architecture for robotic
exoskeletons exploiting neuronal control and learning mechanisms aiming to enable pos-
itive co-adaptation and seamless interaction with humans.
Within BIOMOT, research wil be carried out to provide novel capabilities to perform
walking in unstructured environments. This wil provide not only extended capabilities
to the therapy, but a way to extend the therapy beyond clinical environment to daily
living activities. The research conducted in this framework wil bring transparent robotic
devices, in which the boundary between functional compensation and rehabilitation of
walking is interleaved.
Finaly, the H2 integration with the neural interface for the clinical study has generated
a large database of kinematic, kinetic and EEG data. Based on the study of this data,
new algorithms are being developed to create a brain-machine interface to improve the
H2 control. The brain-machine interface could provide the patients with a more natural,
direct and intuitive way to control the exoskeleton during gait. Additionaly, for patients
with limited voluntary movement control, this technique could enhance their engagement
during the training session, consequently inducing greater functional recovery. Moreover,
further EEG data analysis can show how the neural activity of patient’s brain is changing
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during the rehabilitation process. Understanding these changes could lead to the design
of better techniques to improve motor recovery of the disabilities caused by stroke.

Appendix A
Protocol Approval
The experimental protocol, including al procedures with stroke patients and healthy
subjects described in this dissertation were approved by the Institutional Review Board
at the University of Houston. In the next folowing pages is presented the document
with the approval details, under the Application ID number 14107-01(4838). The study
protocol is also registered and available at ClinicalTrials.gov, under the reference num-
ber NCT02114450. Al subjects enroled on this study did it voluntary and provided
informed consent prior to participation.
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Institutional Review Board 
Application ID : 14107-01 - (4838)
Title : Human-machine system for the H2 lower limb Exoskeleton
Approval details for the Application Id: 4838 
 Decision Approver Name Date Comment
PI 
signature ApprovedContreras-Vidal, Jose Dr. 07/28/2014 
DOR 
signature ApprovedAdmin, IRB 08/04/2014 
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Application Data for Application ID: 4838 
Title Human-machine system for the H2 lower limb Exoskeleton
Application Type Revision
Review Type Ful
Expedite Code Not Applicable
Exemption Code Not Applicable
Research Reason Unfunded Research,Longitudinal Study
Investigator Data for Application ID: 4838 
PI Name Is Pricipal?
Is Co-
Investigator?
Is 
External?
Other Personnel 
Type?
Is 
Student?
Faculty Sponsor 
Name
Venkatakrishnan, Anusha 
Dr.  Yes No  No Not Applicable
Contreras-Vidal, Jose Dr. Yes  No  No Not Applicable
Kilicarslan, Atila Dr.   No Other Research Personnel No Not Applicable
Agashe, Harshavardhan 
Mr.   No
Other Research 
Personnel Yes Not Applicable
Paek, Andrew Mr.   No Other Research Personnel Yes Not Applicable
Nathan, Kevin   No Other Research Personnel Yes Not Applicable
He, Yongtian Mr.   No Other Research Personnel Yes Not Applicable
Ozdemir, Recep Mr.   No Other Research Personnel Yes Not Applicable
Francisco, Gerard Dr.   Yes Other Research Personnel No Not Applicable
Cruz, Jesus Mr.   No Other Research Personnel Yes Not Applicable
Bhagat, Nikunj Mr.   No Other Research Personnel Yes Not Applicable
Hernandez, Zachary Mr.   No Other Research Personnel Yes Not Applicable
Zhu, Fangshi Mr.   No Other Research Personnel Yes Not Applicable
Yozbatiran, Nuray Dr.   Yes Other Research Personnel No Not Applicable
Bortole, Magdo Mr.   Yes Other Research Personnel Yes Not Applicable
Soto , Rogelio Dr.   Yes Other Research Personnel No Not Applicable
Pons, Jose Dr.   Yes Other Research Personnel No Not Applicable
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Chang, Shuo-Hsiu Dr.   Yes Other Research Personnel No Not Applicable
Keun-Tae, Kim Mr.   No Other Research Personnel Yes Not Applicable
No-Sang, Kwak Mr.   No Other Research Personnel Yes Not Applicable
Grassi, Sara Dr.   Yes Other Research Personnel No Not Applicable
Peroud, Laetitia Dr.   Yes Other Research Personnel No Not Applicable
Goodal, Brian Mr.   No Other Research Personnel Yes Not Applicable
Revision application data for application Id: 4838 
Question Answer
1) Revision Description (check al that are 
appropriate) Revision to curently approved protocol
2) Risk Involve:(Check One) This revision does not increase risks to participants enroled in this study. (For students, signature of faculty sponsor is required.)
3) Describe the proposed revision. If applicable, 
include a scientific justification for the revision ( for 
example, changes in the study population).
This revision is to amend the protocol without increasing risks to any 
participants. As this is the first clinical investigation of the use of H2 in gait 
training for stroke-survivors, we would like to amend the protocol to indicate 
that the first 10 stroke participants wil be recruited in to the study in an 
open-label design. That is, the first 10 participants with stroke wil be 
assigned to H2 robot-assisted training. This wil enable obtaining initial safety 
and eficacy data for the H2 robot in this population. Subsequently, 
participants with stroke who are recruited wil be assigned to either H2 
robot-assisted training or supervised motor practice as previously indicated in 
the protocol. This revision does not impact the Consent form and 
Recruitment documents, therefore, these have not been revised. This revision 
is also to add Brian Goodal, and undergraduate research assistant to this 
protocol. His CITI completion certificate is uploaded in the Other folder. 
Additionaly, we would like to request an amendment to alow use of existing 
structural MRI scan images of participants to create 3-D models of their 
brains (these could be obtained via accessing the medical records of the 
patients if scans are available). Medical records of participants are accessed 
with patient's consent in accordance with HIPPA. This wil help perform 
source localization analysis to estimate the neural regions contributing to EEG 
activity that is recorded. This wil not increase any risk to participants or 
compromise subject confidentiality. The Consent form has been amended to 
request patient permission to access existing structural MRI scans.
Project Review Summary Data for Application ID: 4838 
Question Answer
This research study wil investigate the use of smart lower limb robotic 
exoskeleton (developed by the CSIC, Spain) in rehabilitation after stroke. It 
wil compare robotic-assisted rehabilitation with standard of care 
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4) State the specific research hypotheses or 
questions to be addressed in this study
(conventional physical rehabilitation). Additionaly, it wil also examine the use 
of noninvasive scalp electroencephalography (EEG) to learn specific brain 
wave paterns associated with learning to walk on the powered lower limb 
exoskeleton. The findings wil be used to understand human-robot interaction 
and to design smart orthotic devices that can be controled by thought activity 
and assist those that have lost al or part of their walking abilities.
5) What is the importance/significance of the 
knowledge that may result?
Stroke is the leading cause of neurological disability in the United States 
(Wolf et al., 1999) and accounts for the poor physical health and the social 
dysfunction evident in survivors (Veliste et al., 2008). Gait impairment is a 
large contributor to long-term disability and ambulatory function in daily living 
(Mauritz, 2002). Many patients, however, lose the ability to walk 
independently, and furthermore, a large proportion do not regain their normal 
walking speeds folowing a stroke (Pennycot et al., 2012). Physical 
rehabilitation tends to remain the mainstay in long-term stroke treatment to 
regain functional independence. In this regard, therapeutic approaches as wel 
as underlying theoretical models to stroke physical therapy are diverse. More 
recently, body-weight supported robot-assisted treadmil training has been 
shown to lead to beter functional outcomes (Hesse et al., 2001; Wemer et 
al., 2002; Pohl et al., 2007). However, the limitation of these devices is that 
they are largely restricted to the clinical or research seting owing to their size 
and therefore are less amenable to training with other functional tasks such as 
siting, climbing stairs etc. Therefore, newer robotic-aided therapeutic tools 
include ¿wearable¿ lower-limb robotic exoskeletons, which alow for the user 
to be augmented by mechanicaly actuated lower limb joints that can either 
completely or partialy assist movements of the lower limb segments 
depending on the patient needs. The H2 exoskeleton (developed by 
Technaid S.L., Spain) is an example of one such system that has hip, knee 
and ankle joints actuated for both lower limbs. These devices are very new, 
and therefore, systematic investigations of therapeutic benefits of these 
devices are lacking in the field. Further, the nature of adaptive plasticity in the 
brain and peripheral neuro-muscular system triggered by wearing and training 
such exoskeletons is unknown. In this exploratory research study, we aim to 
compare robotic-assisted rehabilitation using the H2 exoskeleton with 
standard of care (conventional physical rehabilitation) particularly in terms of 
functional recovery. Additionaly, this study wil also examine brain plasticity 
associated with robotic-assisted training using non-invasive scalp 
electroencephalography (EEG) and changes in lower limb muscle activity 
during robotic-assisted training using non-invasive skin surface 
electromyography (EMG). Taken together, the findings from this research 
wil be used to understand human-robot interaction and to design smart 
orthotic devices that can be controled directly by brain activity and assist 
those that have lost al or part of their walking abilities due to neurological 
disease or injury. Moreover, this study wil systematicaly track 
neuroplasticity associated with functional recovery after stroke, which wil 
help determine optimal windows for treatment that would maximize 
therapeutic benefit. Lastly, it wil also help characterize markers of learning to 
use these new devices, which wil be important in the clinical seting for 
modifying and adapting rehabilitation protocols to suit changing needs of the 
patient (user). 
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6) Type of Subject Population (check al that are 
appropriate) Adults,Elderly (65yrs and above)
6.01) Expected maximum number of participants
50 adults (males & females) with hemiparesis caused by stroke, 10 healthy 
able-bodied adults (males & females), leading to a total of 60 participants 
who wil be enroled. This number also accounts for potential atrition/drop-
outs.
6.02) Age of proposed subject(s) (check al that 
apply) Adults (18yrs-64yrs),Elderly Adults (65yrs and above)
6.03) Inclusion Criteria:
The participants in these studies wil be males and females aged between 18 
and 75 years: a) healthy able-bodied adults; b) individuals with unilateral 
stroke resulting in hemiplegia or hemiparesis. Inclusion criteria for participants 
with stroke are as folows: - Sub-acute or chronic stroke i.e., interval of at 
least 3 months or interval of at least 6 months from stroke to time of 
enrolment, respectively; - Cognitive ability to assimilate and participate 
actively in the treatment protocol (Mini Mental State Examination score > 24 
points, out of a total 30 indicating normal cognitive ability) and Ranchos Los 
Amigos Level of Cognitive Functioning >= VI (with stage VII being highest 
level of cognitive functions); - Rankin scale scores 2-4 (Mild-Moderate 
functional disability post-stroke); - Modified Ashworth Scale of Spasticity 
score <= 2 (ranges from 0-4 with 4 reflecting maximum spasticity); The 
height range of al the participants wil be between 5'1" (1.55 m) and 
6'2" (1.9 m) with maximum weight 220 lbs (100 Kg). Additional inclusion 
criteria are: have no skin integrity issues; suficient passive range of motion at 
the hip (at least 90 deg flexion, 15-20 deg extension), knee (90 deg flexion, 
complete extension) and ankle (15 deg dorsiflexion, 15 deg plantarflexion); 
and have no contraindications to standing or walking.
6.04) Exclusion Criteria:
For healthy able-bodied subjects: History of neurological, neuromuscular or 
physical disability. Determination wil be based on a telephone screening 
interview performed by the PI or his research staf. For individuals with 
stroke, the exclusion criteria are: severe cognitive and/or visual deficit; hemi-
neglect; severe sensory deficit; joint contractures of any extremity that limits 
normal range of motion during ambulation with assistive devices; skin lesions 
that may hinder or prevent the application of exoskeleton; uncontroled 
angina; severe chronic obstructive pulmonary disease; other medical 
contraindications; any medical co-morbidities that would prevent standard 
rehabilitation. Determination wil be based on clinical examination by our 
clinical research colaborators at TIRR Memorial Hermann Hospital (Dr. 
Gerard Francisco or his appointed staf), Texas Medical Center, Houston. 
6.05) Justification:
Stroke can lead to paresis or paralysis which induces significant gait 
abnormalities and consequent functional limitations. Therefore, this clinical 
population wil likely greatly benefit from robotic-assisted rehabilitation. 
Additionaly, individuals with both sub-acute and chronic stroke are included 
because it is unknown at what time point the robotic devices would have the 
maximal therapeutic efect. The inclusion and exclusion criteria reflect the 
participants who wil have moderate levels of impairment and can adhere to 
the rehabilitation protocol with the exoskeleton. The height and weight 
inclusion criteria reflects the minimum and maximum heights and the maximum 
weight of a subject that the exoskeleton can assist in transporting. The age, 
health, and weight criteria are not due to safety issues but rather study 
design/goals or device limitations. The criterion of age is used to avoid 
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potential confounds due to motor development or degraded movement, and 
cognitive function in advanced age.
6.06) Determination:
The first contact with most potential subjects wil be through the participant 
telephoning our 12-hour phone number. The study personnel wil answer 
queries from the participant about the nature of the study. Study personnel 
wil request permission from the potential participant to colect data that wil 
be part of the telephone-screening interview. The telephone-screening 
interview wil include a) demographic data; b) basic physical status; c) basic 
neurological history. The initial telephone screening process wil improve the 
eficiency of the study since it reduces the likelihood of unsuitable participants 
(i.e., participants meeting exclusion criteria) having to undergo a ful screening 
before being excluded. Healthy participants who pass the telephone 
screening wil be asked to provide their names, telephone numbers, 
addresses/emails to be contacted to be scheduled for the experiment and to 
mail/email them a copy of the Consent Form for their review prior to their 
initial experimental visit. In the case of potential participants with stroke, the 
informed consent process wil begin for those participants who have been 
determined to meet the inclusion criteria via telephone screening or in-person 
screening at The Institute for Rehabilitation Research (TIRR) (by Dr. Gerard 
Francisco). After the potential participant's signed consent has been 
provided, further evaluations for eligibility wil be performed by Dr. Francisco 
(e.g., there are several medical and physical exclusion criteria). Those 
potential participants who meet both the inclusion and exclusion criteria wil 
be given medical clearance and be eligible to enrol into the proposed study. 
Medicaly cleared subjects with stroke interested in participating wil be 
asked to contact Dr. Venkatakrishnan (at UH) to set up an appointment for 
the functional assessment to participate in the study. Dr. Francisco and/or his 
appointed clinical staf and Dr. Venkatakrishnan, a physical therapist, would 
answer queries from the potential participant about the nature of the study. 
7) If this study proposes to include children, this 
inclusion must meet one of the folowing criterion 
for risk/benefits assessment according to the 
federal regulations (45 CFR 46, subpart D). 
Check the appropriate box:
 
8) If the research involves any of the folowing, 
check al that are appropriate: Clinical Studies
9) Location(s) of Research Activities: UH campus,Other (Explain) :TIRR Memorial Hermann hospital facilities (pending approval from TIRR Memorial Hermann). 
10) Informed Consent of Subjects: Your study 
protocol must clearly address one of the folowing 
areas: 
Informed Consent. Signed informed consent is the default. A model consent 
is available on the CPHS website and should be used as a basis for 
developing your informed consent document. If applicable, the proposed 
consent must be included with the application. 
(htp:/www.research.uh.edu/PCC/CPHS/Informed.html) ATTACH COPY 
OF PROPOSED CONSENT DOCUMENT
Research Protocol Data for Application ID: 4838 
Question Answer
This study wil comprise a simple paralel study design. Individuals with 
stroke wil randomly assigned (subsequent to the first 10) to receive either 
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11) Describe the research study design. (Describe 
the research methods to be employed and the 
variables to be studied. Include a description of the 
data colection techniques and/or the statistical 
methods to be employed.)
"Supervised motor practice" or "Robotic-assisted rehabilitation". The 
experimental treatments/interventions wil be administered in addition to any 
other medical/physical therapeutic treatments that stroke participants already 
receive (if at al). However, as this is the first clinical investigation of the use 
of H2 in gait training for stroke-survivors, the first 10 stroke participants wil 
be recruited in to the study in an open-label design. They wil al be assigned 
to H2 robot-assisted training. "Supervised motor practice" wil comprise of 
simple motor tasks/exercises (e.g., squat, forward/backward lunge, walk 
initiation, sit-to-stand, stepping on a stool/pedestal etc.) that are part of a 
conventional physical rehabilitation regimen which participants wil perform 
for a duration of 1-2 hours per session for a total of 3 sessions/week for 4 
weeks under the supervision of Dr. Venkatakrishnan, a physical therapist. 
This group wil serve as a Control group for the experimental robotic 
rehabilitation group by controling for motor practice as an extraneous 
variable. "Robotic-assisted rehabilitation" protocol: On the day of testing, 
eligible participants (that meet both the inclusion and exclusion criteria) and 
that have given Informed consent, wil be fited with an 
electroencephalography (EEG) electrode cap (similar to a swim cap). The 
purpose of the EEG cap is to record electrical brain activity from up to 64 
locations spaced through the scalp. Participants wil also have recording of 
electromyography in the lower limbs i.e., sensors wil be placed on the skin of 
the legs and thighs (4 on each leg) to non-invasively record muscle activity 
during walking. Additional sensors i.e., goniometers wil be placed on the 
skin to non-invasively record joint angles of the hip, knee and ankle on each 
leg. These wil be atached to the skin using hypoalergenic tape. Then, 
participants wil also be comfortably fited to a powered robotic exoskeleton 
(CSIC Techniad S.L.'s H2 exoskeleton). The ankle, knees and hips wil be 
supported within the device by a series of leg braces, straps and harness. The 
fiting procedure entails making adjustments to the device to ensure it fits the 
user's body shape and size, i.e., that the lower limb joints are wel aligned 
with the exoskeleton's articulations and comfort is assured. This process 
needs to be completed so that the user can safely wear the device. 
Participants wil be asked to perform activities such as siting and standing, 
walking forward, turn left or right and stop with the exoskeleton. In addition, 
participants may also be asked to perform movements that are part of a 
standard physical rehabilitation regimen e.g., squating, lunging forward, 
stepping on a 7-8" stool/pedestal etc. They may also be asked to imagine 
performing walking movements. In order to study functional improvements 
associated with training to use the exoskeleton, participants wil likely be 
asked to come in for about 3 sessions per week, each lasting for a maximum 
of 3 hours, for 4 weeks. Dr. Venkatakrishnan, and/or clinical personnel at 
TIRR wil supervise al training sessions and constantly monitor participants 
for safety and comfort and adjust the protocol as necessary to suit participant 
needs and safety. In the case of healthy able-bodied individuals, participants 
wil perform movements with the robotic exoskeleton in a manner similar to 
the "Robotic-assisted rehabilitation" protocol, which wil elucidate 
mechanisms by which the human body learns and adapts to the H2 robotic 
exoskeleton. Healthy adults wil not participate in "Intervention" sessions. 
They wil be invited for a maximum of 5 sessions over 4 weeks. The data 
colected from healthy adults wil inform about human-H2 interactions in the 
absence of any neurological lesion.
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12) Describe each task subjects wil be asked to 
perform.
Stroke participants wil be asked to perform activities such as siting and 
standing, walking forward, turn left or right and stop with the exoskeleton. In 
addition, participants may also be asked to perform movements that are part 
of a standard physical rehabilitation regimen e.g., squating, lunging forward, 
stepping on a 7-8" stool/pedestal, sit-to-stand etc. They wil also be asked to 
imagine performing walking movements. Healthy individuals wil also be 
asked to perform the same tasks as stroke subjects. 
13) Describe how potential subjects wil be 
identified and recruited? (Atach a script or outline 
of al information that wil be provided to potential 
subjects. Include a copy of al writen solicitation, 
recruitment ad, and/or outline for oral 
presentation.)
Recruitment wil take place through flyers (see atached) posted at the 
University of Houston and the Greater Houston Metropolitan area, 
newspapers, email, and targeted recruitment (for participants with stroke) at 
the TIRR Memorial Hermann hospital (through Dr. Gerard Francisco, who is 
participating in this research, is the chair of physical medicine & rehabilitation 
at TIRR and wil recruit interested potential participants). We intend to use 
list-serves, the PI website and electronic buletin boards to announce the 
proposed study. People interested in participating, can phone or email back 
for further information. The recruitment ad, including the provided statement 
above, wil be emailed it to prospective participants. The email which wil 
also be used to send a copy of the Consent Form for those participants that 
qualify for the study Recruitment ad, is atached. Interested stroke 
participants who contact the research team through a recruitment ad wil be 
refered to Dr. Francisco for pre-screening to obtain medical clearance to 
determine eligibility. Participants recruited through targeted recruitment at 
TIRR wil be pre-screened similarly by Dr. Francisco. The informed consent 
process wil begin for those stroke participants who have been determined to 
meet the inclusion criteria. After the potential participant's signed consent has 
been provided, further evaluations for eligibility wil be performed (e.g., there 
are several medical and physical exclusion criteria). Those potential 
participants who meet both the inclusion and exclusion criteria wil be eligible 
to enrol into the proposed study. Medicaly cleared stroke subjects who are 
interested in participating wil be asked to contact Dr. Venkatakrishnan (at 
UH) to set up an appointment for the intial functional assessment to 
participate in the study. Healthy adults who are interested wil be invited to 
participate in the first experimental session wherein they wil be consented 
(see response to Q. 14). 
14) Describe the process for obtaining informed 
consent and/or assent. How wil investigators 
ensure that each subjects participation wil be 
voluntary (i.e., free of direct or implied coercion)?
For healthy adults, on the day of the first study session, there wil be a 
consent document discussion and any questions wil be answered by Dr. 
Contreras-Vidal (PI) or Dr. Venkatakrishnan (Co-I) prior to signature. For 
stroke subjects, the consenting process wil occur at the time of clinical 
evaluation for inclusion by Dr. Francisco (participants wil be mailed/emailed 
a copy of the Consent Form for their review prior to arival to the first study 
session). Participants wil be provided with the study information, study 
rationale, risks, potential benefits, and the role of the IRB. Participants wil be 
weighed using a digital scale and measured using a measuring tape (head 
circumference and lower limb segmental lengths). Al participants wil be 
asked to complete and sign the Informed Consent form in writing. By signing 
the form, subjects wil atest they are between 18-75 years of age, 
understand the experimental details and voluntarily wish to participate in the 
study. The consent form wil be dated and countersigned by the PI or the 
Co-I, and one signed copy wil be provided to the participant. 
We wil use telephone to administer the telephone screening instrument. The 
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15) Briefly describe each measurement instrument 
to be used in this study (e.g., questionnaires, 
surveys, tests, interview questions, observational 
procedures, or other instruments) AND atach to 
the application a copy of each (appropriately 
labeled and colated). If any are omited, please 
explain.
folowing measurements wil be conducted at the Laboratory for Noninvasive 
Brain-Machine Interface Systems at the University of Houston or at the 
designated space in a rehabilitation gym at the TIRR Memorial Hermann: - A 
digital weighing scale and a measuring tape wil be used to weight the subject 
as wel as the length of his/her legs. - The EEG system is a noninvasive 
electrophysiological measurement instrument that measures brain waves 
outside the scalp. - The EMG system is a noninvasive electrophysiological 
measurement instrument that measures surface muscular activity. - 
Goniometry is a noninvasive measurement instrument to record joint angles 
during movement such as walking using angular sensors placed on the skin 
near a joint e.g., hip, knee and ankle. - The robotic exoskeleton (H2) is a 
wearable powered robot that can assist in transporting (carying) a person 
and which can be controled either through its on-board computer/smart 
phone application/personal computer operated by the study personnel. The 
exoskeleton provides information about lower limb movements, specificaly 
movements of the various joints. - Functional assessments in individuals with 
stroke wil be performed before and after training. It wil inlcude the folowing 
(see atached appendices): 1. NIH Stroke Scale 2. Modified Rankin Scale 3. 
Modified Ashworth scale for spasticity 4. Barthel Index 5. Berg Balance 
Scale 6. Fugl-Meyer Assessment 7. 6-minute walk test 8. Timed Up and Go 
Test 9. Functional Gait Assessment Additionaly, for every session, 
participant's physical comfort wil be monitored for documentation of safety. 
Pain, discomfort, fatigue wil be assessed at the start and end of each 
experimental session on a 11-point visual analogue scale ranging from 0 
(none) to 10 (worst). The progress note wil also document experimental 
session details (e.g., task performed, date, time etc.). This progress note wil 
include the coded-name for each participant. Al assessments wil be 
conducted in a quiet, enclosed room in order to maintain patient privacy.
16) Describe the seting and mode for 
administering any materials listed in question 15 
(e.g., telephone, one-on-one, group). Include the 
duration, intervals of administration, and amount of 
time required for each survey/procedure. Also 
describe how you plan to maintain privacy and 
confidentiality during the administration.
Telephone: The interview wil take 5-10 minutes. Other measurement 
instruments, such as the EEG, EMG, goniometry and motion capture via the 
robotic exoskeleton, wil be administered at the Laboratory for Noninvasive 
Brain Machine Interface Systems at the University of Houston or at TIRR 
Memorial Hermann hospital. The clinical evaluation, in the case of 
prospective participants with stroke, according to the inclusion/exclusion 
criteria to be performed by Dr. Francisco or his appointed staf wil take 30-
60 minutes. In addition, Dr. Venkatakrishnan wil perform functional 
assessments (see atached Appendices) to quantify motor impairment in 
individuals with stroke in order to assess participant response to training with 
exoskeleton, which wil take additional 60-90 minutes and wil be performed 
at 4 time points i.e., once before, and 3 times after training. Other 
measurement instruments, such as the weighing scale, measuring tape, EEG, 
and motion capture via the robotic exoskeleton, wil be administered at the 
Laboratory for Noninvasive Brain-Machine Interface Systems at the 
University of Houston or at TIRR Memorial Hermann hospital. Al these 
interactions/assessments wil take place in quiet, private seting (curtained 
area/side room), wherein every efort wil be made to protect participant's 
privacy.
Stroke participants: For each session, a maximum of 3 hours are needed to 
colect data. Participants wil be recruited to perform 3 sessions per week for 
4 weeks. The total time commitment is 36 hours for the training program. The 
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17) Approximately how much time wil be required 
of each subject? Provide both a total time 
commitment as wel as a time commitment for each 
visit/session.
initial clinical evaluation for inclusion/exclusion to participate in the study wil 
take an additional 1/2 to 1 hr and functional assessments wil take 1-2 hours 
for the individuals with stroke (8 hours total for 4 sessions). Therefore, each 
participant's maximal time commitment would be 45 hours. Healthy 
individuals: Each study session wil last a maximum of 3 hours. Healthy 
participants wil be invited for up to 5 sessions in total, therefore, total study 
time commitment would be maximum of 15 hours.
18) Wil Subjects experience any possible risks 
involved with participation in this project?  
18.01) Risk of Physical Discomfort or Harm
Yes: :The procedures described above are widely used in research and are 
not known to be physicaly harmful to the participant. There are no known 
long-term efects associated with the tasks or events experienced during this 
study. The procedures of this study involve minimal risk and are non-invasive. 
It is possible that subjects may experience some discomfort and slight 
sensations and skin iritation when fited with the EEG cap. To minimize 
discomfort, participant wil be questioned and cap wil be adjusted for 
maximal comfort. It is also possible that they may show fatigue and/or muscle 
soreness from walking with the H2 exoskeleton. There is a minimal risk of 
faling during walking with the exoskeleton. To minimize this risk, participants 
with stroke wil walk with a walker while being supervised by Dr. 
Venkatakrishnan, who is a physical therapist and/or clinical personnel at 
TIRR. She wil also be assisted by two research assistants, one at each side 
of the subject to hold him/her if necessary. The H2 exoskeleton device is 
designed with hardware and software safety features that minimize the risk of 
injury due to the use of the robot. A series of automatic motion stop features 
are implemented to limit movement to a set of safe boundaries. The 
exoskeleton cannot move outside of the normal range of motion of the 
individual user. There is some risk of minor injury due to rubbing while using 
the robot as wel as while entering or exiting the robot. There is also a risk of 
pressure sores where the exoskeleton is atached to the user. We wil assist 
the subjects in entering and exiting the robot and apply padding to the robot 
where necessary to prevent rubbing. Breaks wil be taken if subjects become 
tired. Dr. Venkatakrishnan wil constantly monitor participants for their 
comfort, fatigue levels. Subjects are also free to cal a break or end the 
experimental session for any reason without penalty. The risks of persons 
using H2 exoskeleton wil be mitigated by existing device safety features and 
standard procedures for device preparation and use. These include: 1) 
Ensuring corect alignment of the user's joint positions with the device centers 
of rotation by corect size adjustment of the device. These adjustments wil 
be caried out by lab personnel trained by Technaid S.L. and/or CSIC, the 
manufacturers of H2 exoskeleton. The device is prevented from exceeding 
the users normal physiological range of motion by the same extensive 
mechanical, electronic, and software safety features as apply to al uses of the 
device. 2) Able-bodied users might tend to try balancing more during device 
movements, which may be counter to what the device is trying to do, 
potentialy afecting stability. To minimize this risk, al users wil learn normal 
device movement paterns. Since healthy, able-bodied individuals wil not be 
using a walker, we wil have 2 spoters/research assistants to minimize risk of 
faling.
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18.02) Risk of Psychological Harm (including 
stress/discomfort) No:
18.03) Risk of Legal Actions (such as criminal 
prosecution or civil sanctions) No:
18.04) Risk of Harm to Social Status (such as loss 
of friendship) No:
18.05) Risk of Harm to Employment Status No:
18.06) Other Risks No:
19) Does the research involve any of these 
possible risks or harms to subjects? Check al that 
apply.
 
20) What benefits, if any, can the subject expect 
from their participation?
While able-bodied individuals wil not directly benefit from participation, their 
participation may help elucidate how the brain and body adapts to the use of 
an assistive device (H2 exoskeleton). In the case of individuals with stroke, 
we expect that they should have improved sensory-motor functions, and 
possibly improved independence in functional activities of daily living such as 
walking etc.
21) What inducements or rewards (e.g., financial 
compensation, extra credit, and other incentives), if 
any, wil be ofered to potential subjects for their 
participation?
Upon completion of each experimental session, subjects wil receive $20 
(either as cash or gift cards for departmental stores such as Target, Walmart 
etc.) as compensation for their time, for a total possible compensation of 
$320 for stroke participants (if 16 experimental sessions are completed) OR 
$100 for healthy participants (if 5 sessions are completed). Compensation 
wil be prorated based on the number of sessions completed if participants 
do not complete the entire study. Moreover, parking in one of the reserved 
parking spots in the Department of Electrical and Computer Engineering, wil 
be provided free of charge for sessions performed at the University of 
Houston campus. [Note: There is no compensation for the initial clinical 
evaluation for inclusion/exclusion criteria by Dr. Francisco and/or his 
appointed staf.]
Research Data for Application ID: 4838 
Question Answer
22) Wil you record any direct identifiers, names, 
social security numbers, addresses, telephone 
numbers, patient or student ID numbers, etc.? 
Yes: :During the initial telephone screening, the participant's name and 
telephone number wil be recorded on a cover sheet. This information wil be 
used to contact the participant for scheduling the study session. The cover 
sheets of participants who do not qualify for the study wil be immediately 
destroyed. A code number (i.e. 123) wil be assigned for each participant 
who qualifies for the study and their personal information wil be destroyed 
right after they finish the testing session.
23) Wil you retain a link between study code 
numbers and direct identifiers after the data 
colection is complete?
No:
24) Wil anyone outside the research team have 
access to the links or identifiers? No:
25) Where, how long, and in what format (such as 
paper, digital or electronic media, video, audio or 
photographic) wil data be kept? In addition, 
describe what security provisions wil be taken to 
Al data wil be stored on DVDs or secured hard drives for at least three 
years, and possibly as long as ten years after completion of the study. 
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protect these data (password protection, 
encryption, etc.). [Note: University of Houston 
policy on data retention requires that research data 
be maintained for a minimum of 3 years after 
completion of the project. Al research data 
colected during this project is subject to the 
University of Houston data retention policy found 
at htp:/www.research.uh.edu/Home/Division-of-
Research/Research-Services/Research-
Policies/Access-to-and-Retention-of-Research-
Data.aspx ]
Audio/video wil only be obtained if the participant provides his/her consent 
in the Informed Consent Form to use such video for presentation purposes (if 
approval is not given by the participant, no audio/video wil be recorded). If 
approved audio/video is recorded, the data wil be stored in DVDs and 
locked in the PI's or Co-I's ofice, and wil not contain identifiable data 
(W310 or E413, Engineering Bldg 2, UH). Al progress notes and functional 
assessment documents wil include the participant's coded name i.e., not 
contain identifiable information and wil be stored separately from consent 
forms (i.e., de-linked data).
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Appendix B
Consent Form
In the next pages is presented the consent form document that al participants signed
before enroling on the experiments. The consent form explicit al the rights of subjects
participating on the study. Al subjects taken part on this study did it voluntary and
they were alowed to refuse their participation at any time without any penalty or loss
of benefits to which they were otherwise entitled. Every e↵ort is made to maintain the
confidentiality of any subject’s participation. Al names are kept confidential and they
are replaced by a code number to appear on al written materials.
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 Page%1%of%7#####Subject#Initials: 
UNIVERSITY#OF#HOUSTON#
CONSENT#TO#PARTICIPATE#IN#RESEARCH#
%
PROJECT#TITLE:%HumanBmachine#system#for#the#H2#lower#limb#Exoskeleton#
%
You%are%being%invited%to%take%part%in%a%research%project%conducted%by%Professor%Jose%L.%Contreras=Vidal%
from%the%Department%of%Electrical%and%Computer%Engineering%at%the%University%of%Houston.%%
%
NONBPARTICIPATION#STATEMENT#
Taking%part%in%the%research%project%is%voluntary%and%you%may%refuse%to%take%part%or%withdraw%at%any%time%
without%penalty%or%loss%of%benefits%to%which%you%are%otherwise%entitled.%You%may%also%refuse%to%answer%
any%research=related%questions%that%make%you%uncomfortable.%
%
PURPOSE#OF#THE#STUDY#
This%research%study%wil%investigate%the%use%of%smart%lower%limb%robotic%exoskeleton%(H2)%in%rehabilitation%
after%stroke.%It%wil%also%examine%the%use%of%noninvasive%scalp%electroencephalography%(EEG)%to%learn%
specific%brain%wave%patterns%associated%with%learning%to%walk%on%the%powered%lower%limb%exoskeleton%
and%study%the%diferences%between%individuals%with%stroke%and%able=bodied%individuals.%
These%findings%wil%be%used%to%understand%human=robot%interaction%and%to%design%smart%orthotic%
devices%that%can%be%controled%by%thought%activity%and%assist%those%that%have%lost%al%or%part%of%their%
walking%abilities.%This%research%study%wil%last%for%approximately%1%year.%
If%you%are%an%individual%with%stroke,%you%may%be%invited%to%participate%in%training%sessions%with%
the%H2%exoskeleton%i.e.,%3%visits%per%week%for%4%weeks.%In%addition,%you%may%be%invited%for%4%additional%
sessions%for%other%tests%of%movement%before%and%after%training,%constituting%a%total%of%about%16%
sessions/visits%(including%the%training%sessions).%
If%you%are%an%able=bodied%individual,%then%you%wil%be%invited%to%participate%in%up%to%5%sessions%
over%4%weeks.%
%
PROCEDURES#
A%total%of%60%subjects%at%2%locations%(Laboratory%for%Non=invasive%Brain%Machine%Interface%systems,%
University%of%Houston%and%TIRR%Memorial%Hermann%Hospital)%wil%be%invited%to%take%part%in%this%project.%
You%wil%be%one%of%approximately%60%subjects%invited%to%take%part%in%this%study.%
If%you%are%an%individual%with%stroke,%and%have%passed%a%pre=screening%for%potential%eligibility%to%
participate%in%this%study,%you%wil%be%undergo%further%evaluations%for%eligibility%as%there%are%several%
medical%and%physical%inclusion%and%exclusion%criteria%that%must%be%met%before%enroling%in%this%study.%This%
screening%wil%be%performed%by%Gerard%Francisco,%M.D.%
%
Screening(Procedure:%Medical%screening%for%eligibility%to%participate%in%this%study%(for%individuals%with%
stroke%only)%wil%be%performed%to%ensure%you%meet%both%the%inclusion%and%exclusion%criteria%for%the%
study.%
Screening%outcome:%%%%%%%%%%%%Eligible%%%%%%Non%Eligible.%You%cannot%enrol%in%this%study.%
(To%be%filed%by%physician)%
%
Physician:%Gerard#Francisco,#M.D.%%%%%%%Signature%of%Physician:%_________________________%
%
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If%you%are%eligible%for%this%study,%you%wil%be%asked%to%perform%the%folowing%procedures%at%the%Laboratory%
for%Non=invasive%Brain=Machine%Interface%Systems,%room%E413,%Engineering%Building%I%at%the%University%
of%Houston%or%at%TIRR%Memorial%Hermann%Hospital.%
%
Procedure(1:(Baseline(Assessments(and(Preparation(
1. Your%weight%and%height%wil%be%recorded,%and%measurements%of%your%leg%length%wil%be%taken%for%
the%purpose%of%adjusting%the%H2%exoskeleton%to%best%align%with%your%body.%You%wil%have%the%
opportunity%to%see%the%exoskeleton%device%and%the%EEG%cap%before%signing%this%consent%form.%
2. If%you%are%an%individual%with%stroke,%you%wil%be%asked%to%perform%some%tasks%to%assess%your%leg%
functions%and%walking%etc.%This%wil%involve%simple%tasks%such%as%moving%your%leg%in%diferent%
positions,%walking%on%the%ground,%stepping%over%obstacles,%getting%up%from%a%chair%etc.%These%
tests%wil%be%performed%at%the%beginning%of%the%study,%and%then%again%2=3%times%after%the%4%week%
training%period.%
3. You%wil%also%be%asked%to%provide%information%about%your%medications.%If%you%are%an%individual%
with%stroke,%you%may%also%be%given%a%medication%diary%to%document%al%changes%in%type%and%
dosage%of%the%medication%you%have%been%using%throughout%the%duration%of%the%study.%This%wil%
alow%us%to%diferentiate%a%potential%efect%of%a%change%in%dosage%or%type%of%medication%on%
movement%recovery%while%training%with%the%H2%exoskeleton.%
4. Next,%your%head%size%wil%be%measured%with%a%measuring%tape%and%then%you%wil%have%your%head%
fitted%with%an%electroencephalographic%(EEG)%cap%(similar%to%a%swim%cap)%of%an%appropriate%size.%
This%wil%measure%non=invasively%the%activity%of%your%brain.%
5. Next,%additional%electromyographic%(EMG)%sensors%wil%be%attached%to%the%skin%on%your%legs%to%
measure%the%muscle%activity%of%your%legs%non=invasively.%This%wil%help%diferentiate%between%the%
work%done%by%your%muscles%in%comparison%to%the%robot%when%you%move%your%legs.%Similarly,%
goniometric%sensors%wil%be%attached%to%your%skin%to%record%the%amount%of%movement%in%your%leg%
joints%(joint%angles%of%hips,%knees,%ankles).%This%measurement%is%known%as%Goniometry.%
6. You%wil%then%be%fitted%with%the%H2,%powered%robotic%exoskeleton%in%a%seated%position%and%your%
ankle,%knees%and%hips%wil%be%supported%within%the%device%by%a%series%of%leg%braces,%straps%and%
harness.%The%fitting%procedure%entails%making%adjustments%to%the%device%to%ensure%it%fits%your%
body%shape%and%size,%i.e.,%that%your%lower%limb%joints%are%wel%aligned%with%the%H2's%articulations%
and%comfort%is%assured.%This%process%needs%to%be%completed%so%that%you%can%safely%wear%the%
device.%
(
Procedure(2:(Familiarization(with(the(H2(and(Training(
1. H2%Familiarization:%To%familiarize%you%with%the%H2%robotic%exoskeleton,%the%research%staf%
member%wil%use%a%personal%computer%or%mobile%phone%application%to%control%movement%of%the%
H2,%such%as%standing=up,%walking%forward,%and%turning%left%or%right,%stopping,%or%sitting%up.%
During%this%part%of%the%testing%session,%you%wil%have%an%opportunity%to%learn%and%feel%how%your%
body%moves%with%H2%exoskeleton.%You%wil%be%provided%with%a%walker%for%added%stability,%while%
moving%with%the%H2.%%
2. Training:%If%you%are%an%individual%with%stroke%who%is%participating%in%the%4%week%training%program,%
you%wil%be%fitted%with%the%EEG%cap%and%H2%exoskeleton%based%on%your%previous%measurements%at%
each%training%visit.%Then,%you%wil%perform%various%exercises/movements%as%part%of%the%training%
program,%similar%to%your%physical%therapy%sessions%(e.g.,%getting%up%from%a%chair,%squatting,%
walking%on%the%ground,%navigating%around%obstacles%while%walking,%stepping%on%a%stool%etc.).%%The%
training%wil%consist%of%3%sessions%per%week%for%2=3%hours%each,%for%4%weeks.%Your%total%time%
commitment%wil%be%up%to%36%hours%for%training.%Additionaly,%the%initial%clinical%evaluation%for%
Appendix B Consent Form 131
    
%
Page%3%of%7#####Subject#Initials:#%
%
inclusion/exclusion%to%participate%in%the%study%wil%take%an%additional%1/2%to%1%hour%and%
functional%assessments%wil%take%1=2%hours.%We%wil%accommodate%any%requests%for%participation%
before%or%after%normal%business%(9=5)%hours.%
%
If%you%are%an%able=bodied%individual,%then%you%wil%be%invited%for%up%to%5%sessions%over%4%weeks.%
You%wil%perform%various%exercises/movements,%which%wil%mimic%physical%therapy%treatments%
for%individuals%with%stroke%(e.g.,%getting%up%from%a%chair,%squatting,%walking%on%the%ground,%
navigating%around%obstacles%while%walking,%stepping%on%a%stool%etc.).%%Your%total%time%
commitment%wil%be%up%to%15%hours%(3%hours%per%session).%We%wil%accommodate%any%requests%
for%participation%before%or%after%normal%business%(9=5)%hours.%
%
CONFIDENTIALITY#
Every%efort%wil%be%made%to%maintain%the%confidentiality%of%your%participation%in%this%project.%Each%
subject’s%name%wil%be%paired%with%a%code%number%by%the%principal%investigator.%This%code%number%wil%
appear%on%al%written%materials.%The%list%pairing%the%subject’s%name%to%the%assigned%code%number%wil%be%
kept%separate%from%al%research%materials%and%wil%be%available%only%to%the%principal%investigator.%
Confidentiality%wil%be%maintained%within%legal%limits.%
%
RISKS/DISCOMFORTS#
The%procedures%described%above%are%widely%used%in%research%and%are%not%known%to%be%physicaly%harmful%
to%you.%There%are%no%known%long=term%efects%associated%with%the%tasks%or%events%experienced%during%
this%study.%The%procedures%of%this%study%involve%minimal%risk%and%are%noninvasive.%
EEG:%The%EEG%procedures%are%widely%used%in%research%and%are%not%known%to%be%physicaly%harmful.%There%
are%no%known%long=term%efects%associated%with%the%tasks%or%events%experienced%during%EEG%procedures.%
Subjects%may%experience%a%slight%discomfort%and%slight%sensations%and%skin%irritation%when%fitted%with%the%
EEG%cap.%
EMG%and%Goniometry:%The%EMG%and%Goniometry%system%are%not%known%to%be%physicaly%harmful.%They%
wil%only%require%attachment%of%sensors%with%adhesive%tape%on%your%skin,%which%may%cause%minor%skin%
irritations.%
Robotic%training%with%the%H2:%It%is%possible%that%you%may%show%fatigue%and/or%muscle%soreness%from%
walking%with%H2.%There%is%a%minimal%risk%of%faling%during%walking%with%H2.%To%minimize%this%risk,%you%wil%
be%provided%with%a%walker%to%use%while%walking%and%two%research%assistants%wil%always%be%by%your%side%
to%hold%you%if%necessary.%The%H2%device%is%designed%with%hardware%and%software%safety%features%that%
minimize%the%risk%of%injury%due%to%the%use%of%the%robot.%A%series%of%automatic%motion%stop%features%are%
implemented%to%limit%movement%to%a%set%of%safe%boundaries.%The%exoskeleton%cannot%move%outside%of%
the%normal%range%of%motion%of%the%individual%user.%There%is%some%risk%of%minor%injury%due%to%rubbing%
while%using%the%robot%as%wel%as%while%entering%or%exiting%the%robot.%There%is%also%a%risk%of%pressure%sores%
where%the%exoskeleton%is%attached%to%the%user.%We%wil%assist%you%in%entering%and%exiting%the%robotic%
exoskeleton%and%apply%padding%to%the%exoskeleton%where%necessary%to%prevent%rubbing.%Breaks%wil%be%
taken%if%and%when%you%become%tired.%You%are%also%free%to%cal%a%break%or%end%the%experimental%session%
for%any%reason%without%penalty.%
%
BENEFITS#
Your%ability%to%move%your%legs,%stand,%walk,%and/or%independence%in%functional%activities%of%daily%living%
may%improve%as%a%result%of%the%training%(if%you%are%an%individual%with%stroke),%but%this%is%not%certain,%and%
there%may%not%be%any%direct%benefit%to%you.%Nevertheless%even%if%you%wil%not%directly%benefit%from%
participation,%your%participation%may%help%investigators%better%understand%how%the%brain%and%body%
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%
adapts%to%the%use%of%an%assistive%device%(H2%exoskeleton).%Society%may%benefit%by%having%a%more%cost=
efective%way%to%provide%therapy.%
%
ALTERNATIVES#
Participation%in%this%project%is%voluntary%and%the%only%alternative%to%this%project%is%non=participation.%
%
INCENTIVES/REMUNERATION##
Upon%completion%of%each%experimental%session,%you%wil%receive%$20%as%compensation%for%your%time.%You%
are%free%to%withdraw%from%any%session%at%any%time%without%penalty%and%stil%be%compensated%with%$20%for%
that%session.%If%you%are%an%individual%with%stroke,%the%total%compensation%wil%depend%upon%the%number%
of%sessions%you%participate%in%and%could%be%a%maximum%of%$320%($20%per%session%x%16%visits).%If%you%are%an%
able=bodied%individual,%the%total%compensation%wil%depend%upon%the%number%of%sessions%you%participate%
in%and%could%be%a%maximum%of%$100%($20%per%session%x%5%visits).%Compensation%wil%be%provided%either%as%
cash% or% gift% cards% for% departmental% stores% (e.g.,% Target,% Walmart,% etc).%The% total% compensation% wil% be%
prorated%if%you%do%not%complete%the%entire%study.%Free%parking%wil%be%provided%in%one%of%two%parking%
spots%reserved%by%the%Department%of%Electrical%and%Computer%Engineering%for%sessions%conducted%at%the%
University%of%Houston.%
 
PUBLICATION#STATEMENT#
The%results%of%this%study%may%be%published%in%scientific%journals,%professional%publications,%or%educational%
presentations;%however,%no%individual%subject%wil%be%identified.%%
%
AGREEMENT#FOR#THE#USE#OF#AUDIO/VIDEO#TAPES#
If%you%consent%to%take%part%in%this%study,%please%indicate%whether%you%agree%to%be%audio/video%taped%
during%the%study%by%checking%the%appropriate%box%below.%If%you%agree,%please%also%indicate%whether%the%
audio/video%tapes%can%be%used%for%publication/presentations.%
%
I%agree%to%be%audio/video%taped%during%the%interview.%
I%agree%that%the%audio/%video%tape(s)%can%be%used%in%publication/presentations.%
I%do%not%agree%that%the%audio/%video%tape(s)%can%be%used%in%publication/presentations.%
I%do%not%agree%to%be%audio/video%taped%during%the%interview.%%
You%wil%stil%be%able%to%participate%in%the%study%even%if%you%refuse%to%be%audio/video%taped.%
%
YOUR#HEALTH#INFORMATION#
We%may%be%colecting%health%information%that%could%be%linked%to%you%(protected%health%information).%This%
protected%health%information%might%have%your%name,%address,%social%security%number%or%something%else%
that%identifies%you%attached%to%it.%Federal%law%wants%us%to%get%your%permission%to%use%your%protected%
health%information%for%this%study.%Your%signature%on%this%form%means%that%you%give%us%permission%to%use%
your%protected%health%information%for%this%research%study.%
%
For%this%research%study%we%wil%be%accessing%your%TIRR%Memorial%Hermann/University%of%Texas%Health%
Center%medical%record%and%colecting%portions%of%this%data%to%include%information%about%the%brain%injury%
you%experienced%at%the%time%of%stroke.%We%wil%also%review%your%medication%records%to%make%sure%they%
don't%interfere%with%your%involvement%in%this%research%study.%Also,%we%would%like%to%access%your%MRI%
brain%scans%for%data%analysis%if%available,%please%check%the%box%below%if%you%authorize%us%to%do%so:%
%%%%I%consent%and%approve%the%release%of%my%most%recent%structural%MRI%scans%(if%any)%for%this%study.%
%
%
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%
This%authorization%to%release%your%protected%health%information%is%valid%until%you%finish%your%participation%
in%this%study.%The%period%of%your%participation%in%this%research%study%is%expected%to%be%less%than%three%
months.%We%wil%not%access%your%protected%health%information%after%you%complete%the%study.%Once%the%
study%is%completed%and%there%is%no%longer%a%need%for%your%identifiable%information,%it%wil%be%destroyed.%
%
If%you%decide%to%take%part%in%the%study,%your%protected%health%information%wil%not%be%given%out%except%as%
alowed%by%law%or%as%described%in%this%form.%Everyone%working%with%your%protected%health%information%
wil%work%to%keep%this%information%private.%The%results%of%the%data%from%the%study%may%be%published.%
However,%you%wil%not%be%identified%by%name.%People%who%give%medical%care%and%ensure%quality%from%the%
institutions%where%the%research%is%being%done,%the%sponsor(s)%listed%in%the%sections%above,%
representatives%of%the%sponsor,%and%regulatory%agencies%such%as%the%U.S.%Department%of%Health%and%
Human%Services%wil%be%alowed%to%look%at%sections%of%your%medical%and%research%records%related%to%this%
study.%Because%of%the%need%for%the%investigator%and%study%staf%to%release%information%to%these%parties,%
complete%privacy%cannot%be%guaranteed.%The%people%listed%above%wil%be%able%to%access%your%information%
for%as%long%as%they%need%to,%even%after%the%study%is%completed.%
%
If%you%decide%to%stop%taking%part%in%the%study%or%if%you%are%removed%from%the%study,%you%may%decide%that%
you%no%longer%alow%protected%health%information%that%identifies%you%to%be%used%in%this%research%study.%
Contact%the%study%staf%to%tel%them%of%this%decision,%and%they%wil%give%you%an%address%so%that%you%can%
inform%the%investigator%in%writing.%The%investigator%wil%honor%your%decision%unless%not%being%able%to%use%
your%identifiable%health%information%would%afect%the%safety%or%quality%of%the%research%study.%
%
Your%signature%below%indicates%that%you%have%read%the%above%and%authorize%the%staf%of%TIRR%Memorial%
Hermann/University%of%Texas%Health%Center%medical%record%to%disclose%such%information%referenced%
above.%You%have%the%right%to%withdraw%this%authorization%in%writing%at%any%time,%except%to%the%extent%that%
action%has%been%taken%during%the%period%of%authorization.%You%have%also%been%informed%that%when%this%
information%is%used%or%disclosed%in%accordance%with%this%authorization,%it%may%be%subject%to%re=disclosure%
by%the%researcher%and%may%no%longer%be%protected.%
%
The%Principal%investigator,%Prof.%Jose%L.%Contreras=Vidal,%or%Co=Investigator,%Dr.%Anusha%Venkatakrishnan%
wil%try%to%answer%al%of%your%questions.%If%you%have%questions%or%concerns%at%any%time,%or%if%you%need%to%
report%an%injury%related%to%the%research,%you%may%speak%with%a%member%of%the%study%staf.%If%you%have%
questions%or%concerns%at%any%time,%or%if%you%need%to%report%an%injury%related%to%the%research,%you%may%
speak%with%a%member%of%the%study%staf:%Dr.#Jose#L.#ContrerasBVidal;%email:%jlcontreras=vidal@uh.edu;%
phone%number:%713=743=4429%or%Dr.#Anusha#Venkatakrishnan;%email:%avenkatakrishnan@uh.edu;%
phone%number:%713=743=0796.%
%
Members%of%the%Institutional%Review%Board%for%University%at%Houston%can%also%answer%your%questions%
and%concerns%about%your%rights%as%a%research%subject.%The%IRB%ofice%number%is%713=743=9204.%Cal%the%
IRB%ofice%if%you%would%like%to%speak%to%a%person%independent%of%the%investigator%and%research%staf%for%
complaints%about%the%research,%if%you%cannot%reach%the%research%staf,%or%if%you%wish%to%talk%to%someone%
other%than%the%research%staf.%
#
CIRCUMSTANCES#FOR#DISMISSAL#FROM#PROJECT##
Your%participation%in%this%project%may%be%terminated%by%the%principal%investigator:%
• if%the%principal%investigator%determines%that%staying%in%the%project%is%harmful%to%your%health%or%is%
not%in%your%best%interest%%
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%
%
PARTICIPANT#RIGHTS#
%
1. I%understand%that%informed%consent%is%required%of%al%persons%participating%in%this%project.%
%
2. I%have%been%told%that%I%may%refuse%to%participate%or%to%stop%my%participation%in%this%project%at%any%
time%before%or%during%the%project.%I%may%also%refuse%to%answer%any%question.%
%
3. Any%risks%and/or%discomforts%have%been%explained%to%me,%as%have%any%potential%benefits.%
%
4. I%understand%the%protections%in%place%to%safeguard%any%personaly%identifiable%information%related%to%
my%participation.%
%
5. I%understand%that,%if%I%have%any%questions,%I%may%contact%Professor#Jose#L.#ContrerasBVidal%at%713B
743B4429#or#Dr.#Anusha#Venkatakrishnan#at#713B743B0796.%I%may%also%contact%Dr.#Gerard#
Francisco,%at%713B797B5282.%
%
6. Any#questions#regarding#my#rights#as#a#research#subject#may#be#addressed#to#the#University#of#
Houston#Committee#for#the#Protection#of#Human#Subjects#(713B743B9204).#Al#research#projects#
that#are#carried#out#by#Investigators#at#the#University#of#Houston#are#governed#be#requirements#of#
the#University#and#the#federal#government.#
%
SIGNATURES#
#
I"have"read"(or"have"had"read"to"me)"the"contents"of"this"consent"form"and"have"been"encouraged"to"
ask"questions."I"have"received"answers"to"my"questions"to"my"satisfaction."I"give"my"consent"to"
participate"in"this"study,"and"have"been"provided"with"a"copy"of"this"form"for"my"records"and"in"case"I"
have"questions"as"the"research"progresses.(
%
Study%Participant%(print%name):%___________________________________________________________%
%
Signature%of%Study%Participant:%____________________________________________________________%
%
Date:%________________________________________________________________________________%
%
===========================================================%
%
I"have"read"this"form"to"the"subject"and/or"the"subject"has"read"this"form."An"explanation"of"the"
research"was"provided"and"questions"from"the"subject"were"solicited"and"answered"to"the"subject’s"
satisfaction."In"my"judgment,"the"subject"has"demonstrated"comprehension"of"the"information.(
%
Principal%Investigator/Co=Investigator:%______________________________________________________%
(Print%name%and%title)%
%
Signature%of%Principal%Investigator/Co=Investigator:%___________________________________________%
%
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